10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended	September 29, 2023

Or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to ______

Commission File Number: 001-35419

KAMAN CORPORATION

(Exact name of registrant as specified in its charter)

Connecticut	06-0613548
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

1332 Blue Hills Avenue,	Bloomfield,	Connecticut	06002
(Address of principal executive offices)			(Zip Code)

(860)	243-7100
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock ($1 par value)	KAMN	New York Stock Exchange LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐	Non-accelerated filer	☐
		Smaller reporting company	☐	Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ☐ No ☒

At October 27, 2023, there were 28,256,389  shares of Common Stock outstanding.

PART I

Item 1. Financial Statements

CONDENSED CONSOLIDATED BALANCE SHEETS

KAMAN CORPORATION AND SUBSIDIARIES

(In thousands, except share and per share amounts) (Unaudited)

	September 29, 2023		December 31, 2022
Assets
Current assets:
Cash and cash equivalents	$	30,065	$	24,154
Accounts receivable, net	106,647		87,659
Contract assets	100,709		113,182
Inventories	201,439		172,383
Income tax refunds receivable	4,680		14,843
Other current assets	21,063		16,114
Total current assets	464,603		428,335
Property, plant and equipment, net of accumulated depreciation of $283,272 and $268,089, respectively	203,704		201,606
Operating right-of-use assets, net	6,325		7,391
Goodwill	380,243		379,854
Other intangible assets, net	352,208		372,331
Deferred income taxes	45,878		47,385
Other assets	54,831		51,207
Total assets	$	1,507,792	$	1,488,109
Liabilities and Shareholders’ Equity
Current liabilities:
Current portion of long-term debt, net of debt issuance costs	$	198,854	$	—
Accounts payable – trade	45,890		48,277
Accrued salaries and wages	31,027		31,395
Contract liabilities, current portion	7,884		4,081
Operating lease liabilities, current portion	3,110		3,332
Income taxes payable	2,214		393
Other current liabilities	45,540		39,097
Total current liabilities	334,519		126,575
Long-term debt, excluding current portion, net of debt issuance costs	382,000		561,061
Deferred income taxes	6,490		6,079
Underfunded pension	49,813		52,309
Contract liabilities, noncurrent portion	19,653		20,515
Operating lease liabilities, noncurrent portion	3,452		4,534
Other long-term liabilities	32,570		36,280
Commitments and contingencies (Note 14)
Shareholders' equity:
Preferred stock, $1 par value, 200,000 shares authorized; none outstanding	—		—
Common stock, $1 par value, 50,000,000 shares authorized; voting; 30,910,177 and 30,640,068 shares issued, respectively	30,910		30,640
Additional paid-in capital	251,843		245,436
Retained earnings	674,271		685,234
Accumulated other comprehensive income (loss)	(154,794)		(158,421)
Less 2,663,437 and 2,607,841 shares of common stock, respectively, held in treasury, at cost	(122,935)		(122,133)
Total shareholders’ equity	679,295		680,756
Total liabilities and shareholders’ equity	$	1,507,792	$	1,488,109

See accompanying notes to condensed consolidated financial statements.

2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

KAMAN CORPORATION AND SUBSIDIARIES

(In thousands, except per share amounts) (Unaudited)

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
Net sales	$	183,031	$	172,004	$	572,731	$	490,818
Cost of sales	117,977		117,326		368,246		334,008
Program inventory impairment (Note 10)	417		—		1,013		—
Gross profit	64,637		54,678		203,472		156,810
Selling, general and administrative expenses	42,501		49,009		127,765		127,980
Research and development costs	4,022		3,937		15,122		14,265
Intangible asset amortization expense	5,593		3,118		19,937		8,024
Restructuring and severance costs	571		(243)		3,033		2,853
Gain on sale of business	—		(457)		—		(457)
Net loss on disposition of assets	78		15		496		71
Operating income (loss)	11,872		(701)		37,119		4,074
Interest expense, net	9,405		3,614		29,349		8,088
Non-service pension and post-retirement benefit income	(310)		(5,142)		(930)		(15,429)
Other expense, net	849		1,221		377		2,415
Earnings (loss) before income taxes	1,928		(394)		8,323		9,000
Income tax expense (benefit)	462		(114)		2,371		1,631
Net earnings (loss)	$	1,466	$	(280)	$	5,952	$	7,369
Earnings per share:
Basic earnings (loss) per share	$	0.05	$	(0.01)	$	0.21	$	0.26
Diluted earnings (loss) per share	$	0.05	$	(0.01)	$	0.21	$	0.26
Average shares outstanding:
Basic	28,247		28,037		28,189		27,997
Diluted	28,350		28,037		28,324		28,076

See accompanying notes to condensed consolidated financial statements.

3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

KAMAN CORPORATION AND SUBSIDIARIES

(In thousands) (Unaudited)

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
Net earnings (loss)	$	1,466	$	(280)	$	5,952	$	7,369
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(5,766)		(9,875)		(2,297)		(25,347)
Change in pension and post-retirement benefit plan liabilities, net of tax expense of $445 and $259 and $1,336 and $756, respectively	1,478		821		4,434		2,483
(Loss) gain on derivative instruments, net of tax (benefit) expense of $(13) and $0 and $449 and $0, respectively	(42)		—		1,490		(7)
Other comprehensive (loss) income	(4,330)		(9,054)		3,627		(22,871)
Comprehensive (loss) income	$	(2,864)	$	(9,334)	$	9,579	$	(15,502)

See accompanying notes to condensed consolidated financial statements.

4

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

KAMAN CORPORATION AND SUBSIDIARIES

(In thousands) (Unaudited)

	For the Nine Months Ended
	September 29, 2023		September 30, 2022
Cash flows from operating activities:
Net earnings	5,952		7,369
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization	38,244		27,037
Amortization of debt issuance costs	2,985		1,882
Provision for doubtful accounts	1,495		619
Gain on sale of business	—		(457)
Net loss on disposition of assets	496		71
Program inventory impairment	1,013		—
Net loss on derivative instruments	620		2,670
Stock compensation expense	5,190		6,145
Non-cash consideration received for blade exchange	(1,309)		(827)
Deferred income taxes	212		1,600
Changes in assets and liabilities, excluding effects of acquisitions/divestitures:
Accounts receivable	(20,736)		(23,640)
Contract assets	12,467		(5,405)
Inventories	(30,952)		(19,478)
Income tax refunds receivable	10,158		(2,401)
Operating right of use assets	1,052		3,347
Other assets	(3,802)		(3,230)
Accounts payable - trade	(2,423)		(8,780)
Contract liabilities	2,951		4,246
Operating lease liabilities	(1,290)		(3,296)
Other current liabilities	5,057		(4,591)
Income taxes payable	1,867		(227)
Pension liabilities	3,005		(13,309)
Other long-term liabilities	(2,579)		(3,045)
Net cash provided by (used in) operating activities	29,673		(33,700)
Cash flows from investing activities:
Expenditures for property, plant & equipment	(19,864)		(17,626)
Investment in Near Earth Autonomy	—		(10,000)
Acquisition of businesses	(1,487)		(441,340)
Other, net	(708)		2,438
Net cash used in investing activities	(22,059)		(466,528)
Cash flows from financing activities:
Net borrowings under revolving credit agreement	19,000		412,000
Purchase of treasury shares	(780)		(762)
Dividends paid	(16,871)		(16,760)
Debt issuance costs	(4,833)		(4,285)
Other, net	1,903		1,725
Net cash (used in) provided by financing activities	(1,581)		391,918
Net increase (decrease) in cash and cash equivalents	6,033		(108,310)
Effect of exchange rate changes on cash and cash equivalents	(122)		(1,132)
Cash and cash equivalents at beginning of period	24,154		140,800
Cash and cash equivalents at end of period	$	30,065	$	31,358

See accompanying notes to condensed consolidated financial statements.

5

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

1. BASIS OF PRESENTATION

In the opinion of management, the condensed consolidated financial information reflects all adjustments necessary for a fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented, but do not include all disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). All such adjustments are of a normal recurring nature, unless otherwise disclosed in this report. Certain amounts in prior year financial statements and notes thereto have been reclassified to conform to current year presentation. The condensed consolidated financial statements for the period ended September 29, 2023 should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

The Company has a calendar year-end; however, its first three fiscal quarters follow a 13-week convention, with each quarter ending on a Friday. The third quarters for 2023 and 2022 ended on September 29, 2023, and September 30, 2022, respectively.

2. ACCOUNTING CHANGES

Revision of Previously Issued Consolidated Financial Statements

During the three-month fiscal period ended June 30, 2023, the Company identified errors related to (1) the accounting for certain labor costs at one business in the Precision Products segment and (2) the net realizable value on certain portions of the Company's inventory at another business in the Structures segment, each resulting in an overstatement of inventory and an understatement of cost of sales and related tax impacts. The Company concluded that these errors were not material, either individually or in aggregate, to previously issued consolidated financial statements; however, the Company has determined it was appropriate to revise its previously issued consolidated financial statements as of December 31, 2022, and for the years ended December 31, 2022 and 2021 and its unaudited condensed consolidated financial statements as of and for the quarters and year-to-date fiscal periods ended July 1, 2022, September 30, 2022 and March 31, 2023. Accordingly, the accompanying financial statements and relevant footnotes to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q have been revised to correct for these errors. The Company will present the revision of its previously issued consolidated financial statements for the years ended December 31, 2022 and 2021 in connection with the future filing of its Annual Report on Form 10-K for the year ended December 31, 2023. Additionally, the Company will present the revision of its previously issued unaudited condensed consolidated financial statements for the quarter ended March 31, 2023 with the future filing of its Quarterly Report on Form 10-Q for the quarter ending March 29, 2024.

The revision to the accompanying unaudited condensed consolidated balance sheet, condensed consolidated statements of operations, condensed consolidated statements of comprehensive income and condensed consolidated statement of cash flows are as follows. There were no changes to the consolidated statement of stockholders' equity that have not otherwise been reflected in the condensed consolidated balance sheets, condensed consolidated statements of operations, and condensed consolidated statements of comprehensive income as detailed in the tables below.

Condensed Consolidated Balance Sheet
In thousands
	December 31, 2022
	As Previously Reported		Adjustments		As Corrected
Assets
Inventories(1)	$	176,468	$	(4,085)	$	172,383
Income tax refunds receivable	13,981		862		14,843
Total	$	190,449	$	(3,223)	$	187,226
Shareholders' equity
Retained earnings	$	688,457	$	(3,223)	$	685,234

(1) At December 31, 2022, the adjustments to inventories consisted of an adjustment of $2.5 million for certain labor costs at a business within the Precision Products segment and an adjustment of $1.6 million for the net realizable value on certain portions of the inventory at a business within the Structures segment.

6

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

2. ACCOUNTING CHANGES (CONTINUED)

Revision of Previously Issued Consolidated Financial Statements - continued

Condensed Consolidated Statements of Operations
In thousands, except per share amounts
	For the Three Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Cost of sales	$	116,179	$	1,147	$	117,326
Income tax expense	128		(242)		(114)
Net earnings	625		(905)		(280)
Basic earnings per share	$	0.02	$	(0.03)	$	(0.01)
Diluted earnings per share	$	0.02	$	(0.03)	$	(0.01)
	For the Nine Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Cost of sales	$	332,299	$	1,709	$	334,008
Income tax expense	1,992		(361)		1,631
Net earnings	8,717		(1,348)		7,369
Basic earnings per share	$	0.31	$	(0.05)	$	0.26
Diluted earnings per share	$	0.31	$	(0.05)	$	0.26

Condensed Consolidated Statements of Comprehensive Income (Loss)
In thousands
	For the Three Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Comprehensive (loss) income	$	(8,429)	$	(905)	$	(9,334)
	For the Nine Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Comprehensive (loss) income	$	(14,154)	$	(1,348)	$	(15,502)

Condensed Consolidated Statement of Cash Flows
In thousands
	For the Nine Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Net earnings	$	8,717	$	(1,348)	$	7,369
Inventories	(21,187)		1,709		(19,478)
Income tax refunds receivable	(2,040)		(361)		(2,401)
Net cash used in operating activities	(33,700)		—		(33,700)

7

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

3. BUSINESS COMBINATIONS AND INVESTMENTS

Aircraft Wheel & Brake

On September 16, 2022, the Company acquired all of the assets and related liabilities of Parker-Hannifin Corporation's ("Parker") Aircraft Wheel and Brake division, of Avon, Ohio, at a purchase price of $442.8 million. Aircraft Wheel and Brake is a leader in the design, development, qualification, manufacturing and assembly, product support and repair of wheels, brakes and related hydraulic components for fixed-wing aircraft and rotorcraft. With this acquisition, the Company has expanded its portfolio of engineered products, broadening the number of offerings available to serve customers across a range of critical applications and has increased the Company's exposure within the aerospace and defense end markets.

This acquisition was accounted for under the acquisition method. The assets acquired and liabilities assumed were recorded based on their fair values at the date of acquisition as follows (in thousands):

Accounts receivable	$	7,635
Contract assets	171
Inventories	11,246
Property, plant and equipment	7,686
Goodwill	171,277
Other intangible assets(1)	250,500
Contract costs, noncurrent	41
Liabilities	(5,729)
Net assets acquired	442,827
Less cash received	—
Net consideration	$	442,827

(1)Refer to Note 3, Business Combinations and Investments, in the Annual Report on Form 10-K for the year ended December 31, 2022 for information on the Company's determination of the fair value of identifiable intangible assets.

During the first quarter of 2023, the Company paid Parker an additional $1.5 million for the working capital adjustment, which resulted in an increase to goodwill. All purchase price allocations were finalized within the one-year measurement period and no further adjustments are expected.

The goodwill associated with this acquisition is tax deductible and is the result of expected synergies from combining the operations of the acquired business with the Company's operations and intangible assets that do not qualify for separate recognition, such as an assembled workforce. The goodwill associated with this acquisition was recognized in the Engineered Products segment.

Pro Forma Information (Unaudited)

Aircraft Wheel and Brake's results of operations have been included in the Company's financial statements for the period subsequent to the completion of the acquisition on September 16, 2022. In the three-month and nine-month fiscal periods ended September 29, 2023, Aircraft Wheel and Brake contributed $16.9 million and $56.6 million of revenue, respectively, and $1.9 million and $5.8 million of operating income, respectively. Aircraft Wheel and Brake contributed $2.7 million of revenue and $1.1 million of operating loss for both the three-month and nine-month fiscal periods ended September 30, 2022.

The following table reflects the pro forma operating results of the Company for the three-month and nine-month fiscal periods

ended September 30, 2022 which gives effect to the Acquisition as if the company had been acquired on January 1, 2021. The pro forma results are based on assumptions that the Company believes are reasonable under the circumstances. The pro forma results are not necessarily indicative of the operating results that would have occurred had this acquisition been effective January 1, 2021, nor are they intended to be indicative of results that may occur in the future. The underlying pro forma information includes the historical financial results of the Company and the acquired business adjusted for certain items discussed below. The pro forma information does not include the effects of any synergies, cost reduction initiatives or anticipated integration costs related to the acquisition.

8

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

3. BUSINESS COMBINATIONS AND INVESTMENTS (CONTINUED)

Aircraft Wheel & Brake - continued

Pro Forma Information (Unaudited) - continued

	For the Three Months Ended	For the Nine Months Ended
	September 30, 2022	September 30, 2022
In thousands
Net sales	188,554	543,817
Net earnings	8,949	17,035

These pro forma results include adjustments such as inventory step-up, amortization of acquired intangible assets, depreciation of acquired plant, property, and equipment and interest expense on debt financing in connection with this acquisition. Material pro forma adjustments directly attributable to this acquisition for the three-month and nine-month fiscal period ended September 30, 2022 include:

•Increases in depreciation of $0.1 million and $0.5 million relating to fixed assets acquired;

•Increases in amortization of $1.8 million and $7.9 million relating to intangible assets acquired;

•Decreases in selling, general and administrative costs of $10.1 million and $12.1 million relating to transaction costs for this acquisition;

•Increases in interest expense of $3.4 million and $11.4 million relating to debt financing in connection with this acquisition; and

•Increase in income tax expense of $1.0 million for the three-month fiscal period and decrease in income tax expense of $1.6 million for the nine-month fiscal period relating to the above adjustments.

4. REVENUE AND SEGMENT INFORMATION

The Company is organized based upon the nature of its products and services, and is composed of three operating segments, each overseen by a segment manager. These segments are reflective of how the Company’s Chief Executive Officer, who is its Chief Operating Decision Maker ("CODM"), reviews operating results for the purposes of allocating resources and assessing performance. The Company has not aggregated operating segments for purposes of identifying reportable segments.

The Engineered Products segment serves the aerospace and defense, industrial and medical markets providing sophisticated proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; and wheels, brakes and related hydraulic components for helicopters and fixed-wing and unmanned aerial vehicle ("UAV") aircraft.

The Precision Products segment serves the aerospace and defense markets providing precision safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of the Company's SH-2G Super Seasprite maritime helicopters; support of the heavy lift K-MAX® manned helicopter; and development of the KARGO UAV unmanned aerial system, a purpose built autonomous medium lift logistics vehicle.

The Structures segment serves the aerospace and defense and medical end markets providing sophisticated complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft, and medical imaging solutions.

9

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

4. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Summarized financial information by business segment is as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Net sales:
Engineered Products	$	123,598	$	92,052	$	380,437	$	263,269
Precision Products	27,098		46,282		93,128		135,098
Structures	32,335		33,670		99,166		92,451
Net sales	$	183,031	$	172,004	$	572,731	$	490,818
Operating income (loss):
Engineered Products	$	29,026	$	14,156	$	78,924	$	40,665
Precision Products	(3,241)		5,296		(3,996)		10,725
Structures	(3,020)		(642)		(3,769)		(2,121)
Corporate expense	(9,828)		(20,196)		(29,499)		(42,728)
Other unallocated (expenses) income, net(1)	(1,065)		685		(4,541)		(2,467)
Operating income (loss)	$	11,872	$	(701)	$	37,119	$	4,074
Interest expense, net	9,405		3,614		29,349		8,088
Non-service pension and post-retirement benefit income, net	(310)		(5,142)		(930)		(15,429)
Other expense, net	849		1,221		377		2,415
Earnings (loss) before income taxes	$	1,928	$	(394)	$	8,323	$	9,000

(1) Other unallocated expenses, net include program inventory impairment, restructuring and severance costs and net loss on disposition of assets.

10

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

4. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Disaggregation of Revenue

The following tables disaggregate segment revenue by major product line:

	For the Three Months Ended
	September 29, 2023
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	18,859	$	7,541	$	17,324	$	43,724
Safe and Arm Devices	—		12,890		—		12,890
Commercial, Business & General Aviation	61,550		5,459		13,374		80,383
Medical	23,005		—		1,637		24,642
Industrial & Other	20,184		1,208		—		21,392
Total revenue	$	123,598	$	27,098	$	32,335	$	183,031
	For the Three Months Ended
	September 30, 2022
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	13,356	$	5,171	$	20,805	$	39,332
Safe and Arm Devices	—		37,460		—		37,460
Commercial, Business & General Aviation	39,852		2,457		11,006		53,315
Medical	21,782		—		1,859		23,641
Industrial & Other	17,062		1,194		—		18,256
Total revenue	$	92,052	$	46,282	$	33,670	$	172,004

	For the Nine Months Ended
	September 29, 2023
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	57,362	$	20,502	$	55,461	$	133,325
Safe and Arm Devices	—		49,486		—		49,486
Commercial, Business & General Aviation	190,471		19,548		38,232		248,251
Medical	73,463		—		5,473		78,936
Industrial & Other	59,141		3,592		—		62,733
Total revenue	$	380,437	$	93,128	$	99,166	$	572,731
	For the Nine Months Ended
	September 30, 2022
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	32,351	$	17,122	$	53,158	$	102,631
Safe and Arm Devices	—		96,345		—		96,345
Commercial, Business & General Aviation	109,874		18,119		33,138		161,131
Medical	65,614		—		6,155		71,769
Industrial & Other	55,430		3,512		—		58,942
Total revenue	$	263,269	$	135,098	$	92,451	$	490,818

11

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

4. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Disaggregation of Revenue - continued

The following table disaggregates total revenue by product types.

	For the Three Months Ended								For the Three Months Ended
	September 29, 2023								September 30, 2022
	Engineered Products		Precision Products		Structures		Total		Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	47	%	3	%	18	%	68	%	40	%	2	%	19	%	61	%
Aftermarket	20	%	5	%	—	%	25	%	14	%	3	%	—	%	17	%
Safe and Arm Devices	—	%	7	%	—	%	7	%	—	%	22	%	—	%	22	%
Total revenue	67	%	15	%	18	%	100	%	54	%	27	%	19	%	100	%
	For the Nine Months Ended								For the Nine Months Ended
	September 29, 2023								September 30, 2022
	Engineered Products		Precision Products		Structures		Total		Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	47	%	3	%	17	%	67	%	41	%	4	%	19	%	64	%
Aftermarket	20	%	4	%	—	%	24	%	12	%	4	%	—	%	16	%
Safe and Arm Devices	—	%	9	%	—	%	9	%	—	%	20	%	—	%	20	%
Total revenue	67	%	16	%	17	%	100	%	53	%	28	%	19	%	100	%

Disaggregation of Research and Development Costs

The following table presents research and development costs by segment:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Engineered Products	$	1,620	$	2,106	$	6,738	$	6,470
Precision Products	2,387		1,812		8,308		7,599
Structures	15		19		76		196
Total research and development costs	$	4,022	$	3,937	$	15,122	$	14,265

12

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

4. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Other

For contracts in which revenue is recognized over time, the Company performs detailed quarterly reviews of the progress and execution of its performance obligations under these contracts. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities and the related changes in estimates of revenues and costs. The risks and opportunities include management's judgment about the ability and cost to achieve the schedule (e.g., the number and type of milestone events), technical requirements (e.g., a newly-developed product versus a mature product) and other contract requirements. Management must make assumptions and estimates regarding labor productivity and availability, the complexity of the work to be performed, the availability of materials, the length of time to complete the performance obligation (e.g., to estimate increases in wages and prices for materials and related support cost allocations), execution by subcontractors, the availability and timing of funding from customers and overhead cost rates, among other variables. Based upon these reviews, the Company will record the effects of adjustments in profit estimates each period. If at any time management determines that in the case of a particular contract total costs will exceed total contract revenue, a provision for the entire anticipated contract loss is recorded at that time.

Net changes in revenue associated with cost growth on the Company's over time contracts were as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Net change in revenue due to change in profit estimates	$	(3,123)	$	(892)	$	(5,987)	$	580

In the three-month and nine-month fiscal periods ended September 29, 2023, the net decreases in revenue were primarily related to cost growth on certain structures and precision products contracts. In the nine-month fiscal period, this decrease was partially offset by favorable cost performance on the joint programmable fuze ("JPF") contract with the U.S. Government ("USG").

In the three-month fiscal period ended September 30, 2022, the net decrease in revenue was primarily related to cost growth on certain structures programs and legacy fuzing contracts, partially offset by favorable cost performance on memory and measuring programs. In the nine-month fiscal period ended September 30, 2022, the net increase in revenue was primarily related to favorable cost performance on the JPF contract with the USG, partially offset by cost growth on certain structures programs and legacy fuzing contracts.

Unfulfilled Performance Obligations

Unfulfilled performance obligations ("backlog") represents the transaction price of firm orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts. Backlog at September 29, 2023 and December 31, 2022, and the portion of backlog the Company expects to recognize revenue on over the next twelve months is as follows:

	September 29, 2023(1)		December 31, 2022
	(in thousands)
Engineered Products	$	363,228	$	322,452
Precision Products	100,712		134,903
Structures	254,633		263,581
Total Backlog	$	718,573	$	720,936

(1) The Company expects to recognize revenue on approximately 69% of backlog as of September 29, 2023 over the next twelve months.

13

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

5. RESTRUCTURING AND SEVERANCE COSTS

Restructuring and severance costs are included in restructuring and severance costs on the Company's Condensed Consolidated Statements of Operations and other unallocated expenses, net in Note 4, Revenue and Segment Information.

Transformation Restructuring

In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improve working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result of this review, the Company identified areas to reduce annualized costs in the Precision Products segment and at Corporate through streamlining processes, consolidating the production of fuzes for the JPF program at its Middletown facility, discontinuing K-MAX® helicopter production and right-sizing the Company's total cost structure. In the three-month and nine-month fiscal periods ended September 29, 2023, the Company incurred $0.6 million and $3.0 million, respectively, in severance costs associated with these actions. Of this amount, $0.3 million was related to share-based compensation expense in the nine-month fiscal period ended September 29, 2023. No share-based compensation expense was recorded to restructuring and severance costs in the three-month fiscal period ended September 29, 2023.

The following table summarizes the accrual balances by cost type for the restructuring actions:

	Severance		Other(1)		Total
In thousands
Restructuring accrual balance at December 31, 2022(2)	$	6,629	$	—	$	6,629
Provision	2,147		625		2,772
Cash payments	(5,767)		(625)		(6,392)
Changes in foreign currency exchange rates	(2)		—		(2)
Restructuring accrual balance at September 29, 2023	$	3,007	$	—	$	3,007

(1) Includes costs associated with the consolidation of facilities.

(2) Of the above accrual balance, $1.0 million was included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets as of December 31, 2022. The remainder was included in other current liabilities.

Other Matters

The Company identified workforce reductions and other reductions in certain general and administrative expenses, which resulted in $1.9 million in restructuring and severance costs in the nine-month fiscal period ended September 30, 2022. In conjunction with the sale of the Company's Mexico operations in the third quarter of 2022, the Company reversed severance costs previously accrued, which were partially offset by costs incurred in the period. This resulted in a net reduction to restructuring and severance costs of $0.2 million for the three-month fiscal period ended September 30, 2022.

In addition to the restructuring and severance costs discussed above, in the nine-month fiscal period ended September 30, 2022, the Company incurred $1.0 million in other severance expense.

14

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

6. ACCOUNTS RECEIVABLE, NET

Accounts receivable, net consisted of the following:

	September 29, 2023		December 31, 2022
In thousands
Trade receivables	$	42,931	$	31,126
U.S. Government contracts:
Billed	16,333		14,150
Cost and accrued profit - not billed	2,460		661
Commercial and other government contracts
Billed	46,751		41,520
Cost and accrued profit - not billed	1,069		2,268
Less allowance for doubtful accounts	(2,897)		(2,066)
Accounts receivable, net	$	106,647	$	87,659

The Company performs ongoing evaluations of its customers’ current creditworthiness, as determined by the review of their credit information, to determine if events have occurred subsequent to the recognition of revenue and the related receivable that provide evidence that such receivable will be realized in an amount less than that recognized at the time of sale. Estimates of credit losses are based on historical losses, current economic conditions, geographic considerations, and in some cases, evaluating specific customer accounts for risk of loss.

The following table summarizes the activity in the allowance for doubtful accounts in the nine-month fiscal period ended September 29, 2023:

In thousands
Balance at December 31, 2022	$	(2,066)
Provision	(1,495)
Amounts written off	307
Recoveries	356
Changes in foreign currency exchange rates	1
Balance at September 29, 2023	$	(2,897)

There were no amounts included in accounts receivable, net for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at September 29, 2023 and December 31, 2022.

15

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

7. CONTRACT ASSETS, CONTRACT COSTS AND CONTRACT LIABILITIES

Activity related to contract assets, contract costs and contract liabilities was as follows:

	September 29, 2023		December 31, 2022		$ Change		% Change
In thousands
Contract assets	$	100,709	$	113,182	$	(12,473)	(11.0)	%
Contract costs, current portion(1)	$	139	$	695	$	(556)	(80.0)	%
Contract costs, noncurrent portion(2)	$	643	$	673	$	(30)	(4.5)	%
Contract liabilities, current portion	$	7,884	$	4,081	$	3,803	93.2	%
Contract liabilities, noncurrent portion	$	19,653	$	20,515	$	(862)	(4.2)	%

(1) Contract costs, current portion are included within other current assets on the Company's Condensed Consolidated Balance Sheets.

(2) Contract costs, noncurrent portion are included within other assets on the Company's Condensed Consolidated Balance Sheets.

Contract Assets

The decrease in contract assets was primarily due to amounts billed in the current period on the JPF program and higher unliquidated progress payments on our legacy fuzing contracts, partially offset by the recognition of revenue related to the satisfaction or partial satisfaction of performance obligations for work performed and not yet billed on various contracts. There were no significant impairment losses related to the Company's contract assets during the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022.

There were no amounts included in contract assets for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at September 29, 2023 and December 31, 2022.

Contract Costs

At September 29, 2023 and December 31, 2022, costs to fulfill a contract were $0.8 million and $1.4 million, respectively. These amounts were included in other current assets and other assets on the Company's Condensed Consolidated Balance Sheets at September 29, 2023 and December 31, 2022. There were no costs to obtain a contract at September 29, 2023 and December 31, 2022.

Contract costs, current portion at September 29, 2023 decreased compared to the balance at December 31, 2022. This was primarily attributable to the write-off of contract costs on the A-10 contract and amortization of contract costs. For the three-month and nine-month fiscal periods ended September 29, 2023, amortization of contract costs was $0.1 million and $0.3 million, respectively. For the three-month and nine-month fiscal periods ended September 30, 2022, amortization of contract costs was $0.2 million and $0.5 million, respectively.

Contract costs, noncurrent portion at September 29, 2023 remained relatively flat when compared to the balance at December 31, 2022.

Contract Liabilities

Contract liabilities, current portion at September 29, 2023 increased compared to the balance at December 31, 2022, primarily driven by the FireBurstTM enhanced fuzing capability program and SH-2G program. Revenue recognized related to contract liabilities, current portion was $1.2 million and $1.7 million in the three-month and nine-month fiscal periods ended September 29, 2023, respectively. Revenue recognized related to contract liabilities, current portion was $0.2 million and $1.4 million in the three-month and nine-month fiscal periods ended September 30, 2022, respectively.

16

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

7. CONTRACT ASSETS, CONTRACT COSTS AND CONTRACT LIABILITIES (CONTINUED)

Contract Liabilities - continued

Contract liabilities, noncurrent portion at September 29, 2023 decreased compared to the balance at December 31, 2022 due to the reclassification of liabilities on the FireBurstTM enhanced fuzing capability program to contract liabilities, current portion. For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022, the Company did not recognize revenue against contract liabilities, noncurrent portion. Refer to Note 14, Commitments and Contingencies, for further information on the Company's offset agreements.

8. FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date.

The Company uses a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: 

•Level 1 — Quoted prices in active markets for identical assets or liabilities.

•Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data.

•Level 3 — Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following table presents the carrying value and fair value of financial instruments that are not carried at fair value:

	September 29, 2023				December 31, 2022
	Carrying Value		Fair Value		Carrying Value		Fair Value
In thousands
Debt (1)	$	581,500	$	547,294	$	562,500	$	547,393

(1) These amounts are classified within Level 2.

The above fair values were computed based on quoted market prices and discounted future cash flows (observable inputs), as applicable. Differences from carrying values are attributable to interest rate changes subsequent to when the transactions occurred.

The fair values of cash and cash equivalents, accounts receivable, net and accounts payable - trade approximate their carrying amounts due to the short-term maturities of these instruments. The Company's cash and cash equivalents at September 29, 2023 and December 31, 2022 included $5.4 million and $0.1 million, respectively, of Level 1 money market funds.

Recurring Fair Value Measurements

The Company holds derivative instruments for foreign exchange contracts and interest rate swaps that are measured at fair value using observable market inputs such as forward rates and its counterparties’ credit risks. Based on these inputs, the derivative instruments are classified within Level 2 of the valuation hierarchy. At September 29, 2023, the interest rate swaps were included in other assets and other long-term assets on the Company's Condensed Consolidated Balance Sheets. At September 29, 2023, the foreign exchange contracts were included in other current liabilities on the Company's Condensed Consolidated Balance Sheets. At December 31, 2022, the foreign exchange contracts were included in other current assets and other current liabilities on the Company's Condensed Consolidated Balance Sheets. Based on the Company's continued ability to trade and enter into forward contracts and interest rate swaps, the Company considers the markets for its fair value instruments to be active.

The Company evaluated the credit risk associated with the counterparties to these derivative instruments and determined that as of September 29, 2023, such credit risks had not had an adverse impact on the fair value of these instruments.

17

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

8. FAIR VALUE MEASUREMENTS (CONTINUED)

Nonrecurring Fair Value Measurements

In the three-month and nine-month fiscal periods ended September 29, 2023, the Company incurred impairment charges of $0.4 million and $1.0 million, respectively, associated with the write-off of inventory related to the K-MAX® program. Refer to Note 10, Inventories, for further information.

9. DERIVATIVE FINANCIAL INSTRUMENTS

The Company is exposed to certain risks relating to its ongoing business operations, including market risks relating to fluctuations in foreign currency exchange rates and interest rates. Derivative financial instruments are recognized on the Condensed Consolidated Balance Sheets as either assets or liabilities and are measured at fair value. Changes in the fair values of derivatives are recorded each period in earnings or accumulated other comprehensive income, depending on whether a derivative is effective as part of a hedged transaction. Gains and losses on derivative instruments reported in accumulated other comprehensive income (loss) are subsequently included in earnings in the periods in which earnings are affected by the hedged item. The Company does not use derivative instruments for speculative purposes.

Cash Flow Hedges

Interest Rate Swaps

The Company's Credit Agreement (as defined in Note 12, Debt) contains floating rate obligations and is subject to interest rate fluctuations. At September 29, 2023, the Company has interest rate swap agreements with a notional value of $175.0 million, for the purposes of hedging the eight quarterly variable-rate Credit Agreement interest payments due in 2023 and 2024. These interest rate swap agreements were designated as cash flow hedges and intended to manage interest rate risk associated with the Company's variable-rate borrowings and minimize the impact on earnings and cash flows of interest rate fluctuations attributable to changes in the Secured Overnight Financing Rate ("SOFR"). These interest rate swaps were not material to the Company's Condensed Consolidated Financial Statements as of and for the three-month and nine-month fiscal periods ended September 29, 2023. Over the next twelve months, the income related to cash flow hedges expected to be reclassified from other comprehensive income is $1.6 million.

Forward Exchange Contracts

The Company holds forward exchange contracts designed to hedge forecasted transactions denominated in foreign currencies and to minimize the impact of foreign currency fluctuations on the Company’s earnings and cash flows. These contracts were not material to the Company's Condensed Consolidated Balance Sheets as of September 29, 2023 and December 31, 2022. The activity related to these contracts was not material to the Company's Condensed Consolidated Financial Statements for the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022.

10. INVENTORIES

Inventories consisted of the following:

	September 29, 2023		December 31, 2022
In thousands
Raw materials	$	35,228	$	24,572
Contracts and other work in process (including certain general stock materials)	127,779		107,803
Finished goods	38,432		40,008
Inventories	$	201,439	$	172,383

There were no amounts included in inventories associated with matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at September 29, 2023 and December 31, 2022.

18

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

10. INVENTORIES (CONTINUED)

At September 29, 2023 and December 31, 2022, $22.9 million and $24.7 million, respectively, of K-MAX® inventory was included in contracts and other work in process inventory and finished goods on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately $9.5 million of the K-MAX® inventory will be sold after September 30, 2024, based upon the requirements to support the fleet for the foreseeable future. In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improving working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result, the Company determined it would discontinue K-MAX® aircraft production and wrote off $44.5 million of inventory associated with the program as of December 31, 2022. Additionally, production material for the K-MAX® includes long lead parts, which the Company evaluates for alternative use as received. Any write-offs related to these parts are not expected to have a material adverse effect on the Company's results of

operations or financial position. Inventory write-offs for the three-month and nine-month fiscal periods ended September 29, 2023 were $0.4 million and $1.0 million, respectively.

At September 29, 2023 and December 31, 2022, $5.4 million and $6.2 million, respectively, of SH-2G(I) inventory was included in contracts and other work in process inventory on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately $4.1 million of the SH-2G(I) inventory will be sold after September 30, 2024. This balance represents spares requirements and inventory to be used on SH-2G programs.

11. GOODWILL AND OTHER INTANGIBLE ASSETS, NET

Goodwill

The following table sets forth the change in the carrying amount of goodwill for each reportable segment and for the Company:

	Engineered Products		Precision Products		Structures		Total
In thousands
Gross balance at December 31, 2022	$	363,785	$	41,375	$	66,559	$	471,719
Accumulated impairment	—		(25,306)		(66,559)		(91,865)
Net balance at December 31, 2022	363,785		16,069		—		379,854
Additions	1,487		—		—		1,487
Impairments	—		—		—		—
Foreign currency translation	(1,098)		—		—		(1,098)
Ending balance at September 29, 2023	$	364,174	$	16,069	$	—	$	380,243
Accumulated impairment at end of period	$	—	$	(25,306)	$	(66,559)	$	(91,865)

In accordance with ASC 350 - Intangibles - Goodwill and Other ("ASC 350"), the Company evaluates goodwill for possible impairment on an at least annual basis. The Company is currently in the process of updating its long-term forecast, which it will use to complete its annual evaluation during the fourth quarter. Management has determined that the Company will perform a quantitative assessment, rather than a qualitative assessment, for the Precision Products reporting unit, a division of the Precision Products segment which manufactures and produces the JPF. The quantitative assessment could result in a determination that there has been an impairment of some or all of the goodwill associated with this reporting unit. At September 29, 2023, the goodwill associated with the Precision Products reporting unit is $16.1 million.

19

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

11. GOODWILL AND OTHER INTANGIBLE ASSETS, NET (CONTINUED)

Other Intangible Assets

Other intangible assets consisted of:

		At September 29,				At December 31,
		2023				2022
	Amortization Period	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
In thousands
Customer lists / relationships	6-38 years	$	363,269	$	(51,311)	$	363,549	$	(41,695)
Developed technologies	7-20 years	44,923		(20,582)		45,028		(17,508)
Trademarks / trade names	15-40 years	16,619		(3,583)		16,681		(3,153)
Non-compete agreements and other	1-15 years	17,332		(14,516)		17,336		(7,974)
Patents	17 years	551		(494)		551		(484)
Total intangible assets		$	442,694	$	(90,486)	$	443,145	$	(70,814)

12. DEBT

Credit Agreement

On June 21, 2023 (the "Closing Date"), the Company closed an amended and restated $740.0 million Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A., as Administrative Agent and as Collateral Agent. The Credit Agreement amends and restates the Company's previously existing credit facility in its entirety to, among other things: (i) extend the maturity date to June 21, 2028; (ii) reduce the aggregate amount of revolving commitments from $800.0 million to $740.0 million; (iii) modify the financial covenants set forth in Article 6 of the previously existing credit facility; and (iv)

effectuate certain additional modifications set forth in the previously existing facility, including its pricing. Capitalized terms used but not defined within this discussion of the Credit Agreement have the meanings ascribed thereto in the Credit Agreement, which with amendments is included as Exhibit 10.5 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2023.

The financial covenants associated with the Credit Agreement require that (i) the Consolidated Total Net Leverage Ratio, as defined by the Credit Agreement, cannot be greater than 5.00 to 1.00 for any quarter ending on or after the Closing Date through September 28, 2023, 4.75 to 1.00 for each quarter ending thereafter through September 26, 2024, 4.50 to 1.00 for each quarter ending thereafter through September 25, 2025 and 4.00 to 1.00 for each quarter ending thereafter. The Company may elect to increase the Consolidated Total Net Leverage Ratio by 0.50 to 1.00 if the Company consummates a Material Permitted Investment, which shall not exceed 5.00 to 1.00 for each of the four consecutive quarters that included the fiscal quarter in which the Material Permitted Investment is consummated. As of September 29, 2023, the Consolidated Total Net Leverage Ratio was 3.89, as calculated in accordance with the Credit Agreement.

In addition to the Consolidated Total Net Leverage Ratio, as defined in the Credit Agreement and discussed above, the financial covenants associated with the Credit Agreement also include a requirement that (i) the Interest Coverage Ratio cannot be less than 3.00 to 1.00; and (ii) Liquidity cannot be less than (a) an amount equal to 50% of the aggregate principal amount of the Convertible Notes as of the last day of the third quarter of 2023 and (b) an amount equal to 100% of the aggregate principal of the 2024 Convertible Notes in the fourth quarter of 2023 and the first quarter of 2024. The Company was in compliance with these financial covenants as of and for the quarter ended September 29, 2023, and management does not anticipate noncompliance in the foreseeable future.

Interest rates on amounts outstanding under the Credit Agreement are variable based on the SOFR. The interest rate at September 29, 2023 was 7.13%. We are required to pay a quarterly commitment fee on the unused revolving loan commitment amount at a rate ranging from 0.200% to 0.350% per annum, based on the Senior Secured Net Leverage Ratio. Fees for outstanding letters of credit range from 1.375% to 2.250%, based on the Senior Secured Net Leverage Ratio. At September 29, 2023, $382.0 million was outstanding under the revolving credit facility and total average bank borrowings were $391.9 million during the nine-month fiscal period ended September 29, 2023. Total average bank borrowings were $120.7 million during the year ended December 31, 2022.

20

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

12. DEBT (CONTINUED)

Credit Agreement - continued

The following table shows the amounts available for borrowing under the Company's revolving credit facility:

	September 29, 2023		December 31, 2022
In thousands
Total facility	$	740,000	$	800,000
Amounts outstanding, excluding letters of credit	382,000		363,000
Amounts available for borrowing, excluding letters of credit	358,000		437,000
Letters of credit under the credit facility(1)(2)	70,549		51,630
Amounts available for borrowing	$	287,451	$	385,370
Amounts available for borrowing subject to EBITDA, as defined by the Credit Agreement(3)	$	129,313	$	196,256

(1) The Company has entered into standby letters of credit issued on the Company's behalf by financial institutions, and directly issued guarantees to third parties primarily related to advances received from customers and the guarantee of future performance on certain contracts. Letters of credit generally are available for draw down in the event the Company does not perform its obligations.

(2) Of these amounts, $65.1 million and $46.1 million in letters of credit relate to a JPF DCS contract in the periods ended September 29, 2023 and December 31, 2022, respectively.

(3) The Company's Convertible Notes will mature in 2024. The Company currently expects to settle the Convertible notes with available borrowing capacity under our Credit Agreement; however we are assessing potential options for the refinancing of these instruments prior to their scheduled maturity. With the extension of the Credit Agreement, the Company maintained sufficient capacity to use proceeds from this facility to repay the Convertible Notes. The amounts available for borrowing subject to EBITDA represents amounts available for borrowing after considering the Company's total debt obligations including its Credit Agreement and Convertible Notes.

Debt issuance costs in connection with the Credit Agreement have been capitalized. The Company incurred $4.8 million of debt issuance costs in connection with the amendment of the Credit Agreement in 2023, which are being amortized over the term of the agreement with the debt issuance costs associated with the previous existing credit facility for lenders that remained in the Credit Agreement. In the second quarter of 2023, the Company recorded a write-off of debt issuance costs of $0.6 million

related to lenders that are no longer participating in the Credit Agreement. Total amortization expense for the three-month fiscal periods ended September 29, 2023 and September 30, 2022 was $0.4 million and $0.7 million, respectively. Total amortization expense for the nine-month fiscal periods ended September 29, 2023 and September 30, 2022 was $1.6 million and $1.2 million, respectively.

13. PENSION PLANS

Components of net pension cost for the Qualified Pension Plan and Supplemental Employees’ Retirement Plan ("SERP") were as follows:

	For the Three Months Ended
	Qualified Pension Plan				SERP
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Service cost	$	1,445	$	840	$	—	$	—
Interest cost on projected benefit obligation	7,296		4,300		44		22
Expected return on plan assets	(9,573)		(10,544)		—		—
Amortization of net loss	1,923		1,064		—		16
Net pension cost (income)	$	1,091	$	(4,340)	$	44	$	38

21

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

13. PENSION PLANS (CONTINUED)

	For the Nine Months Ended
	Qualified Pension Plan				SERP
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Service cost	$	4,336	$	2,522	$	—	$	—
Interest cost on projected benefit obligation	21,888		12,899		132		66
Expected return on plan assets	(28,720)		(31,633)		—		—
Amortization of net loss	5,770		3,193		—		46
Net pension cost (income)	$	3,274	$	(13,019)	$	132	$	112

No contributions have been or are expected to be made to the qualified pension plan during 2023. The Company contributed $0.4 million to the SERP through the end of the third quarter of 2023 and plans to contribute an additional $0.1 million to the SERP in 2023. No contributions were made to the qualified pension plan during 2022. For the 2022 plan year, the Company contributed $0.5 million to the SERP.

14. COMMITMENTS AND CONTINGENCIES

New Hartford Property

In connection with the sale of the Company’s Music segment in 2007, the Company assumed responsibility for meeting certain requirements of the Connecticut Transfer Act (the “Transfer Act”) that applied to the transfer of the New Hartford, Connecticut, facility leased by that segment for guitar manufacturing purposes (“Ovation”). Under the Transfer Act, those responsibilities essentially consist of assessing the site's environmental conditions and remediating environmental impairments, if any, caused by Ovation's operations prior to the sale. The site is a multi-tenant industrial park, in which Ovation and other unrelated entities lease space. The environmental assessment process, which began in 2008, has been completed and site remediation is in process.

The Company's estimate of its portion of the cost to assess the environmental conditions and remediate this site is $2.3 million, all of which has been accrued. The remediation has been nearly completed and the Company continues to monitor the results of the remediation. The total amount paid to date in connection with these environmental remediation activities is $1.8 million. At September 29, 2023, the Company had $0.5 million accrued for these environmental remediation activities. A portion ($0.1 million) of the accrual related to this property is included in other current liabilities and the balance is included in other long-term liabilities. The remaining balance of the accrual reflects the total anticipated cost of completing these environmental remediation activities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time.

Bloomfield Property

In connection with the Company’s 2008 purchase of the portion of the Bloomfield campus that Kaman Aerospace Corporation had leased from NAVAIR, the Company assumed responsibility for environmental remediation at the facility as may be required under the Transfer Act and is currently remediating the property under the guidance of the Connecticut Department of Environmental Protection. The assumed environmental liability of $10.3 million was determined by taking the undiscounted estimated remediation liability of $20.8 million and discounting it at a rate of 8%. This remediation process will take many years to complete. The total amount paid to date in connection with these environmental remediation activities is $15.5 million. At September 29, 2023, the Company had $2.3 million accrued for these environmental remediation activities. A portion ($0.4 million) of the accrual related to this property is included in other current liabilities, and the balance is included in other long-term liabilities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time.

22

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

14. COMMITMENTS AND CONTINGENCIES (CONTINUED)

Offset Agreement

The Company has entered into offset agreements as a condition to obtaining orders from a Middle Eastern customer for the Company's JPF product. Offset agreements are designed to return economic value to the foreign country by requiring the Company to engage in activities supporting local defense or commercial industries, promoting a balance of trade, developing in-country technology capabilities or addressing other local development priorities. Such agreements may be satisfied through activities that do not require a direct cash payment, including transferring technology, providing manufacturing, training and other consulting support to in-country projects and the purchase by third parties of supplies from in-country vendors. The agreements may also be satisfied through the Company's use of cash for activities, such as subcontracting with local partners, purchasing supplies from in-country vendors, providing financial support for in-country projects and making investments in local ventures. At September 29, 2023, the aggregate amount of the Company's offset agreements had an outstanding notional value of approximately $220.9 million, which is equal to sixty percent of the value of the contracts as defined by the agreement between the customer and the Company. The amount ultimately applied against offset agreements is based on negotiations with the customer and may require cash outlays that represent only a fraction of the notional value in the offset agreement.

The Company continues to work with the customer to further define the requirements to satisfy the offset agreements. In February 2023, the Company announced that it received a Business Plan Approval Letter to establish a manufacturing and final assembly facility in collaboration with an in-country vendor, which will enhance the technological capabilities available in this country. At September 29, 2023, the Company continues to work with the Tawazun Council to identify a suitable in-country vendor to support the manufacturing and final assembly facility as the Company is no longer working with the previously announced vendor. Offset programs typically extend over several years and may provide for penalties in the event the Company fails to perform according to offset requirements. The satisfaction of the offset requirements will be determined by the customer. In the event the offset requirements of the contracts are not met, the Company could be liable for potential penalties up to $18.8 million payable to the customer. Failure to satisfy the offset requirements could also negatively impact the Company's ability to attract future orders from this customer. The Company considers these potential penalties to be a reduction to the transaction price in its determination of the value of the performance obligations within these contracts. At September 29, 2023, $18.8 million in contract liabilities associated with the potential penalties of the offset requirements were included on the Company's Condensed Consolidated Balance Sheets.

Guarantees

During 2020, the Company and the USG entered into a Guaranty Agreement, pursuant to which the Company agreed to guarantee the full, complete and satisfactory performance of its subsidiary, Kaman Precision Products, Inc. ("KPPI") under all current and future contracts with the USG. As of the date of this filing, the only contract in place between KPPI and the USG relates to the production and sale of the JPF. KPPI fulfilled the requirements of Option 16 in the second quarter of 2023 and the USG has indicated that they will not award the Company any future options. The guaranty will remain in effect until the USG has confirmed that the Company has completed all obligations and the Company requests the expiration, which is expected to occur before the end of the fiscal year. The guaranty was provided in lieu of a periodic financial capability review by the Financial Capacity Team ("FCT") of the Defense Contract Management Agency ("DCMA"). The Company is unable to estimate the maximum potential amount of future payments under the guaranty as it is dependent on costs incurred by the USG in the event of default. Although the Company believes the risk of default is low given the maturity and operational performance of the JPF program, there can be no assurance that the guaranty will not have a material adverse effect on the Company's results of operations, financial position and cash flows.

On September 16, 2022, the Company acquired all of the assets and related liabilities of Parker's Aircraft Wheel and Brake division. In association with the acquisition, the Company entered into a novation agreement in which Parker's contractual obligations with respect to Aircraft Wheel and Brake at the time of the acquisition were transferred to the Company. There can be no assurance that this agreement will not have a material adverse effect on the Company's results of operations, financial position and cash flows.

23

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

15. COMPUTATION OF EARNINGS PER SHARE

The computation of basic earnings per share is based on net earnings divided by the weighted average number of shares of common stock outstanding for each period. The computation of diluted earnings per share reflects the common stock equivalency of dilutive options granted to employees under the Company's stock incentive plan, shares issuable on redemption of its convertible notes and shares issuable upon redemption of outstanding warrants.

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands, except per share amounts
Net earnings (loss)	$	1,466	$	(280)	$	5,952	$	7,369
Basic:
Weighted average number of shares outstanding	28,247		28,037		28,189		27,997
Basic earnings (loss) per share	$	0.05	$	(0.01)	$	0.21	$	0.26
Diluted:
Weighted average number of shares outstanding	28,247		28,037		28,189		27,997
Weighted average shares issuable on exercise of dilutive stock options	103		—		135		79
Total	28,350		28,037		28,324		28,076
Diluted earnings (loss) per share	$	0.05	$	(0.01)	$	0.21	$	0.26

Equity awards

For the three-month and nine-month fiscal periods ended September 29, 2023, respectively, 660,947 and 664,923 shares issuable under equity awards granted to employees were excluded from the calculation of diluted earnings per share as they were anti-dilutive based on the average stock price during the periods. For the three-month and nine-month fiscal periods ended September 30, 2022, respectively, 756,809 and 707,584 shares issuable under equity awards granted to employees were excluded from the calculation of diluted earnings per share as they were anti-dilutive based on the average stock price during the periods. For the three-month fiscal period ended September 30, 2022, an additional 50,792 shares issuable under equity awards, which would have been dilutive if exercised based on the average market price being higher than the exercise price, were excluded from the computation of diluted earnings per share as their effect was antidilutive due to the net loss.

Convertible Notes

For both three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022, 3,056,879 shares issuable under Convertible Notes due 2024 were excluded from the diluted earnings per share calculation because their effect was antidilutive.

24

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

16. SHARE-BASED ARRANGEMENTS

The Company accounts for stock options, restricted stock awards ("RSAs"), restricted stock units ("RSUs") and performance stock units ("PSUs") as equity awards and measures the cost of all share-based payments, including stock options, at fair value on the grant date and recognizes this cost in the statement of operations. The Company also has an employee stock purchase plan, which is accounted for as a liability award. Compensation expense for stock options, RSAs, RSUs and PSUs is recognized on a straight-line basis over the vesting period of the awards. Throughout the course of the vesting period, the Company monitors the achievement level for the return on invested capital ("ROIC") metric of the PSUs compared to the ROIC target and adjusts the number of shares expected to be earned, and the related compensation expense recorded thereafter, to reflect the most probable outcome. The PSUs granted in 2023 and 2022 assumed a 100% achievement level. Share-based compensation expense recorded for the three-month and nine-month fiscal periods ended September 29, 2023 was $1.3 million and $5.2 million, respectively. For the nine-month fiscal period ended September 29, 2023, $0.3 million was recorded to restructuring and severance costs and the remaining amount was recorded to selling, general and administrative expenses on the Company's Condensed Consolidated Statements of Operations. No share-based compensation expense was recorded to restructuring and severance costs in the three-month fiscal period ended September 29, 2023. Share-based compensation expense recorded for the three-month and nine-month fiscal periods ended September 30, 2022 was $1.3 million and $6.1 million, respectively. For the nine-month fiscal period ended September 30, 2022, $0.2 million was recorded to restructuring and severance costs and the remaining amounts were recorded to selling, general and administrative expenses on the Company's Condensed Consolidated Statements of Operations. Restructuring and severance costs associated with share-based compensation for the three-month fiscal period ended September 30, 2022 were not material.

Stock option activity was as follows:

	For the Three Months Ended			For the Nine Months Ended
	September 29, 2023			September 29, 2023
	Options	Weighted - average exercise price		Options	Weighted - average exercise price
Options outstanding at beginning of period	615,742	$	54.31	710,782	$	54.12
Granted	48,987	$	24.48	48,987	$	24.48
Exercised	—	$	—	—	$	—
Forfeited or expired	(5,505)	$	63.09	(100,545)	$	53.45
Options outstanding at September 29, 2023	659,224	$	52.02	659,224	$	52.02

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. The following table indicates the weighted-average assumptions used in estimating fair value:

	For the Nine Months Ended
	September 29, 2023			September 30, 2022
Expected option term (years)	6.9			6.5
Expected volatility	40.2		%	35.5		%
Risk-free interest rate	4.0		%	2.9		%
Expected dividend yield	3.3		%	2.0		%
Per share fair value of options granted	$	8.17		$	10.22

25

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

16. SHARE-BASED ARRANGEMENTS (CONTINUED)

Restricted stock award and restricted stock unit activity were as follows:

	For the Three Months Ended			For the Nine Months Ended
	September 29, 2023			September 29, 2023
	Restricted  Stock	Weighted- average grant date fair value		Restricted  Stock	Weighted- average grant date fair value
Restricted Stock outstanding at beginning of period	227,196	$	32.58	159,521	$	45.78
Granted	26,740	$	24.31	167,572	$	24.53
Vested	(34,507)	$	42.02	(99,239)	$	45.08
Forfeited or expired	(13,960)	$	32.98	(22,385)	$	35.58
Restricted Stock outstanding at September 29, 2023	205,469	$	29.89	205,469	$	29.89

Performance stock unit activity was as follows:

	For the Three Months Ended			For the Nine Months Ended
	September 29, 2023			September 29, 2023
	Performance Stock	Weighted- average grant date fair value		Performance Stock	Weighted- average grant date fair value
Performance Stock outstanding at beginning of period	314,552	$	45.00	172,144	$	60.44
Granted	—	$	—	178,385	$	32.03
Vested	—	$	—	—	$	—
Forfeited or expired	(34,705)	$	42.98	(70,682)	$	48.89
Performance Stock outstanding at September 29, 2023	279,847	$	45.25	279,847	$	45.25

The fair value of the PSUs based on total shareholder return ("TSR") was estimated on the date of grant using a Monte-Carlo simulation model. The following table indicates the weighted-average assumptions used in estimating fair value:

	For the Nine Months Ended
	September 29, 2023			September 30, 2022
Expected term (years)	2.9			2.9
Expected volatility	41.2		%	39.4		%
Risk-free interest rate	4.4		%	1.7		%
Expected dividend yield	3.3		%	1.9		%
Per share fair value of performance stock granted	$	38.83		$	68.10

26

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

17. SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME

Changes in shareholders’ equity for the three-month and nine-month fiscal periods ended September 29, 2023, and September 30, 2022, were as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Beginning balance(1)	$	686,329	$	777,623	$	680,756	$	795,453
Comprehensive (loss) income	(2,864)		(9,334)		9,579		(15,502)
Dividends declared (per share of common stock, $0.20 and $0.20 and $0.60 and $0.60, respectively)	(5,650)		(5,604)		(16,915)		(16,791)
Employee stock plans and related tax benefit	495		430		1,465		1,696
Purchase of treasury shares	(277)		(64)		(780)		(762)
Share-based compensation expense	1,262		1,334		5,190		6,145
Impact of change in accounting standard(2)	—		—		—		(5,854)
Ending balance	$	679,295	$	764,385	$	679,295	$	764,385

(1) For the three-month and nine-month fiscal periods ended September 30, 2022, the Company revised its previously issued financial statements for errors related to (1) the accounting for certain labor costs at one business in the Precision Products segment and (2) the net realizable value on certain portions of the Company's inventory at another business in the Structures segment. The impact of these items on the beginning shareholders' equity and accumulated other comprehensive income balances noted above was approximately $1.3 million and $0.9 million, respectively. Refer to Note 2, Accounting Changes, for further information.

(2) At January 1, 2022, the Company adopted Accounting Standard Update 2020-06, "Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity" ("ASU 2020-06"). Refer to Note 1, Summary of Significant Accounting Policies, of the Company's Annual Report on Form 10-K for the year ended December 31, 2022 for further information on the adoption of ASU 2020-06.

27

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

17. SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME (CONTINUED)

The components of accumulated other comprehensive income (loss) are shown below:

	For the Three Months Ended
	September 29, 2023		September 30, 2022
In thousands
Foreign currency translation:
Beginning balance	$	1,398	$	(6,707)
Net loss on foreign currency translation	(5,766)		(9,875)
Other comprehensive income (loss), net of tax	(5,766)		(9,875)
Ending balance	$	(4,368)	$	(16,582)
Pension and other post-retirement benefits(1):
Beginning balance	$	(153,394)	$	(118,495)
Amortization of net loss, net of tax expense of $445 and $259, respectively	1,478		821
Other comprehensive income, net of tax	1,478		821
Ending balance	$	(151,916)	$	(117,674)
Derivative instruments(2):
Beginning balance	$	1,532	$	—
Gain on derivative instruments, net of tax expense of $138 and $0, respectively	460		—
Reclassification to net income, net of tax benefit of $(151) and $0, respectively	(502)		—
Other comprehensive income (loss), net of tax	(42)		—
Ending balance	$	1,490	$	—
Total accumulated other comprehensive loss	$	(154,794)	$	(134,256)

(1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost.

(See Note 13, Pension Plans, for additional information.)

(2) See Note 9, Derivative Financial Instruments, for additional information regarding derivative instruments.

28

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Continued

For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022

(Unaudited)

17. SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME (CONTINUED)

	For the Nine Months Ended
	September 29, 2023		September 30, 2022
In thousands
Foreign currency translation:
Beginning balance	$	(2,071)	$	8,765
Net loss on foreign currency translation	(2,297)		(25,347)
Other comprehensive income (loss), net of tax	(2,297)		(25,347)
Ending balance	$	(4,368)	$	(16,582)
Pension and other post-retirement benefits(1):
Beginning balance	$	(156,350)	$	(120,157)
Amortization of net loss, net of tax expense of $1,336 and $756, respectively	4,434		2,483
Other comprehensive income, net of tax	4,434		2,483
Ending balance	$	(151,916)	$	(117,674)
Derivative instruments(2):
Beginning balance	$	—	$	7
Gain on derivative instruments, net of tax expense of $692 and $0, respectively	2,298		—
Reclassification to net income, net of tax benefit of $(243) and $0, respectively	(808)		(7)
Other comprehensive income (loss), net of tax	1,490		(7)
Ending balance	$	1,490	$	—
Total accumulated other comprehensive loss	$	(154,794)	$	(134,256)

(1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost.

(See Note 13, Pension Plans, for additional information.)

(2) See Note 9, Derivative Financial Instruments, for additional information regarding derivative instruments.

18. INCOME TAXES

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
Effective Income Tax Rate	24.0	%	28.9	%	28.5	%	18.1	%

The effective income tax rate represents the combined federal, state and foreign tax effects attributable to pretax earnings for the period. The effective tax rate for the three-month fiscal period ended September 29, 2023 decreased when compared to the corresponding rate in the prior year period, attributable to higher net earnings in the current period. The effective rate for the nine-month fiscal period ended September 29, 2023 increased when compared to the corresponding rate in the prior year period, primarily driven by a charge to record additional valuation allowances relating to the Company’s state tax loss carryforwards, partially offset by a benefit relating to the reversal of uncertain tax positions.

19. SUBSEQUENT EVENTS

The Company has evaluated subsequent events through the issuance date of these financial statements. No material subsequent events were identified that require disclosure.

29

Item 2.         Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations is intended to provide readers of our condensed consolidated financial statements with the perspectives of management. It presents, in narrative and tabular form, information regarding our financial condition, results of operations, liquidity and certain other factors that may affect our future results, and is designed to enable the readers of this report to obtain an understanding of our businesses, strategies, current trends and future prospects. It should be read in conjunction with our Annual Report on Form 10-K for the year ended December 31, 2022 ("2022 Form 10-K") and the Condensed Consolidated Financial Statements included in Item 1 of this Quarterly Report on Form 10-Q.

OVERVIEW OF BUSINESS

Kaman Corporation ("the Company") conducts business through three business segments:

•The Engineered Products segment serves the aerospace and defense, industrial and medical markets providing sophisticated, proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; and wheels, brakes and related hydraulic components for helicopters, fixed-wing and UAV aircraft.

•The Precision Products segment serves the aerospace and defense markets providing precision safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of the Company's SH-2G Super Seasprite maritime helicopters; support of the heavy lift K-MAX® manned helicopter; and development of the KARGO UAV unmanned aerial system, a purpose built autonomous medium lift logistics vehicle.

•The Structures segment serves the aerospace and defense and medical end markets providing sophisticated complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft, and medical imaging solutions.

Executive Summary

Consolidated net sales increased by 6.4% to $183.0 million compared to the prior year period, primarily driven by sales from our Aircraft Wheel and Brake acquisition and continued strong organic growth in the Engineered Products segment, partially offset by lower sales on our Joint Programmable Fuze ("JPF") program. Gross margin as a percentage of sales increased in the quarter to 35.3% compared to 31.8% in the prior year period, due to improved performance on our bearings and PMA aftermarket products and the addition of gross profit associated with our Aircraft Wheel and Brake acquisition. Selling, general and administrative expenses ("S,G&A") decreased by 13.3% primarily due to the absence of $10.3 million in corporate development costs incurred in the prior year related to the acquisition of Aircraft Wheel and Brake. Operating income in the period increased as a result of the drivers discussed above, partially offset by a $2.5 million increase in intangible asset amortization expense driven by the Aircraft Wheel and Brake acquisition.

Other financial highlights

•Net earnings were $1.5 million in the three-month fiscal period ended September 29, 2023, $1.7 million higher than the comparable fiscal period in the prior year. The increase in net earnings was primarily driven by higher operating income resulting from the contribution of Aircraft Wheel and Brake and improved performance, partially offset by an increase in interest expense and lower non-service pension and post-retirement benefit income. The resulting GAAP diluted earnings per share was $0.05 in the three-month fiscal period ending September 29, 2023, compared to loss per share of $0.01 in the prior year period.

•Net earnings were $6.0 million in the nine-month fiscal period ended September 29, 2023, $1.4 million lower than the comparable fiscal period in the prior year. This decrease in net earnings was primarily driven by an increase in interest expense and lower non-service pension and post-retirement benefit income, partially offset by higher operating income resulting from the contribution of Aircraft Wheel and Brake and improved performance. The resulting GAAP diluted earnings per share was $0.21 in the nine-month fiscal period ending September 29, 2023, compared to earnings per share of $0.26 in the prior year period.

•Cash provided by operating activities during the nine-month fiscal period ended September 29, 2023, was $29.7 million, a $63.4 million improvement over cash used in the comparable period in 2022. This change was largely driven by improved performance, income tax refunds received in the current period and the wind down of work on the JPF program.

30

•Total unfulfilled performance obligations ("backlog") remained relatively flat at $718.6 million compared to total backlog at December 31, 2022, driven by revenue recognized in the period, mostly offset by new orders in the Engineered Products segment.

Recent Events

•In October 2023, the Company received an order for a K-MAX® medium-to-heavy lift helicopter from Black Tusk Helicopter. The aircraft is expected to be delivered in the fourth quarter of 2023.

•In October 2023, the U.S. Army awarded Kaman Air Vehicles, a division of Kaman Corporation, and Near Earth Autonomy, Inc. a contract to demonstrate a heavy-lift resupply uncrewed aerial system.

Impacts from Current Economy

We are currently operating in a period of global economic uncertainty, which has been significantly impacted by geopolitical instability due to ongoing military conflicts, such as between Ukraine and Russia and between Israel and Hamas, continuing U.S. sanctions on China's microchip manufacturing, inflation and rising interest rates. U.S. and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions. Although the length and impact of the ongoing military conflicts are highly unpredictable, they could lead to market disruptions, including volatility in credit and capital markets, increases in commodity prices, supply chain interruptions, as well as the potential for increased risk of cyber disruptions. We are continuing to monitor the ongoing military conflicts, including their global effects, and assessing their potential impact on our business, including the timing of our sales as certain customers purchase safety stock for their own supply chains. As of the date of this filing, we have not been materially impacted by the ongoing military conflicts. It is impossible to predict the extent to which our operations, or those of our customers or suppliers, will be impacted, or the ways in which these conflicts may impact our business, cash flows or results of operations.

The above forces have impacted our supply chain; we are seeing quality issues and defects, part shortages and increased lead times for certain parts. In addition to supply chain impacts, we have been and believe we will continue to be impacted by higher interest expense given our outstanding borrowings under our revolving credit facility with a floating interest rate. These impacts are likely to persist through the fourth quarter of 2023 and beyond. To mitigate risks associated with the floating interest rate on our credit facility, we entered into interest rate swap agreements, effective January 1, 2023, for the purposes of hedging the eight quarterly variable-rate Credit Agreement interest payments due in 2023 and 2024. These swaps will provide a fixed interest rate on approximately 65% of the Company's total long-term debt. We cannot predict the impact on the Company’s end markets or input costs nor the ability of the Company to recover cost increases through pricing.

RESULTS OF OPERATIONS

Refer to Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations, of the Quarterly Report on Form 10-Q for the period ended September 30, 2022 for a discussion of changes for the earliest periods presented.

Net Sales

	For the Three Months Ended						For the Nine Months Ended
	September 29, 2023			September 30, 2022			September 29, 2023			September 30, 2022
	(in thousands)
Net sales	$	183,031		$	172,004		$	572,731		$	490,818
$ change	11,027			(7,832)			81,913			(43,028)
% change	6.4		%	(4.4)		%	16.7		%	(8.1)		%
Acquisition sales(1)	12,317			—			52,062			—
Organic sales	$	170,714		$	172,004		$	520,669		$	490,818
$ change	(1,290)						29,851
% change	(0.7)		%				6.1		%

(1) Sales contributed by an acquisition are included in organic sales one year following the date of acquisition. As such, acquisition sales for the three-month and nine-month fiscal periods reflects sales for Aircraft Wheel and Brake through September 16, 2023.

31

For the Three Months Ended

Net sales for the three-month fiscal period ended September 29, 2023 increased when compared to the corresponding period in 2022, primarily attributable to $12.3 million in acquisition sales from Aircraft Wheel and Brake. Organic sales remained relatively flat due to $19.2 million in lower sales at our Precision Products segment and $1.3 million in lower sales at the Structures segment, mostly offset by higher organic sales at the Engineered Products segment. Foreign currency exchange rates relative to the U.S. dollar had a favorable impact of $2.4 million on net sales. See Segment Results of Operations and Financial Condition below for further discussion of segment net sales.

The table below summarizes the changes in organic net sales by product line for the three-month fiscal period ended September 29, 2023, compared to the corresponding period in 2022.

Product Line	Increase (Decrease)	$ (in millions)	%
Defense	↑	$0.8	2.1%
Safe and Arm Devices	↓	$(24.6)	(65.6)%
Commercial, Business and General Aviation	↑	$18.4	34.3%
Medical	↑	$1.0	4.2%
Industrial	↑	$3.1	17.2%

For the Nine Months Ended

Net sales for the nine-month fiscal period ended September 29, 2023 increased when compared to the corresponding period in 2022, attributable to a 6.1% increase in organic sales and $52.1 million in acquisition sales from Aircraft Wheel and Brake. The increase in organic sales was driven by $65.1 million in higher organic sales at the Engineered Products segment and $6.7 million in higher sales at the Structures segment, partially offset by $42.0 million in lower sales at our Precision Products segment. Foreign currency exchange rates relative to the U.S. dollar had a favorable impact of $1.9 million on net sales. See Segment Results of Operations and Financial Condition below for further discussion of segment net sales.

The table below summarizes the changes in organic net sales by product line for the nine-month fiscal period ended September 29, 2023, compared to the corresponding period in 2022.

Product Line	Increase (Decrease)	$ (in millions)	%
Defense	↑	$13.2	12.9%
Safe and Arm Devices	↓	$(46.9)	(48.6)%
Commercial, Business and General Aviation	↑	$52.6	32.6%
Medical	↑	$7.2	10.0%
Industrial	↑	$3.8	6.4%

Gross Profit

	For the Three Months Ended						For the Nine Months Ended
	September 29, 2023			September 30, 2022			September 29, 2023			September 30, 2022
	(in thousands)
Gross profit	$	64,637		$	54,678		$	203,472		$	156,810
$ change	9,959			(8,299)			46,662			(21,052)
% change	18.2		%	(13.2)		%	29.8		%	(11.8)		%
% of net sales	35.3		%	31.8		%	35.5		%	31.9		%

32

Gross profit increased for the three-month and nine-month fiscal periods ended September 29, 2023, as compared to the corresponding periods in 2022. These increases were primarily attributable to the addition of gross profit from our Aircraft Wheel and Brake acquisition and higher sales volume and related gross profit on our bearings products, PMA aftermarket parts and for our K-MAX® spares and exchanges. Additionally, in the nine-month fiscal period, we saw higher sales and gross profit on seals, springs and contacts. These increases, totaling $23.5 million and $69.5 million, respectively, were partially offset by lower sales and gross profit on our JPF program and cost growth on legacy fuzing and memory and measuring programs.

Gross profit as a percentage of sales increased for the three-month and nine-month fiscals period ended September 29, 2023, as compared to the corresponding periods in 2022. These increases were primarily attributable to the addition of gross profit from our Aircraft Wheel and Brake acquisition and improved performance on our K-MAX® spares and exchanges, bearings products and PMA aftermarket parts. These changes were partially offset by cost growth on certain fuzing, memory and measuring and composites programs and the write-off of $0.4 million and $1.0 million, respectively, in long lead parts that have no alternative use associated with the K-MAX® program.

Selling, General & Administrative Expenses (S,G&A)

	For the Three Months Ended						For the Nine Months Ended
	September 29, 2023			September 30, 2022			September 29, 2023			September 30, 2022
	(in thousands)
S,G&A	$	42,501		$	49,009		$	127,765		$	127,980
$ change	(6,508)			9,674			(215)			11,798
% change	(13.3)		%	24.6		%	(0.2)		%	10.2		%
% of net sales	23.2		%	28.5		%	22.3		%	26.1		%

S,G&A decreased for the three-month fiscal period ended September 29, 2023, when compared to the corresponding period in 2022, primarily attributable to the absence of $10.3 million in corporate development costs incurred in the prior year related to the acquisition of Aircraft Wheel and Brake and lower compensation and benefit costs as we realize savings associated with our restructuring activities announced earlier in the year. These decreases were partially offset by the addition of S,G&A from Aircraft Wheel and Brake.

S,G&A remained relatively flat for the nine-month fiscal period ended September 29, 2023, when compared to the corresponding period in 2022, primarily due to the absence of $12.3 million in corporate development costs incurred in the prior year related to the acquisition of Aircraft Wheel and Brake, mostly offset by the addition of S,G&A from Aircraft Wheel and Brake.

Restructuring and Severance Costs

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
	(in thousands)
Restructuring and severance costs	$	571	$	(243)	$	3,033	$	2,853

In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improve working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result of this review, the Company identified areas to reduce annualized costs in the Precision Products segment and at Corporate through streamlining processes, consolidating the production of fuzes for the JPF program at its Middletown facility, discontinuing K-MAX® helicopter production and right-sizing the Company's total cost structure. In connection with these restructuring actions, the Company currently expects to incur approximately $10.0 to $12.0 million in total pre-tax restructuring charges, consisting of approximately $9.0 to $10.0 million of cash expenditures relating to various headcount reduction and personnel initiatives and approximately $1.0 to $2.0 million of cash expenditures relating to facility closing costs, which we anticipate will generate approximately $25.0 million in total annualized costs savings by 2024. In the three-month and nine-month fiscal periods ended September 29, 2023, the Company incurred $0.6 million and $3.0 million, respectively, in severance costs associated with these actions. Since the announcement of these actions, we have incurred $9.7 million in costs through September 29, 2023.

33

Operating Income

	For the Three Months Ended						For the Nine Months Ended
	September 29, 2023			September 30, 2022			September 29, 2023			September 30, 2022
	(in thousands)
Operating income	$	11,872		$	(701)		$	37,119		$	4,074
$ change	12,573			(16,575)			33,045			(32,279)
% change	1,793.6		%	(104.4)		%	811.1		%	(88.8)		%
% of net sales	6.5		%	(0.4)		%	6.5		%	0.8		%

Operating income increased for the three-month and nine-month fiscal periods ended September 29, 2023, as compared to the corresponding periods in 2022. These increases were primarily driven by higher operating income at the Engineered Products segment and the absence of corporate development costs associated with the Aircraft Wheel and Brake acquisition, partially offset by lower operating income at the Precision Products and Structures segments. See Segment Results of Operations and Financial Condition below for further discussion of segment operating income.

Interest Expense, Net

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
	(in thousands)
Interest expense, net	$	9,405	$	3,614	$	29,349	$	8,088

Interest expense, net, generally consists of interest charged on our Credit Agreement, which includes a revolving credit facility, our convertible notes and the amortization of debt issuance costs, offset by interest income. Interest expense, net for the three-month and nine-month fiscal periods ended September 29, 2023 increased when compared to the corresponding periods in 2022, primarily due to increases of $6.3 million and $18.7 million, respectively, in interest expense on our revolving credit facility as a result of higher borrowings. Additionally, in the nine-month fiscal period, there was higher interest expense associated with our deferred compensation plan.

Effective Income Tax Rate

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
Effective income tax rate	24.0	%	28.9	%	28.5	%	18.1	%

The effective income tax rate represents the combined federal, state and foreign tax effects attributable to pretax earnings for the period. The effective tax rate for the three-month fiscal period ended September 29, 2023 decreased when compared to the corresponding rate in the prior year period, attributable to higher net earnings in the current period. The effective rate for the nine-month fiscal period ended September 29, 2023 increased when compared to the corresponding rate in the prior year period, primarily driven by a charge to record additional valuation allowances relating to the Company’s state tax loss carryforwards, partially offset by a benefit relating to the reversal of uncertain tax positions.

34

SEGMENT RESULTS OF OPERATIONS AND FINANCIAL CONDITION

Engineered Products Segment

Results of Operations

	For the Three Months Ended						For the Nine Months Ended
	September 29, 2023			September 30, 2022			September 29, 2023			September 30, 2022
	(in thousands)
Net sales	$	123,598		$	92,052		$	380,437		$	263,269
$ change	31,546			7,653			117,168			28,135
% change	34.3		%	9.1		%	44.5		%	12.0		%
Operating income	$	29,026		$	14,156		$	78,924		$	40,665
$ change	14,870			(775)			38,259			11,070
% change	105.0		%	(5.2)		%	94.1		%	37.4		%
% of net sales	23.5		%	15.4		%	20.7		%	15.4		%

Net Sales

Net sales for the three-month and nine-month fiscal periods ended September 29, 2023 increased compared to the corresponding periods in 2022, driven by higher sales volume of bearings products across each of our product lines, PMA aftermarket parts and $14.1 million and $53.9 million in additional revenue, respectively, from our Aircraft Wheel and Brake division. Additionally, in the nine-month fiscal period, higher sales were driven by an increase in volume for springs, seals and contacts used in medical applications. For the three-month and nine-month fiscal periods ended September 29, 2023, foreign currency exchange rates relative to the U.S. dollar had a favorable impact of $2.4 million and $1.9 million on net sales, respectively.

Operating Income

Operating income for the three-month and nine-month fiscal periods ended September 29, 2023 increased when compared to the corresponding periods in 2022, primarily due to the contribution of gross profit from our Aircraft Wheel and Brake acquisition, higher sales and associated gross profit on our commercial and defense bearings products and PMA aftermarket parts. These increases in gross profit, totaling $20.4 million and $61.6 million, respectively, were partially offset by the addition of S,G&A and $2.5 million and $11.9 million, respectively, in intangible asset amortization, primarily driven by Aircraft Wheel and Brake.

Precision Products Segment

Results of Operations

	For the Three Months Ended						For the Nine Months Ended
	September 29, 2023			September 30, 2022			September 29, 2023			September 30, 2022
	(in thousands)
Net sales	$	27,098		$	46,282		$	93,128		$	135,098
$ change	(19,184)			(17,302)			(41,970)			(60,558)
% change	(41.5)		%	(27.2)		%	(31.1)		%	(31.0)		%
Operating (loss) income	$	(3,241)		$	5,296		$	(3,996)		$	10,725
$ change	(8,537)			(8,408)			(14,721)			(35,495)
% change	(161.2)		%	(61.4)		%	(137.3)		%	(76.8)		%
% of net sales	(12.0)		%	11.4		%	(4.3)		%	7.9		%

35

Net Sales

Net sales for the three-month fiscal period ended September 29, 2023 decreased when compared to the corresponding period in 2022, primarily due to lower sales on the JPF program and legacy fuzing programs. These decreases, totaling $30.5 million, were partially offset by higher sales on our FireBurstTM and KARGO programs and from K-MAX® spares and exchanges.

Net sales for the nine-month fiscal period ended September 29, 2023 decreased when compared to the corresponding period in 2022, primarily due to lower sales on the JPF program, partially offset by higher sales on our JASSM® fuzing program, FireBurstTM program and K-MAX® spares and exchanges.

Operating (Loss) Income

Operating income decreased for the three-month and nine-month fiscal periods ended September 29, 2023 when compared to the corresponding periods in 2022, primarily attributable to lower sales and gross profit on the JPF program and cost growth on legacy measuring programs, partially offset by higher gross profit on the K-MAX® spares and exchanges. Additionally, in the nine-month fiscal period, there was higher gross profit on the JASSM® fuzing program.

Major Programs/Product Lines

Below is a discussion of significant changes in major programs within the Precision Products segment during the first nine months of 2023. See our 2022 Form 10-K, including Item 1A, "Risk Factors", for a complete discussion of our major programs.

FMU-152 A/B – JPF

We manufacture and produce the FMU 152 A/B (the "JPF"), an electro-mechanical bomb safe and arming device, which allows the settings of a weapon to be programmed in flight. Sales of these fuzes can be direct to the U.S. Government ("USG"), Foreign Military Sales ("FMS") through the USG and Direct Commercial Sales (“DCS”) to foreign militaries that, although not funded by or sold through the USG, require regulatory approvals from the USG.

A total of 102 fuzes were delivered to our customers during the third quarter of 2023, bringing the year-to-date total to 8,548 fuzes. We expect to deliver 8,500 to 10,000 fuzes in 2023. Total JPF backlog at September 29, 2023 was $9.6 million, down from $20.0 million at December 31, 2022.

Our JPF program continues to wind down as it moves to the end of its lifecycle, reflecting the previously announced decision of the United States Air Force ("USAF") to move from the JPF to the FMU-139 D/B (which we do not manufacture or produce) as its primary fuze system. We completed Option 16 of our JPF contract with the USG in the second quarter of 2023, which related solely to the procurement of fuzes by or in support of foreign militaries and does not include any sales to the USAF. The USG has indicated that they will not award us any future options; therefore, the future viability of our JPF program will depend entirely on our ability to market and sell the JPF to foreign militaries in DCS transactions. We are currently in discussions with two Middle Eastern customers for one or more follow-on orders aggregating a minimum of $45.0 million that would further extend the life of the program, but there can be no assurance as to the receipt, magnitude and timing of these orders. Moreover, any such orders, if received, would be subject to the receipt of all necessary export approvals, licenses and other authorizations needed to effectuate the sales, which are subject to political and geopolitical conditions beyond our control. In the fourth quarter of 2022, we announced a restructuring plan that will lead to the permanent closure of our Orlando, Florida manufacturing facility by the end of 2024. The Company has consolidated JPF production in its Middletown, Connecticut, facility as the facility has the potential capacity to fulfill the requirements for future DCS orders.

36

Structures Segment

Results of Operations

	For the Three Months Ended						For the Nine Months Ended
	September 29, 2023			September 30, 2022			September 29, 2023			September 30, 2022
	(in thousands)
Net sales	$	32,335		$	33,670		$	99,166		$	92,451
$ change	(1,335)			1,817			6,715			(10,605)
% change	(4.0)		%	5.7		%	7.3		%	(10.3)		%
Operating loss	$	(3,020)		$	(642)		$	(3,769)		$	(2,121)
$ change	2,378			972			1,648			1,250
% change	370.4		%	294.5		%	77.7		%	143.5		%
% of net sales	(9.3)		%	(1.9)		%	(3.8)		%	(2.3)		%

Net Sales

Net sales for the three-month fiscal period ended September 29, 2023 decreased when compared to the corresponding period in 2022, primarily due to lower sales on our A-10 program and Sikorsky UH-60 BLACK HAWK program. These decreases, totaling $3.9 million, were partially offset by higher sales on our programs with Rolls Royce and a certain program with Sikorsky.

Net sales for the nine-month fiscal period ended September 29, 2023 increased when compared to the corresponding period in 2022, primarily due to higher sales on our programs with Rolls Royce and certain programs with Sikorsky. These increases, totaling $13.2 million, were partially offset by the wind down of the AH-1Z program and lower sales on our Sikorsky UH-60 BLACK HAWK program and Bell commercial program.

Operating Loss

Structures had a higher operating loss in the three-month fiscal period ended September 29, 2023 when compared to the corresponding period in 2022, primarily driven by lower gross profit on the A-10 program and the Sikorsky UH-60 BLACK HAWK program.

Structures had a higher operating loss in the nine-month fiscal period ended September 29, 2023 when compared to the corresponding period in 2022, primarily due to lower gross profit on certain composites programs and the A-10 program. These changes, totaling $3.4 million, were partially offset by higher sales and gross profit on our programs with Rolls Royce and the receipt of an insurance claim settlement of $1.5 million in the current period related to a fire at one of our suppliers in the prior year.

Backlog

	September 29, 2023		December 31, 2022
	(in thousands)
Engineered Products	$	363,228	$	322,452
Precision Products	100,712		134,903
Structures	254,633		263,581
Total Backlog	$	718,573	$	720,936

Backlog remained relatively flat during the first nine months of 2023, primarily attributable to revenue recognized in the period, mostly offset by new orders in our Engineered Products segment and on our Sikorsky UH-60 BLACK HAWK, K-MAX® and Rolls Royce programs.

37

LIQUIDITY AND CAPITAL RESOURCES

Discussion and Analysis of Cash Flows

We assess liquidity in terms of our ability to generate cash to fund working capital requirements and investing and financing activities. Significant factors affecting liquidity include: cash flows generated from or used by operating activities, capital expenditures, investments in our business and programs, acquisitions, divestitures, dividends, availability of future credit, share repurchase programs, adequacy of available bank lines of credit, and factors that might otherwise affect the Company's business and operations generally, as described under the heading “Risk Factors” and “Forward-Looking Statements” in Item 1A of Part I of our 2022 Form 10-K.

A summary of our consolidated cash flows is as follows:

	For the Nine Months Ended
	September 29, 2023		September 30, 2022		2023 vs. 2022
	(in thousands)
Total cash provided by (used in):
Operating activities	$	29,673	$	(33,700)	$	63,373
Investing activities	(22,059)		(466,528)		444,469
Financing activities	(1,581)		391,918		(393,499)
Free Cash Flow (a)
Net cash provided by (used in) operating activities	$	29,673	$	(33,700)	$	63,373
Expenditures for property, plant and equipment	(19,864)		(17,626)		(2,238)
Free cash flow	$	9,809	$	(51,326)	$	61,135

(a) Free Cash Flow, a non-GAAP financial measure, is defined as net cash (used in) provided by operating activities less expenditures for property, plant and equipment, both of which are presented in our Condensed Consolidated Statements of Cash Flows. See Management’s Discussion and Analysis of Financial Condition and Results of Operations—Non-GAAP Financial Measures for more information regarding Free Cash Flow.

Net cash provided by operating activities was $29.7 million for the nine-month fiscal period ended September 29, 2023, compared to net cash used of $33.7 million in the comparable period in 2022. This change was largely driven by improved performance, the receipt of income tax refunds in the current period, the wind down of work performed on the JPF program, the timing of payments and lower incentive compensation payments, partially offset by inventory purchased for various programs.

Net cash used in investing activities was $22.1 million for the nine-month fiscal period ended September 29, 2023, $444.5 million less than cash used in the comparable period in 2022. This decrease was primarily attributable to the acquisition of Aircraft Wheel and Brake in the prior year. Refer to Note 3, Business Combinations and Investments, for further information on this acquisition.

Net cash used by financing activities was $1.6 million for the nine-month fiscal period ended September 29, 2023, compared to net cash provided of $391.9 million in the comparable period in 2022. This decrease was primarily due to borrowings under our Credit Agreement in the prior year for the acquisition of Aircraft Wheel and Brake.

We anticipate a variety of items will have an impact on our liquidity during the next twelve months, in addition to our working capital requirements. These could include one or more of the following:

•the maturity of our Convertible Notes;

•the matters described in Note 14, Commitments and Contingencies, in the Notes to Condensed Consolidated Financial Statements, including the cost of existing environmental remediation matters;

•contributions to our qualified pension plan and Supplemental Employees’ Retirement Plan (“SERP”);

•deferred compensation payments to officers;

•interest payments on outstanding debt;

•income tax payments;

•costs associated with acquisitions and corporate development activities;

•finance and operating lease payments;

•capital expenditures;

38

•research and development expenditures;

•repurchase of common stock under share repurchase programs;

•payment of dividends;

•costs associated with the start-up of new programs; and

•the timing of payments and the extension of payment terms by our customers.

Financing Arrangements

We continue to rely upon bank financing as an important source of liquidity for our business activities, including acquisitions. We believe this, when combined with cash generated from operating activities, will be sufficient to support our anticipated future cash requirements; however, we may decide to borrow additional funds or raise additional equity capital to support other business activities, including potential future acquisitions. We regularly monitor credit market conditions to identify potential issues that may adversely affect, or provide opportunities for, the securing and/or advantageous pricing of additional financing, if any, that may be necessary to continue with our growth strategy and finance working capital requirements. Our Convertible Notes will mature in 2024, as discussed below. We currently expect to settle our Convertible Notes with available borrowing capacity under our Credit Agreement; however we continue to assess other potential options for the refinancing of these instruments prior to their scheduled maturity. With the extension of our Credit Agreement, we maintained sufficient capacity to use proceeds from this facility to repay the Convertible Notes and satisfy our working capital requirements. Refer to Note 14, Debt, in the Notes to the Consolidated Financial Statements, included in Item 8, Financial Statements and Supplementary Data, of the 2022 Form 10-K for further information on our Convertible Notes.

Convertible Notes

During May 2017, we issued $200.0 million aggregate principal amount of convertible senior unsecured notes due May 2024 (the "2024 Notes") pursuant to an indenture, dated May 12, 2017, between the Company and U.S. Bank National Association, as trustee (as amended by the First Supplemental Indenture thereto, dated July 15, 2019, the "Indenture"). In connection therewith, we entered into certain capped call transactions that cover, collectively, the number of shares of the Company's common stock underlying the 2024 Notes. The 2024 Notes bear 3.25% interest per annum on the principal amount, payable semiannually in arrears on May 1 and November 1 of each year, beginning on November 1, 2017. The 2024 Notes will mature on May 1, 2024, unless earlier repurchased by the Company or converted. We will settle any conversions of the 2024 Notes in cash, shares of the Company's common stock or a combination of cash and shares of common stock, at our election.

The sale of our former Distribution business in the third quarter of 2019 was deemed to be a "Fundamental Change" and a "Make-Whole Fundamental Change" pursuant to the terms and conditions of the indenture governing the 2024 Notes. As a result, the sale triggered the right of the holders of our 2024 Notes to require us to repurchase all of the 2024 Notes, or any portion thereof that is a multiple of $1,000 principal amount on September 27, 2019. The aggregate principal amount of the 2024 Notes validly tendered and not validly withdrawn was $0.5 million, representing approximately 0.25% of all outstanding notes. Holders of such notes received the repurchase price equal to 100% of the principal amount of the 2024 Notes being purchased, plus accrued and unpaid interest.

We incurred $7.4 million of debt issuance costs in connection with the sale of the 2024 Notes, which were allocated between the debt and equity components of the instrument at issuance. Of the total amount, $0.7 million was recorded as an offset to additional paid-in capital. The balance, $6.7 million, was recorded as a contra-debt balance and was being amortized over the term of the 2024 Notes. As a result of the adoption of ASU 2020-06, the amount recorded to additional paid-in capital was reclassified to retained earnings in the cumulative effect adjustment recorded on January 1, 2022. The remaining balance of debt issuance costs is being amortized over the term of the convertible notes. In both periods, total amortization expense for the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022 was $0.3 million and $0.8 million, respectively.

Credit Agreement

On June 21, 2023 (the "Closing Date"), the Company closed an amended and restated $740.0 million Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A., as Administrative Agent and as Collateral Agent. The Credit Agreement amends and restates the Company's previously existing credit facility in its entirety to, among other things: (i) extend the maturity date to June 21, 2028; (ii) reduce the aggregate amount of revolving commitments from $800.0 million to $740.0 million; (iii) modify the financial covenants set forth in Article 6 of the previously existing credit facility; and (iv) effectuate certain additional modifications set forth in the previously existing facility, including its pricing. Capitalized terms used but not defined within this discussion of the Credit Agreement have the meanings ascribed thereto in the Credit

39

Agreement, which with amendments is included as Exhibit 10.5 to our Quarterly Report on Form 10-Q for the quarter ended June 30, 2023.

Interest rates on amounts outstanding under the Credit Agreement are variable based on the Secured Overnight Financing Rate ("SOFR"). The interest rate at September 29, 2023 was 7.13%. We are required to pay a quarterly commitment fee on the unused revolving loan commitment amount at a rate ranging from 0.200% to 0.350% per annum, based on the Senior Secured Net Leverage Ratio. Fees for outstanding letters of credit range from 1.375% to 2.250%, based on the Senior Secured Net Leverage Ratio. At September 29, 2023, $382.0 million was outstanding under the revolving credit facility and total average bank borrowings were $391.9 million during the nine-month fiscal period ended September 29, 2023. Total average bank borrowings were $120.7 million during the year ended December 31, 2022. As of September 29, 2023, the Consolidated Total Net Leverage Ratio was 3.89, as calculated in accordance with the Credit Agreement, as compared to the ceiling of 4.75 to 1.00.

The following table shows the amounts available for borrowing under the Company's revolving credit facility:

	September 29, 2023		December 31, 2022
In thousands
Total facility	$	740,000	$	800,000
Amounts outstanding, excluding letters of credit	382,000		363,000
Amounts available for borrowing, excluding letters of credit	358,000		437,000
Letters of credit under the credit facility(1)(2)	70,549		51,630
Amounts available for borrowing	$	287,451	$	385,370
Amounts available for borrowing subject to EBITDA, as defined by the Credit Agreement	$	129,313	$	196,256

(1) The Company has entered into standby letters of credit issued on the Company's behalf by financial institutions, and directly issued guarantees to third parties primarily related to advances received from customers and the guarantee of future performance on certain contracts. Letters of credit generally are available for draw down in the event the Company does not perform its obligations.

(2) Of these amounts, $65.1 million and $46.1 million in letters of credit relate to a JPF DCS contract in the periods ended September 29, 2023 and December 31, 2022, respectively.

(3) The Company's Convertible Notes will mature in 2024. The Company currently expects to settle the Convertible notes with available borrowing capacity under our Credit Agreement; however we are assessing potential options for the refinancing of these instruments prior to their scheduled maturity. With the extension of the Credit Agreement, the Company maintained sufficient capacity to use proceeds from this facility to repay the Convertible Notes. The amounts available for borrowing subject to EBITDA represents amounts available for borrowing after considering the Company's total debt obligations including its Credit Agreement and Convertible Notes.

Debt issuance costs in connection with the Credit Agreement have been capitalized. The Company incurred $4.8 million of debt issuance costs in connection with the amendment of the Credit Agreement in 2023, which are being amortized over the term of the agreement with the debt issuance costs associated with the previous existing credit facility for lenders that remained in the Credit Agreement. In the second quarter of 2023, the Company recorded a write-off of debt issuance costs of $0.6 million related to lenders that are no longer participating in the Credit Agreement. Total amortization expense for the three-month fiscal periods ended September 29, 2023 and September 30, 2022 was $0.4 million and $0.7 million, respectively. Total amortization expense for the nine-month fiscal periods ended September 29, 2023 and September 30, 2022 was $1.6 million and $1.2 million, respectively.

Interest Rate Swaps

During 2022, we entered into interest rate swap agreements, effective January 1, 2023, for the purposes of hedging the eight quarterly variable-rate Credit Agreement interest payments due in 2023 and 2024. These interest rate swap agreements were designated as cash flow hedges and intended to manage interest rate risk associated with our variable-rate borrowings and minimize the impact on our earnings and cash flows of interest rate fluctuations attributable to changes in SOFR. These interest rate swaps were not material to the Company's Condensed Consolidated Financial Statements as of September 29, 2023. Over the next twelve months, the income related to cash flow hedges expected to be reclassified from other comprehensive income is $1.6 million.

40

Other Sources/Uses of Capital

Letters of Credit

Of the standby letters of credit under our credit facility, $65.1 million in letters of credit relate to a JPF DCS contract, including the offset agreement. In the event that we default on the contract and we are unable to fulfill our contractual obligations, our customer has the ability to draw on the letters of credit.

Pension Plans

Management regularly monitors pension plan asset performance and the assumptions used in the determination of our benefit obligation, comparing them to actual performance. We continue to believe the assumptions selected are valid due to the long-term nature of our benefit obligation.

No contributions have been or are expected to be made to the qualified pension plan during 2023. The Company contributed $0.4 million to the SERP through the end of the third quarter of 2023 and plans to contribute an additional $0.1 million to the SERP in 2023. In 2022, no contribution was made to the qualified pension plan and we paid $0.5 million in SERP benefits.

Share-based Arrangements

As of September 29, 2023, future compensation costs related to non-vested stock options, restricted stock grants and performance stock grants is $10.2 million. The Company anticipates that this cost will be recognized over a weighted-average period of 1.9 years.

NON-GAAP FINANCIAL MEASURES

Management believes the non-GAAP (Generally Accepted Accounting Principles) measures used in this report provide investors with important perspectives into our ongoing business performance. We do not intend for the information to be considered in isolation or as a substitute for the related GAAP measures. Other companies may define the measures differently. We define the non-GAAP measures used in this report and other disclosures as follows:

Organic Sales

Organic Sales is defined as "Net Sales" less sales derived from acquisitions completed during the previous twelve months. We believe that this measure provides management and investors with a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding the effect of acquisitions, which can obscure underlying trends. We also believe that presenting Organic Sales separately provides management and investors with useful information about the trends impacting our operations and enables a more direct comparison to other businesses and companies in similar industries. Management recognizes that the term "Organic Sales" may be interpreted differently by other companies and under different circumstances.

Organic Sales (in thousands)
	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
Net sales	$	183,031	$	172,004	$	572,731	$	490,818
Acquisition sales	12,317		—		52,062		—
Organic Sales	$	170,714	$	172,004	$	520,669	$	490,818

41

Free Cash Flow

Free Cash Flow is defined as GAAP “Net cash provided by (used in) operating activities” in a period less “Expenditures for property, plant & equipment” in the same period. Management believes Free Cash Flow provides an important perspective on our ability to generate cash from our business operations and, as such, that it is an important financial measure for use in evaluating the Company's financial performance. Free Cash Flow should not be viewed as representing the residual cash flow available for discretionary expenditures such as dividends to shareholders or acquisitions, as it may exclude certain mandatory expenditures such as repayment of maturing debt and other contractual obligations. Management uses Free Cash Flow internally to assess overall liquidity.

CONTRACTUAL OBLIGATIONS AND OFF-BALANCE SHEET ARRANGEMENTS

There have been no material changes outside the ordinary course of business in our contractual obligations or off-balance sheet arrangements during the first nine months of 2023. See our 2022 Form 10-K for a discussion of our contractual obligations and off-balance sheet arrangements.

CRITICAL ACCOUNTING ESTIMATES

Preparation of the Company’s financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. Management believes the most complex and sensitive judgments, because of their significance to the Consolidated Financial Statements, result primarily from the need to make estimates about the effects of matters that are inherently uncertain. Management’s Discussion and Analysis and the Notes to Consolidated Financial Statements in the Company’s 2022 Form 10-K describe the critical accounting estimates and significant accounting policies used in preparing the Consolidated Financial Statements. Actual results in these areas could differ from management’s estimates.

RECENT ACCOUNTING STANDARDS

There have been no recent changes in accounting standards during the first nine months of 2023.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no significant changes in the Company’s exposure to market risk during the first nine months of 2023. See the Company’s 2022 Form 10-K for a discussion of the Company’s exposure to market risk.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We have carried out an evaluation, under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Act of 1934, as amended, as of September 29, 2023. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives. Based upon our evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that, as of September 29, 2023, our disclosure controls and procedures were effective.

Internal Controls over Financial Reporting

There was no change to our internal control over financial reporting that occurred during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to affect, our internal control over financial reporting.

42

PART II

Item 1. Legal Proceedings

General

From time to time, as a normal incident of the nature and kinds of businesses in which the Company and its subsidiaries are, and were, engaged, various claims or charges are asserted and legal proceedings are commenced by or against the Company and/or one or more of its subsidiaries. Claimed amounts may be substantial but may not bear any reasonable relationship to the merits of the claim or the extent of any real risk of court or arbitral awards. We record accruals for losses related to those matters that we consider to be probable and that can be reasonably estimated. Gain contingencies, if any, are recognized when they are realized and legal costs generally are expensed when incurred.

We evaluate, on a quarterly basis, developments in legal proceedings that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. Our loss contingencies are subject to substantial uncertainties, however, including for each such contingency the following, among other factors: (i) the procedural status of the case; (ii) whether the case has or may be certified as a class action suit; (iii) the outcome of preliminary motions; (iv) the impact of discovery; (v) whether there are significant factual issues to be determined or resolved; (vi) whether the proceedings involve a large number of parties and/or claims in multiple jurisdictions or jurisdictions in which the relevant laws are complex or unclear; (vii) the extent of potential damages, which are often unspecified or indeterminate; and (viii) the status of settlement discussions, if any, and the settlement postures of the parties. Because of these uncertainties, management has determined that, except as otherwise noted below, the amount of loss or range of loss that is reasonably possible in respect of each matter described below (including any reasonably possible losses in excess of amounts already accrued), is not reasonably estimable.

While it is not possible to predict the outcome of these matters with certainty, based upon available information, management believes that all settlements, arbitration awards and final judgments, if any, which are considered probable of being rendered against us in legal proceedings and that can be reasonably estimated are accrued for at September 29, 2023. Despite this analysis, there can be no assurance that the final outcome of these matters will not have a material adverse effect on our business, financial condition, results of operations or cash flows.

As of September 29, 2023, neither the Company nor any of its subsidiaries was a party, nor was any of its or their property subject, to any material pending legal proceedings, other than ordinary routine litigation incidental to the business of the Company and its subsidiaries. Additional information relating to certain of these matters is set forth in Note 14, Commitments and Contingencies, of the Notes to Condensed Consolidated Financial Statements.

Aircraft Safety Matters

The Company designs, manufactures, services and sells complex and sophisticated aerospace parts, subassemblies and aircraft. These products are manufactured according to detailed specifications and are subject to strict approval or certification requirements. Technical, mechanical and other failures may occur as a result of manufacturing or design defects, operational processes or production issues attributable to us, our customers, suppliers, third party integrators or others. Due to the nature of the Company's business, liability claims may arise from accidents involving products the Company has manufactured, including claims for injury or death. Product or system failures could result in product recalls, regulatory directives and product liability and warranty claims (including claims related to the safety or reliability of our products). Such failures could also lead to service, repair and maintenance costs, damages and fines and regulatory and environmental liabilities. While management believes that the Company maintains adequate insurance for these risks, insurance cannot be obtained to protect against all risks and liabilities. It is therefore possible that the insurance coverage may not cover all claims or liabilities, and the Company may be forced to bear unanticipated costs or liabilities. As of September 29, 2023, the Company is party to pending litigation proceedings relating to two incidents involving K-MAX® helicopters that each resulted in a fatality, and the Company has been notified of additional potential claims relating to one of such incidents. Each incident is the subject of one or more investigations undertaken by applicable civil aviation agencies located in the jurisdiction of the incident. These investigations are at varying stages of completion; certain agencies have issued final reports or taken other actions, while other investigations remain in progress. While it is not possible to predict the final outcome of all investigations, litigation or claims relating to these or other potential incidents, management believes that all such investigations, litigation or claims in existence at September 29, 2023, are not reasonably likely to have a material adverse effect on our business, financial condition and results of operations or cash flows.

43

Environmental Matters

The Company and its subsidiaries are subject to numerous U.S. federal, state and international environmental laws and regulatory requirements and are involved from time to time in investigations or litigation of various potential environmental issues concerning activities at our facilities or former facilities or remediation as a result of past activities (including past activities of companies we have acquired). From time to time, we receive notices from the U.S. Environmental Protection Agency or equivalent state or international environmental agencies that we are a potentially responsible party under the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as the “Superfund Act”) and/or equivalent laws. Such notices assert potential liability for cleanup costs at various sites, which may include sites owned by us, sites we previously owned and treatment or disposal sites not owned by us, allegedly containing hazardous substances attributable to us from past operations. While it is not possible to predict the outcome of these proceedings, in the opinion of management, any payments we may be required to make as a result of all such claims in existence at September 29, 2023, will not have a material adverse effect on our business, financial condition and results of operations or cash flows.

Item 1A. Risk Factors

Investors should carefully review and consider the information regarding certain factors that could materially affect our business, results of operations, financial condition and cash flows as set forth under Item 1A. “Risk Factors” in our 2022 Form 10-K and Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023. Except as set forth below, we do not believe there have been any material changes to the risk factors previously disclosed in our 2022 Form 10-K, as updated by our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023, but we may disclose changes to such factors or disclose additional factors from time to time in future filings with the SEC. Additional risks and uncertainties not presently known to us or that we currently believe not to be material may also adversely impact our business, results of operations, financial position and cash flows.

We design, manufacture, service and sell complex aerospace parts, subassemblies and aircraft that subject us to potential risks and liabilities in the event they do not operate as intended.

The Company designs, manufactures, services and sells complex and sophisticated aerospace parts, subassemblies and aircraft. These products are manufactured according to detailed specifications and are subject to strict approval or certification requirements. Technical, mechanical and other failures have occurred in the past, and may occur in the future, whether as a result of manufacturing or design defects, operational processes or production issues attributable to us, our customers, suppliers, third party integrators or others. Our products could also fail as a result of cyber-attacks, such as those that seize control and result in misuse or unintended use of our products, or other intentional acts. Due to the nature of the Company's business, liability claims have arisen, and may arise in the future, from accidents or disasters involving products the Company has manufactured, including claims for injury or death. Product or system failures could result in negative publicity that could reduce demand for our products, product recalls, regulatory directives and product liability and warranty claims (including claims related to the safety or reliability of our products). Such failures could also lead to service, repair and maintenance costs, damages and fines and regulatory and environmental liabilities. While management believes that the Company maintains adequate insurance for these risks, insurance cannot be obtained to protect against all risks and liabilities. It is therefore possible that the insurance coverage may not cover all claims or liabilities, and the Company may be forced to bear unanticipated costs or liabilities. As of September 29, 2023, the Company is party to pending litigation proceedings relating to two incidents involving K-MAX® helicopters that each resulted in a fatality, and the Company has been notified of additional potential claims relating to one of such incidents. Each incident is the subject of one or more investigations undertaken by applicable civil aviation agencies located in the jurisdiction of the incident. These investigations are at varying stages of completion; certain agencies have issued final reports or taken other actions, while other investigations remain in progress. While it is not possible to predict the final outcome of all investigations, litigation or claims relating to these or other potential incidents, management believes that all such investigations, litigation or claims in existence at September 29, 2023, are not reasonably likely to have a material adverse effect on our business, financial condition and results of operations or cash flows.

We are subject to environmental laws and regulations and risks associated with environmental liabilities, violations and litigation.

We are subject to a variety of U.S. federal, state, local and non-U.S. environmental, health and safety laws and regulations concerning, among other things, the health and safety of our employees, the generation, storage, use, transportation and disposal of certain materials including hazardous materials, emissions or discharges of substances into the environment, and investigation and remediation of hazardous substances or materials at various sites. Our operations involve the use, primarily in our manufacturing processes, of substances subject to these laws and regulations. Our failure to comply with these laws or regulations could result in regulatory penalties, fines, and legal liabilities; suspension of production; alteration of our

44

manufacturing; damage to our reputation; and restrictions on our operations or sales. Furthermore, environmental laws outside of the U.S. are becoming more stringent, resulting in increased costs and compliance burdens.

We are also subject to other environmental laws and regulations, including those that require us to investigate and remediate soil or groundwater to meet certain remediation standards. Under federal law, generators of waste materials, and current and former owners or operators of facilities, can be subject to liability for investigation and remediation costs at locations that have been identified as requiring response actions. Liability under these laws may be retroactive, strict, joint and several, meaning that we could be liable for the costs of cleaning up environmental contamination regardless of when it occurred, fault or the amount of waste directly attributable to us. We have liabilities for investigation and remediation costs at various sites; however, the ultimate cost of site cleanup and timing of future cash outflows is difficult to predict, given the uncertainties regarding the extent of the required cleanup, the interpretation of applicable laws and regulations, and alternative cleanup methods.

Additionally, future environmental investigation and remediation costs, including capital expenditures for environmental projects, may increase because of new laws and regulations, changing interpretations and stricter enforcement of current laws and regulations by regulatory authorities, expanding groundwater and other testing requirements, and new information on emerging contaminants such as per- and polyfluoroalkyl substances (“PFAS”), as well as uncertainty regarding remediation methods for such emerging contaminants.

In 2014, the Company sold its former manufacturing facility in Moosup, Connecticut, to TD Development, LLC ("TD"). Although TD, assumed contractual and statutory responsibility for the environmental remediation work required on this site (subject to a cost-sharing arrangement with the Company), the Company may be liable for the full cost of the investigation, remediation and abatement of the site if TD fails to perform its contractual and statutory obligations. In September 2021, TD’s principal, Todd Clifford (“Clifford”) filed for bankruptcy protection, and during the course of that bankruptcy proceeding, the Company has learned that neither TD nor Clifford is expected to have the means to support the investigation, remediation and abatement of the site. Although the Company has filed an objection to the issuance of a discharge in the bankruptcy proceeding, it is currently negotiating a settlement with TD and Clifford pursuant to which the Company would be positioned to assume primary responsibility for the investigation, remediation and abatement of the site, with a modest contribution from Clifford. Any such settlement would be subject to the receipt of bankruptcy court approval. The Company is currently unable to estimate the costs that are likely to be incurred in connection with these environmental investigation and remediation activities.

The costs of complying with current or future environmental protection and health and safety laws and regulations, or liabilities arising from past or future releases of, or exposures to, hazardous substances, may exceed our estimates, or have a material adverse effect on our business, results of operations, financial condition, and cash flows.

FORWARD-LOOKING STATEMENTS

This report contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others: (i) changes in domestic and foreign economic and competitive conditions in markets served by the Company, particularly the defense, commercial aviation and industrial production markets; (ii) changes in government and customer priorities and requirements (including cost-cutting initiatives, government and customer shut-downs, the potential deferral of awards, terminations or reductions of expenditures to respond to the priorities of Congress and the Administration, or budgetary cuts resulting from Congressional actions or automatic sequestration); (iii) risks and uncertainties associated with the successful integration of our Aircraft Wheel and Brake acquisition; (iv) changes in geopolitical conditions in countries where the Company does or intends to do business; (v) the successful conclusion of competitions for government programs (including new, follow-on and successor programs) and thereafter successful contract negotiations with government authorities (both foreign and domestic) for the terms and conditions of the programs; (vi) the timely receipt of any necessary export approvals and/or other licenses or authorizations from the USG; (vii) timely satisfaction or fulfillment of material contractual conditions precedents in customer purchase orders, contracts, or similar arrangements; (viii) the existence of standard government contract provisions permitting

45

renegotiation of terms and termination for the convenience of the government; (ix) the successful resolution of government inquiries or investigations relating to our businesses and programs; (x) risks and uncertainties associated with the successful implementation and ramp up of significant new programs, including the ability to manufacture the products to the detailed specifications required and recover start-up costs and other investments in the programs; (xi) potential difficulties associated with variable acceptance test results, given sensitive production materials and extreme test parameters; (xii) the receipt and successful execution of production orders under the Company's existing USG JPF contract, including the exercise of all contract options and receipt of orders from allied militaries, but excluding any next generation programmable fuze programs, as all have been assumed in connection with goodwill impairment evaluations; (xiii) the continued support of the existing K-MAX® helicopter fleet, including sale of existing K-MAX® spare parts inventory and the receipt of orders for new aircraft sufficient to recover our investments in the K-MAX® production line; (xiv) the accuracy of current cost estimates associated with environmental remediation activities; (xv) the profitable integration of acquired businesses into the Company's operations; (xvi) the ability to recover from cyber-based or other security attacks, information technology failures or other disruptions; (xvii) changes in supplier sales or vendor incentive policies; (xviii) the ability of our suppliers to satisfy their performance obligations, including any supply chain disruptions; (xix) the effects of price increases or decreases; (xx) the effects of pension regulations, pension plan assumptions, pension plan asset performance, future contributions and the pension freeze; (xxi) future levels of indebtedness and capital expenditures; (xxii) compliance with our debt covenants; (xxiii) the continued availability of raw materials and other commodities in adequate supplies and the effect of increased costs for such items; (xxiv) the effects of currency exchange rates and foreign competition on future operations; (xxv) changes in laws and regulations, taxes, interest rates, inflation rates and general business conditions; (xxvi) future repurchases and/or issuances of common stock;(xxvii) the occurrence of unanticipated restructuring costs or the failure to realize anticipated savings or benefits from past or future expense reduction actions; (xxviii) the ability to recruit and retain skilled employees; (xxix) the successful resolution of all pending and future investigations, litigation or claims relating to the manufacture or design of our products, including, without limitation, the K-MAX® helicopter; and (xxx) other risks and uncertainties set forth herein and in our 2022 Form 10-K, as updated by our Quarterly Report on Form 10-Q for the quarters ended March 31, 2023 and June 30, 2023.

Any forward-looking information provided in this report should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

Item 2. Unregistered Sales of Equity Securities, Use of Proceeds and Issuer Purchases of Equity Securities

The following table provides information about purchases of common stock by the Company during the three-month fiscal period ended September 29, 2023:

Period	Total Number of Shares Purchased (a)	Average Price Paid per Share		Total Number of Shares Purchased as Part of a Publicly Announced Plan (b)	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plan(b) (in thousands)
July 1, 2023 - July 28, 2023	1,984	$	24.48	—	$50,000
July 29, 2023 - August 25, 2023	—	$	—	—	$50,000
August 26, 2023 - September 29, 2023	—	$	—	—	$50,000
Total	1,984			—

(a) During the third quarter of 2023, there were 1,984 Company purchased shares in connection with employee tax withholding obligations as permitted by our equity compensation plans, which are SEC Rule 16b-3 qualified compensation plans. These were not purchases under our publicly announced program.

(b) On April 20, 2022, the Company announced that its Board of Directors approved a $50.0 million share repurchase program. For additional information, see "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations -- Liquidity and Capital Resources -- Other Sources/Uses of Capital" in the 2022 Form 10-K.

Item 5. Other Information

During the three-month fiscal period ended September 29, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

46

Item 6.     Index To Exhibits

10.1	Amendment No. 1 to Executive Employment Agreement, by and between Ian K. Walsh and the Company (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K, dated August 9, 2023, File No. 001-35419).	Previously Filed
31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14 under the Securities Exchange Act of 1934	Filed Herewith
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14 under the Securities Exchange Act of 1934	Filed Herewith
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Furnished Herewith
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	Furnished Herewith
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File, formatted in iXBRL and contained in Exhibit 101

47

SIGNATURES

Kaman Corporation and Subsidiaries

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		KAMAN CORPORATION
		Registrant
Date:	November 1, 2023		/s/ Ian K. Walsh
		By:	Ian K. Walsh
			Chairman, President and
			Chief Executive Officer

Date:	November 1, 2023		/s/ Carroll K. Lane
		By:	Carroll K. Lane
			Senior Vice President and
			Interim Chief Financial Officer

48

EX-31.1

Exhibit 31.1

Certification Pursuant to Rule

13a-14 under the Securities

Exchange Act of 1934

I, Ian K. Walsh, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Kaman Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	November 1, 2023	By:	/s/ Ian K. Walsh
			Ian K. Walsh
			Chairman, President and
			Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification Pursuant to Rule

13a-14 under the Securities and

Exchange Act of 1934

I, Carroll K. Lane, certify that:

1.I have reviewed this quarterly report on Form 10-Q of Kaman Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report, based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:	November 1, 2023	By:	/s/ Carroll K. Lane
			Carroll K. Lane
			Senior Vice President and
			Interim Chief Financial Officer

EX-32.1

Exhibit 32.1

Certification Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Kaman Corporation (the "Corporation") on Form 10-Q for the quarter ended September 29, 2023, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ian K. Walsh, Chairman, President and Chief Executive Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

By:	/s/ Ian K. Walsh
	Ian K. Walsh
	Chairman, President and
	Chief Executive Officer
	November 1, 2023

EX-32.2

Exhibit 32.2

Certification Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Kaman Corporation (the "Corporation") on Form 10-Q for the quarter ended September 29, 2023, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Carroll K. Lane, Senior Vice President and Interim Chief Financial Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and

2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

By:	/s/ Carroll K. Lane
	Carroll K. Lane
	Senior Vice President and
	Interim Chief Financial Officer
	November 1, 2023

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 29, 2023	Oct. 27, 2023
Document and Entity Information [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 29, 2023
Document Transition Report	false
Entity File Number	001-35419
Entity Registrant Name	KAMAN CORPORATION
Entity Incorporation, State or Country Code	CT
Entity Tax Identification Number	06-0613548
Entity Address, Address Line One	1332 Blue Hills Avenue,
Entity Address, City or Town	Bloomfield,
Entity Address, State or Province	CT
Entity Address, Postal Zip Code	06002
City Area Code	(860)
Local Phone Number	243-7100
Title of 12(b) Security	Common Stock ($1 par value)
Trading Symbol	KAMN
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		28,256,389
Entity Central Index Key	0000054381
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 29, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 30,065	$ 24,154
Accounts receivable, net	106,647	87,659
Contract assets	100,709	113,182
Inventories	201,439	172,383
Income tax refunds receivable	4,680	14,843
Other current assets	21,063	16,114
Total current assets	464,603	428,335
Property, plant and equipment, net of accumulated depreciation of $283,272 and $268,089, respectively	203,704	201,606
Operating Lease, Right-of-Use Asset	6,325	7,391
Goodwill	380,243	379,854
Other intangible assets, net	352,208	372,331
Deferred income taxes	45,878	47,385
Other assets	54,831	51,207
Total assets	1,507,792	1,488,109
Current liabilities:
Long-Term Debt, Current Maturities	198,854	0
Accounts payable – trade	45,890	48,277
Accrued salaries and wages	31,027	31,395
Contract liabilities, current portion	7,884	4,081
Operating Lease, Liability, Current	3,110	3,332
Income taxes payable	2,214	393
Other current liabilities	45,540	39,097
Total current liabilities	334,519	126,575
Long-term debt, excluding current portion, net of debt issuance costs	382,000	561,061
Deferred income taxes	6,490	6,079
Underfunded pension	49,813	52,309
Contract liabilities, noncurrent portion	19,653	20,515
Operating Lease, Liability, Noncurrent	3,452	4,534
Other Liabilities, Noncurrent	32,570	36,280
Commitments and contingencies (Note 14)
Shareholders' equity:
Preferred stock, $1 par value, 200,000 shares authorized; none outstanding	0	0
Common stock, $1 par value, 50,000,000 shares authorized; voting; 30,910,177 and 30,640,068 shares issued, respectively	30,910	30,640
Additional paid-in capital	251,843	245,436
Retained earnings	674,271	685,234
Accumulated other comprehensive income (loss)	$ (154,794)	$ (158,421)
Treasury Stock, Common, Shares	2,663,437	2,607,841
Less 2,663,437 and 2,607,841 shares of common stock, respectively, held in treasury, at cost	$ (122,935)	$ (122,133)
Total shareholders’ equity	679,295	680,756
Total liabilities and shareholders’ equity	$ 1,507,792	$ 1,488,109

XML

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net sales	$ 183,031	$ 172,004	$ 572,731	$ 490,818
Cost of sales	117,977	117,326	368,246	334,008
Program Inventory Impairment	417	0	1,013	0
Gross profit	64,637	54,678	203,472	156,810
Selling, general and administrative expenses	42,501	49,009	127,765	127,980
Research and Development Expense	4,022	3,937	15,122	14,265
Amortization of Intangible Assets	5,593	3,118	19,937	8,024
Restructuring and severance costs	571	(243)	3,033	2,853
Gain (Loss) on Disposition of Business	0	(457)	0	(457)
Net loss on disposition of assets	78	15	496	71
Operating income (loss)	11,872	(701)	37,119	4,074
Interest expense, net	9,405	3,614	29,349	8,088
Non-service pension and post-retirement benefit income	(310)	(5,142)	(930)	(15,429)
Other expense, net	849	1,221	377	2,415
Earnings (loss) before income taxes	1,928	(394)	8,323	9,000
Income tax expense (benefit)	462	(114)	2,371	1,631
Net earnings (loss)	$ 1,466	$ (280)	$ 5,952	$ 7,369
Earnings per share:
Basic earnings per share (in usd per share)	$ 0.05	$ (0.01)	$ 0.21	$ 0.26
Diluted earnings per share from continuing operations	$ 0.05	$ (0.01)	$ 0.21	$ 0.26
Basic (in shares)	28,247	28,037	28,189	27,997
Diluted (in shares)	28,350	28,037	28,324	28,076

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Net earnings (loss)	$ 1,466	$ (280)	$ 5,952	$ 7,369
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	(5,766)	(9,875)	(2,297)	(25,347)
Change in pension and post-retirement benefit plan liabilities, net of tax expense of $445 and $259 and $1,336 and $756, respectively	1,478	821	4,434	2,483
Other Comprehensive Income, Other, Net of Tax	(42)	0	1,490	(7)
Other comprehensive (loss) income	(4,330)	(9,054)	3,627	(22,871)
Comprehensive (loss) income	$ (2,864)	$ (9,334)	$ 9,579	$ (15,502)

XML

Condensed Consolidated Statement of Cash Flows (Unaudited) $ in Thousands	9 Months Ended
	Sep. 29, 2023 USD ($)	Sep. 30, 2022 USD ($)
Statement of Cash Flows [Abstract]
Net earnings (loss)	$ 5,952	$ 7,369
Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:
Depreciation and amortization	38,244	27,037
Amortization of debt issuance costs	2,985	1,882
Provision for doubtful accounts	1,495	619
Gain (Loss) on Disposition of Business	0	(457)
Net loss on disposition of assets	496	71
Program Inventory Impairment	1,013	0
Net loss on derivative instruments	620	2,670
Stock compensation expense	5,190	6,145
Non-cash consideration received for blade exchange	(1,309)	(827)
Deferred income taxes	212	1,600
Changes in assets and liabilities, excluding effects of acquisitions/divestitures:
Accounts receivable	(20,736)	(23,640)
Increase (Decrease) in Contract with Customer, Asset	12,467	(5,405)
Inventories	(30,952)	(19,478)
Income tax refunds receivable	10,158	(2,401)
Operating Right-of-Use Assets	1,052	3,347
Other assets	(3,802)	(3,230)
Accounts payable - trade	(2,423)	(8,780)
Contract liabilities	2,951	4,246
Operating Lease Liabilities	(1,290)	(3,296)
Other current liabilities	5,057	(4,591)
Income taxes payable	1,867	(227)
Pension liabilities	3,005	(13,309)
Increase (Decrease) in Other Noncurrent Liabilities	(2,579)	(3,045)
Net cash provided by operating activities	29,673	(33,700)
Cash flows from investing activities:
Expenditures for property, plant & equipment	(19,864)	(17,626)
Payments to Acquire Investments	0	(10,000)
Payments to Acquire Businesses, Net of Cash Acquired	1,487	441,340
Other, net	(708)	2,438
Net cash used in investing activities	(22,059)	(466,528)
Cash flows from financing activities:
Proceeds from (Repayments of) Lines of Credit	19,000	412,000
Purchase of treasury shares	(780)	(762)
Dividends paid	(16,871)	(16,760)
Payments of Debt Issuance Costs	(4,833)	(4,285)
Other, net	1,903	1,725
Net cash provided by (used in) financing activities	(1,581)	391,918
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	6,033	(108,310)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(122)	(1,132)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	30,065
Cash and cash equivalents at end of period	$ 30,065	$ 31,358

XML

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals)) - USD ($) $ in Thousands	Sep. 29, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$ 283,272	$ 268,089
Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]
Preferred stock, par value (in usd per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	200,000	200,000
Preferred Stock, Shares Outstanding	0	0
Common stock, par value (in usd per share)	$ 1	$ 1
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	30,910,177	30,640,068
Treasury Stock, Common, Shares	2,663,437	2,607,841

XML

Condensed Consolidated Statements of Comprehensive Income (Unaudited) (Parentheticals) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax	$ 445	$ 259	$ 1,336	$ 756
Net earnings (loss)	1,466	(280)	5,952	7,369
Foreign currency translation adjustments	(5,766)	(9,875)	(2,297)	(25,347)
Change in pension and post-retirement benefit plan liabilities, net of tax expense of $445 and $259 and $1,336 and $756, respectively	1,478	821	4,434	2,483
Other Comprehensive Income, Other, Net of Tax	(42)	0	1,490	(7)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(502)	0	(808)	(7)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	(4,330)	(9,054)	3,627	(22,871)
Comprehensive (loss) income	(2,864)	(9,334)	9,579	(15,502)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	$ (13)	$ 0	$ 449	$ 0

XML

Basis of Presentation

9 Months Ended

Sep. 29, 2023

Accounting Policies [Abstract]

Basis of Presentation

BASIS OF PRESENTATION

In the opinion of management, the condensed consolidated financial information reflects all adjustments necessary for a fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented, but do not include all disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). All such adjustments are of a normal recurring nature, unless otherwise disclosed in this report. Certain amounts in prior year financial statements and notes thereto have been reclassified to conform to current year presentation. The condensed consolidated financial statements for the period ended September 29, 2023 should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

The Company has a calendar year-end; however, its first three fiscal quarters follow a 13-week convention, with each quarter ending on a Friday. The third quarters for 2023 and 2022 ended on September 29, 2023, and September 30, 2022, respectively.

XML

Accounting Changes and Error Corrections

9 Months Ended

Sep. 29, 2023

Accounting Changes and Error Corrections [Abstract]

Change in Accounting Estimate

ACCOUNTING CHANGES

Revision of Previously Issued Consolidated Financial Statements

During the three-month fiscal period ended June 30, 2023, the Company identified errors related to (1) the accounting for certain labor costs at one business in the Precision Products segment and (2) the net realizable value on certain portions of the Company's inventory at another business in the Structures segment, each resulting in an overstatement of inventory and an understatement of cost of sales and related tax impacts. The Company concluded that these errors were not material, either individually or in aggregate, to previously issued consolidated financial statements; however, the Company has determined it was appropriate to revise its previously issued consolidated financial statements as of December 31, 2022, and for the years ended December 31, 2022 and 2021 and its unaudited condensed consolidated financial statements as of and for the quarters and year-to-date fiscal periods ended July 1, 2022, September 30, 2022 and March 31, 2023. Accordingly, the accompanying financial statements and relevant footnotes to the condensed consolidated financial statements in this Quarterly Report on Form 10-Q have been revised to correct for these errors. The Company will present the revision of its previously issued consolidated financial statements for the years ended December 31, 2022 and 2021 in connection with the future filing of its Annual Report on Form 10-K for the year ended December 31, 2023. Additionally, the Company will present the revision of its previously issued unaudited condensed consolidated financial statements for the quarter ended March 31, 2023 with the future filing of its Quarterly Report on Form 10-Q for the quarter ending March 29, 2024.

The revision to the accompanying unaudited condensed consolidated balance sheet, condensed consolidated statements of operations, condensed consolidated statements of comprehensive income and condensed consolidated statement of cash flows are as follows. There were no changes to the consolidated statement of stockholders' equity that have not otherwise been reflected in the condensed consolidated balance sheets, condensed consolidated statements of operations, and condensed consolidated statements of comprehensive income as detailed in the tables below.

Condensed Consolidated Balance Sheet
In thousands
	December 31, 2022
	As Previously Reported		Adjustments		As Corrected
Assets
Inventories(1)	$	176,468	$	(4,085)	$	172,383
Income tax refunds receivable	13,981		862		14,843
Total	$	190,449	$	(3,223)	$	187,226
Shareholders' equity
Retained earnings	$	688,457	$	(3,223)	$	685,234

(1) At December 31, 2022, the adjustments to inventories consisted of an adjustment of $2.5 million for certain labor costs at a business within the Precision Products segment and an adjustment of $1.6 million for the net realizable value on certain portions of the inventory at a business within the Structures segment.

2. ACCOUNTING CHANGES (CONTINUED)

Revision of Previously Issued Consolidated Financial Statements - continued

Condensed Consolidated Statements of Operations
In thousands, except per share amounts
	For the Three Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Cost of sales	$	116,179	$	1,147	$	117,326
Income tax expense	128		(242)		(114)
Net earnings	625		(905)		(280)
Basic earnings per share	$	0.02	$	(0.03)	$	(0.01)
Diluted earnings per share	$	0.02	$	(0.03)	$	(0.01)
	For the Nine Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Cost of sales	$	332,299	$	1,709	$	334,008
Income tax expense	1,992		(361)		1,631
Net earnings	8,717		(1,348)		7,369
Basic earnings per share	$	0.31	$	(0.05)	$	0.26
Diluted earnings per share	$	0.31	$	(0.05)	$	0.26

Condensed Consolidated Statements of Comprehensive Income (Loss)
In thousands
	For the Three Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Comprehensive (loss) income	$	(8,429)	$	(905)	$	(9,334)
	For the Nine Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Comprehensive (loss) income	$	(14,154)	$	(1,348)	$	(15,502)

Condensed Consolidated Statement of Cash Flows
In thousands
	For the Nine Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Net earnings	$	8,717	$	(1,348)	$	7,369
Inventories	(21,187)		1,709		(19,478)
Income tax refunds receivable	(2,040)		(361)		(2,401)
Net cash used in operating activities	(33,700)		—		(33,700)

XML

Business Combinations

9 Months Ended

Sep. 29, 2023

Acquisitions [Abstract]

Business Combination Disclosure

. BUSINESS COMBINATIONS AND INVESTMENTS

Aircraft Wheel & Brake

On September 16, 2022, the Company acquired all of the assets and related liabilities of Parker-Hannifin Corporation's ("Parker") Aircraft Wheel and Brake division, of Avon, Ohio, at a purchase price of $442.8 million. Aircraft Wheel and Brake is a leader in the design, development, qualification, manufacturing and assembly, product support and repair of wheels, brakes and related hydraulic components for fixed-wing aircraft and rotorcraft. With this acquisition, the Company has expanded its portfolio of engineered products, broadening the number of offerings available to serve customers across a range of critical applications and has increased the Company's exposure within the aerospace and defense end markets.

This acquisition was accounted for under the acquisition method. The assets acquired and liabilities assumed were recorded based on their fair values at the date of acquisition as follows (in thousands):

Accounts receivable	$	7,635
Contract assets	171
Inventories	11,246
Property, plant and equipment	7,686
Goodwill	171,277
Other intangible assets(1)	250,500
Contract costs, noncurrent	41
Liabilities	(5,729)
Net assets acquired	442,827
Less cash received	—
Net consideration	$	442,827

(1)Refer to Note 3, Business Combinations and Investments, in the Annual Report on Form 10-K for the year ended December 31, 2022 for information on the Company's determination of the fair value of identifiable intangible assets.

During the first quarter of 2023, the Company paid Parker an additional $1.5 million for the working capital adjustment, which resulted in an increase to goodwill. All purchase price allocations were finalized within the one-year measurement period and no further adjustments are expected.

The goodwill associated with this acquisition is tax deductible and is the result of expected synergies from combining the operations of the acquired business with the Company's operations and intangible assets that do not qualify for separate recognition, such as an assembled workforce. The goodwill associated with this acquisition was recognized in the Engineered Products segment.

Pro Forma Information (Unaudited)

Aircraft Wheel and Brake's results of operations have been included in the Company's financial statements for the period subsequent to the completion of the acquisition on September 16, 2022. In the three-month and nine-month fiscal periods ended September 29, 2023, Aircraft Wheel and Brake contributed $16.9 million and $56.6 million of revenue, respectively, and $1.9 million and $5.8 million of operating income, respectively. Aircraft Wheel and Brake contributed $2.7 million of revenue and $1.1 million of operating loss for both the three-month and nine-month fiscal periods ended September 30, 2022.

The following table reflects the pro forma operating results of the Company for the three-month and nine-month fiscal periods

ended September 30, 2022 which gives effect to the Acquisition as if the company had been acquired on January 1, 2021. The pro forma results are based on assumptions that the Company believes are reasonable under the circumstances. The pro forma results are not necessarily indicative of the operating results that would have occurred had this acquisition been effective January 1, 2021, nor are they intended to be indicative of results that may occur in the future. The underlying pro forma information includes the historical financial results of the Company and the acquired business adjusted for certain items discussed below. The pro forma information does not include the effects of any synergies, cost reduction initiatives or anticipated integration costs related to the acquisition.

3. BUSINESS COMBINATIONS AND INVESTMENTS (CONTINUED)

Aircraft Wheel & Brake - continued

Pro Forma Information (Unaudited) - continued

	For the Three Months Ended	For the Nine Months Ended
	September 30, 2022	September 30, 2022
In thousands
Net sales	188,554	543,817
Net earnings	8,949	17,035

These pro forma results include adjustments such as inventory step-up, amortization of acquired intangible assets, depreciation of acquired plant, property, and equipment and interest expense on debt financing in connection with this acquisition. Material pro forma adjustments directly attributable to this acquisition for the three-month and nine-month fiscal period ended September 30, 2022 include:

•Increases in depreciation of $0.1 million and $0.5 million relating to fixed assets acquired;

•Increases in amortization of $1.8 million and $7.9 million relating to intangible assets acquired;

•Decreases in selling, general and administrative costs of $10.1 million and $12.1 million relating to transaction costs for this acquisition;

•Increases in interest expense of $3.4 million and $11.4 million relating to debt financing in connection with this acquisition; and

•Increase in income tax expense of $1.0 million for the three-month fiscal period and decrease in income tax expense of $1.6 million for the nine-month fiscal period relating to the above adjustments.

XML

Segment and Geographic Information (Notes)

9 Months Ended

Sep. 29, 2023

Revenue [Abstract]

Segment Reporting Disclosure

. REVENUE AND SEGMENT INFORMATION

The Company is organized based upon the nature of its products and services, and is composed of three operating segments, each overseen by a segment manager. These segments are reflective of how the Company’s Chief Executive Officer, who is its Chief Operating Decision Maker ("CODM"), reviews operating results for the purposes of allocating resources and assessing performance. The Company has not aggregated operating segments for purposes of identifying reportable segments.

The Engineered Products segment serves the aerospace and defense, industrial and medical markets providing sophisticated proprietary aircraft bearings and components; super precision, miniature ball bearings; proprietary spring energized seals, springs and contacts; and wheels, brakes and related hydraulic components for helicopters and fixed-wing and unmanned aerial vehicle ("UAV") aircraft.

The Precision Products segment serves the aerospace and defense markets providing precision safe and arming solutions for missile and bomb systems for the U.S. and allied militaries; subcontract helicopter work; restoration, modification and support of the Company's SH-2G Super Seasprite maritime helicopters; support of the heavy lift K-MAX® manned helicopter; and development of the KARGO UAV unmanned aerial system, a purpose built autonomous medium lift logistics vehicle.

The Structures segment serves the aerospace and defense and medical end markets providing sophisticated complex metallic and composite aerostructures for commercial, military and general aviation fixed and rotary wing aircraft, and medical imaging solutions.

4. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Summarized financial information by business segment is as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Net sales:
Engineered Products	$	123,598	$	92,052	$	380,437	$	263,269
Precision Products	27,098		46,282		93,128		135,098
Structures	32,335		33,670		99,166		92,451
Net sales	$	183,031	$	172,004	$	572,731	$	490,818
Operating income (loss):
Engineered Products	$	29,026	$	14,156	$	78,924	$	40,665
Precision Products	(3,241)		5,296		(3,996)		10,725
Structures	(3,020)		(642)		(3,769)		(2,121)
Corporate expense	(9,828)		(20,196)		(29,499)		(42,728)
Other unallocated (expenses) income, net(1)	(1,065)		685		(4,541)		(2,467)
Operating income (loss)	$	11,872	$	(701)	$	37,119	$	4,074
Interest expense, net	9,405		3,614		29,349		8,088
Non-service pension and post-retirement benefit income, net	(310)		(5,142)		(930)		(15,429)
Other expense, net	849		1,221		377		2,415
Earnings (loss) before income taxes	$	1,928	$	(394)	$	8,323	$	9,000

(1) Other unallocated expenses, net include program inventory impairment, restructuring and severance costs and net loss on disposition of assets.

4. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Disaggregation of Revenue

The following tables disaggregate segment revenue by major product line:

	For the Three Months Ended
	September 29, 2023
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	18,859	$	7,541	$	17,324	$	43,724
Safe and Arm Devices	—		12,890		—		12,890
Commercial, Business & General Aviation	61,550		5,459		13,374		80,383
Medical	23,005		—		1,637		24,642
Industrial & Other	20,184		1,208		—		21,392
Total revenue	$	123,598	$	27,098	$	32,335	$	183,031
	For the Three Months Ended
	September 30, 2022
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	13,356	$	5,171	$	20,805	$	39,332
Safe and Arm Devices	—		37,460		—		37,460
Commercial, Business & General Aviation	39,852		2,457		11,006		53,315
Medical	21,782		—		1,859		23,641
Industrial & Other	17,062		1,194		—		18,256
Total revenue	$	92,052	$	46,282	$	33,670	$	172,004

	For the Nine Months Ended
	September 29, 2023
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	57,362	$	20,502	$	55,461	$	133,325
Safe and Arm Devices	—		49,486		—		49,486
Commercial, Business & General Aviation	190,471		19,548		38,232		248,251
Medical	73,463		—		5,473		78,936
Industrial & Other	59,141		3,592		—		62,733
Total revenue	$	380,437	$	93,128	$	99,166	$	572,731
	For the Nine Months Ended
	September 30, 2022
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	32,351	$	17,122	$	53,158	$	102,631
Safe and Arm Devices	—		96,345		—		96,345
Commercial, Business & General Aviation	109,874		18,119		33,138		161,131
Medical	65,614		—		6,155		71,769
Industrial & Other	55,430		3,512		—		58,942
Total revenue	$	263,269	$	135,098	$	92,451	$	490,818

4. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Disaggregation of Revenue - continued

The following table disaggregates total revenue by product types.

	For the Three Months Ended								For the Three Months Ended
	September 29, 2023								September 30, 2022
	Engineered Products		Precision Products		Structures		Total		Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	47	%	3	%	18	%	68	%	40	%	2	%	19	%	61	%
Aftermarket	20	%	5	%	—	%	25	%	14	%	3	%	—	%	17	%
Safe and Arm Devices	—	%	7	%	—	%	7	%	—	%	22	%	—	%	22	%
Total revenue	67	%	15	%	18	%	100	%	54	%	27	%	19	%	100	%
	For the Nine Months Ended								For the Nine Months Ended
	September 29, 2023								September 30, 2022
	Engineered Products		Precision Products		Structures		Total		Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	47	%	3	%	17	%	67	%	41	%	4	%	19	%	64	%
Aftermarket	20	%	4	%	—	%	24	%	12	%	4	%	—	%	16	%
Safe and Arm Devices	—	%	9	%	—	%	9	%	—	%	20	%	—	%	20	%
Total revenue	67	%	16	%	17	%	100	%	53	%	28	%	19	%	100	%

Disaggregation of Research and Development Costs

The following table presents research and development costs by segment:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Engineered Products	$	1,620	$	2,106	$	6,738	$	6,470
Precision Products	2,387		1,812		8,308		7,599
Structures	15		19		76		196
Total research and development costs	$	4,022	$	3,937	$	15,122	$	14,265

4. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Other

For contracts in which revenue is recognized over time, the Company performs detailed quarterly reviews of the progress and execution of its performance obligations under these contracts. As part of this process, management reviews information including, but not limited to, any outstanding key contract matters, progress towards completion and the related program schedule, identified risks and opportunities and the related changes in estimates of revenues and costs. The risks and opportunities include management's judgment about the ability and cost to achieve the schedule (e.g., the number and type of milestone events), technical requirements (e.g., a newly-developed product versus a mature product) and other contract requirements. Management must make assumptions and estimates regarding labor productivity and availability, the complexity of the work to be performed, the availability of materials, the length of time to complete the performance obligation (e.g., to estimate increases in wages and prices for materials and related support cost allocations), execution by subcontractors, the availability and timing of funding from customers and overhead cost rates, among other variables. Based upon these reviews, the Company will record the effects of adjustments in profit estimates each period. If at any time management determines that in the case of a particular contract total costs will exceed total contract revenue, a provision for the entire anticipated contract loss is recorded at that time.

Net changes in revenue associated with cost growth on the Company's over time contracts were as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Net change in revenue due to change in profit estimates	$	(3,123)	$	(892)	$	(5,987)	$	580

In the three-month and nine-month fiscal periods ended September 29, 2023, the net decreases in revenue were primarily related to cost growth on certain structures and precision products contracts. In the nine-month fiscal period, this decrease was partially offset by favorable cost performance on the joint programmable fuze ("JPF") contract with the U.S. Government ("USG").

In the three-month fiscal period ended September 30, 2022, the net decrease in revenue was primarily related to cost growth on certain structures programs and legacy fuzing contracts, partially offset by favorable cost performance on memory and measuring programs. In the nine-month fiscal period ended September 30, 2022, the net increase in revenue was primarily related to favorable cost performance on the JPF contract with the USG, partially offset by cost growth on certain structures programs and legacy fuzing contracts.

Unfulfilled Performance Obligations

Unfulfilled performance obligations ("backlog") represents the transaction price of firm orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts. Backlog at September 29, 2023 and December 31, 2022, and the portion of backlog the Company expects to recognize revenue on over the next twelve months is as follows:

	September 29, 2023(1)		December 31, 2022
	(in thousands)
Engineered Products	$	363,228	$	322,452
Precision Products	100,712		134,903
Structures	254,633		263,581
Total Backlog	$	718,573	$	720,936

(1) The Company expects to recognize revenue on approximately 69% of backlog as of September 29, 2023 over the next twelve months.

XML

Restructuring Costs

9 Months Ended

Sep. 29, 2023

Restructuring Costs [Abstract]

Restructuring Costs

. RESTRUCTURING AND SEVERANCE COSTS

Restructuring and severance costs are included in restructuring and severance costs on the Company's Condensed Consolidated Statements of Operations and other unallocated expenses, net in Note 4, Revenue and Segment Information.

Transformation Restructuring

In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improve working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result of this review, the Company identified areas to reduce annualized costs in the Precision Products segment and at Corporate through streamlining processes, consolidating the production of fuzes for the JPF program at its Middletown facility, discontinuing K-MAX® helicopter production and right-sizing the Company's total cost structure. In the three-month and nine-month fiscal periods ended September 29, 2023, the Company incurred $0.6 million and $3.0 million, respectively, in severance costs associated with these actions. Of this amount, $0.3 million was related to share-based compensation expense in the nine-month fiscal period ended September 29, 2023. No share-based compensation expense was recorded to restructuring and severance costs in the three-month fiscal period ended September 29, 2023.

The following table summarizes the accrual balances by cost type for the restructuring actions:

	Severance		Other(1)		Total
In thousands
Restructuring accrual balance at December 31, 2022(2)	$	6,629	$	—	$	6,629
Provision	2,147		625		2,772
Cash payments	(5,767)		(625)		(6,392)
Changes in foreign currency exchange rates	(2)		—		(2)
Restructuring accrual balance at September 29, 2023	$	3,007	$	—	$	3,007

(1) Includes costs associated with the consolidation of facilities.

(2) Of the above accrual balance, $1.0 million was included in other long-term liabilities on the Company's Condensed Consolidated Balance Sheets as of December 31, 2022. The remainder was included in other current liabilities.

Other Matters

The Company identified workforce reductions and other reductions in certain general and administrative expenses, which resulted in $1.9 million in restructuring and severance costs in the nine-month fiscal period ended September 30, 2022. In conjunction with the sale of the Company's Mexico operations in the third quarter of 2022, the Company reversed severance costs previously accrued, which were partially offset by costs incurred in the period. This resulted in a net reduction to restructuring and severance costs of $0.2 million for the three-month fiscal period ended September 30, 2022.

In addition to the restructuring and severance costs discussed above, in the nine-month fiscal period ended September 30, 2022, the Company incurred $1.0 million in other severance expense.

XML

Accounts Receivable, Net

9 Months Ended

Sep. 29, 2023

Accounts Receivable, after Allowance for Credit Loss [Abstract]

Accounts Receivable, Net

ACCOUNTS RECEIVABLE, NET

Accounts receivable, net consisted of the following:

	September 29, 2023		December 31, 2022
In thousands
Trade receivables	$	42,931	$	31,126
U.S. Government contracts:
Billed	16,333		14,150
Cost and accrued profit - not billed	2,460		661
Commercial and other government contracts
Billed	46,751		41,520
Cost and accrued profit - not billed	1,069		2,268
Less allowance for doubtful accounts	(2,897)		(2,066)
Accounts receivable, net	$	106,647	$	87,659

The Company performs ongoing evaluations of its customers’ current creditworthiness, as determined by the review of their credit information, to determine if events have occurred subsequent to the recognition of revenue and the related receivable that provide evidence that such receivable will be realized in an amount less than that recognized at the time of sale. Estimates of credit losses are based on historical losses, current economic conditions, geographic considerations, and in some cases, evaluating specific customer accounts for risk of loss.

The following table summarizes the activity in the allowance for doubtful accounts in the nine-month fiscal period ended September 29, 2023:

In thousands
Balance at December 31, 2022	$	(2,066)
Provision	(1,495)
Amounts written off	307
Recoveries	356
Changes in foreign currency exchange rates	1
Balance at September 29, 2023	$	(2,897)

There were no amounts included in accounts receivable, net for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at September 29, 2023 and December 31, 2022.

XML

Contract Assets, Contract Costs and Contract Liabilities

9 Months Ended

Sep. 29, 2023

Revenue from Contract with Customer [Abstract]

Contract Assets, Contract Costs and Contract Liabilities

Activity related to contract assets, contract costs and contract liabilities was as follows:

	September 29, 2023		December 31, 2022		$ Change		% Change
In thousands
Contract assets	$	100,709	$	113,182	$	(12,473)	(11.0)	%
Contract costs, current portion(1)	$	139	$	695	$	(556)	(80.0)	%
Contract costs, noncurrent portion(2)	$	643	$	673	$	(30)	(4.5)	%
Contract liabilities, current portion	$	7,884	$	4,081	$	3,803	93.2	%
Contract liabilities, noncurrent portion	$	19,653	$	20,515	$	(862)	(4.2)	%

(1) Contract costs, current portion are included within other current assets on the Company's Condensed Consolidated Balance Sheets.

(2) Contract costs, noncurrent portion are included within other assets on the Company's Condensed Consolidated Balance Sheets.

Contract Assets

The decrease in contract assets was primarily due to amounts billed in the current period on the JPF program and higher unliquidated progress payments on our legacy fuzing contracts, partially offset by the recognition of revenue related to the satisfaction or partial satisfaction of performance obligations for work performed and not yet billed on various contracts. There were no significant impairment losses related to the Company's contract assets during the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022.

There were no amounts included in contract assets for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at September 29, 2023 and December 31, 2022.

Contract Costs

At September 29, 2023 and December 31, 2022, costs to fulfill a contract were $0.8 million and $1.4 million, respectively. These amounts were included in other current assets and other assets on the Company's Condensed Consolidated Balance Sheets at September 29, 2023 and December 31, 2022. There were no costs to obtain a contract at September 29, 2023 and December 31, 2022.

Contract costs, current portion at September 29, 2023 decreased compared to the balance at December 31, 2022. This was primarily attributable to the write-off of contract costs on the A-10 contract and amortization of contract costs. For the three-month and nine-month fiscal periods ended September 29, 2023, amortization of contract costs was $0.1 million and $0.3 million, respectively. For the three-month and nine-month fiscal periods ended September 30, 2022, amortization of contract costs was $0.2 million and $0.5 million, respectively.

Contract costs, noncurrent portion at September 29, 2023 remained relatively flat when compared to the balance at December 31, 2022.

Contract Liabilities

Contract liabilities, current portion at September 29, 2023 increased compared to the balance at December 31, 2022, primarily driven by the FireBurstTM enhanced fuzing capability program and SH-2G program. Revenue recognized related to contract liabilities, current portion was $1.2 million and $1.7 million in the three-month and nine-month fiscal periods ended September 29, 2023, respectively. Revenue recognized related to contract liabilities, current portion was $0.2 million and $1.4 million in the three-month and nine-month fiscal periods ended September 30, 2022, respectively.

7. CONTRACT ASSETS, CONTRACT COSTS AND CONTRACT LIABILITIES (CONTINUED)

Contract Liabilities - continued

Contract liabilities, noncurrent portion at September 29, 2023 decreased compared to the balance at December 31, 2022 due to the reclassification of liabilities on the FireBurstTM enhanced fuzing capability program to contract liabilities, current portion. For the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022, the Company did not recognize revenue against contract liabilities, noncurrent portion. Refer to Note 14, Commitments and Contingencies, for further information on the Company's offset agreements.

XML

Fair Value Measurements

9 Months Ended

Sep. 29, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurements

FAIR VALUE MEASUREMENTS

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date.

The Company uses a three-level fair value hierarchy that prioritizes the inputs used to measure fair value. This hierarchy requires the Company to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows: 

•Level 1 — Quoted prices in active markets for identical assets or liabilities.

•Level 2 — Observable inputs other than quoted prices included in Level 1, such as quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data.

•Level 3 — Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.

The following table presents the carrying value and fair value of financial instruments that are not carried at fair value:

	September 29, 2023				December 31, 2022
	Carrying Value		Fair Value		Carrying Value		Fair Value
In thousands
Debt (1)	$	581,500	$	547,294	$	562,500	$	547,393

(1) These amounts are classified within Level 2.

The above fair values were computed based on quoted market prices and discounted future cash flows (observable inputs), as applicable. Differences from carrying values are attributable to interest rate changes subsequent to when the transactions occurred.

The fair values of cash and cash equivalents, accounts receivable, net and accounts payable - trade approximate their carrying amounts due to the short-term maturities of these instruments. The Company's cash and cash equivalents at September 29, 2023 and December 31, 2022 included $5.4 million and $0.1 million, respectively, of Level 1 money market funds.

Recurring Fair Value Measurements

The Company holds derivative instruments for foreign exchange contracts and interest rate swaps that are measured at fair value using observable market inputs such as forward rates and its counterparties’ credit risks. Based on these inputs, the derivative instruments are classified within Level 2 of the valuation hierarchy. At September 29, 2023, the interest rate swaps were included in other assets and other long-term assets on the Company's Condensed Consolidated Balance Sheets. At September 29, 2023, the foreign exchange contracts were included in other current liabilities on the Company's Condensed Consolidated Balance Sheets. At December 31, 2022, the foreign exchange contracts were included in other current assets and other current liabilities on the Company's Condensed Consolidated Balance Sheets. Based on the Company's continued ability to trade and enter into forward contracts and interest rate swaps, the Company considers the markets for its fair value instruments to be active.

The Company evaluated the credit risk associated with the counterparties to these derivative instruments and determined that as of September 29, 2023, such credit risks had not had an adverse impact on the fair value of these instruments.

8. FAIR VALUE MEASUREMENTS (CONTINUED)

Nonrecurring Fair Value Measurements

In the three-month and nine-month fiscal periods ended September 29, 2023, the Company incurred impairment charges of $0.4 million and $1.0 million, respectively, associated with the write-off of inventory related to the K-MAX® program. Refer to Note 10, Inventories, for further information.

XML

Derivative Financial Instruments

9 Months Ended

Sep. 29, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

DERIVATIVE FINANCIAL INSTRUMENTS

The Company is exposed to certain risks relating to its ongoing business operations, including market risks relating to fluctuations in foreign currency exchange rates and interest rates. Derivative financial instruments are recognized on the Condensed Consolidated Balance Sheets as either assets or liabilities and are measured at fair value. Changes in the fair values of derivatives are recorded each period in earnings or accumulated other comprehensive income, depending on whether a derivative is effective as part of a hedged transaction. Gains and losses on derivative instruments reported in accumulated other comprehensive income (loss) are subsequently included in earnings in the periods in which earnings are affected by the hedged item. The Company does not use derivative instruments for speculative purposes.

Cash Flow Hedges

Interest Rate Swaps

The Company's Credit Agreement (as defined in Note 12, Debt) contains floating rate obligations and is subject to interest rate fluctuations. At September 29, 2023, the Company has interest rate swap agreements with a notional value of $175.0 million, for the purposes of hedging the eight quarterly variable-rate Credit Agreement interest payments due in 2023 and 2024. These interest rate swap agreements were designated as cash flow hedges and intended to manage interest rate risk associated with the Company's variable-rate borrowings and minimize the impact on earnings and cash flows of interest rate fluctuations attributable to changes in the Secured Overnight Financing Rate ("SOFR"). These interest rate swaps were not material to the Company's Condensed Consolidated Financial Statements as of and for the three-month and nine-month fiscal periods ended September 29, 2023. Over the next twelve months, the income related to cash flow hedges expected to be reclassified from other comprehensive income is $1.6 million.

Forward Exchange Contracts

The Company holds forward exchange contracts designed to hedge forecasted transactions denominated in foreign currencies and to minimize the impact of foreign currency fluctuations on the Company’s earnings and cash flows. These contracts were not material to the Company's Condensed Consolidated Balance Sheets as of September 29, 2023 and December 31, 2022. The activity related to these contracts was not material to the Company's Condensed Consolidated Financial Statements for the three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022.

XML

Inventories

9 Months Ended

Sep. 29, 2023

Inventory Disclosure [Abstract]

Inventories

INVENTORIES

Inventories consisted of the following:

	September 29, 2023		December 31, 2022
In thousands
Raw materials	$	35,228	$	24,572
Contracts and other work in process (including certain general stock materials)	127,779		107,803
Finished goods	38,432		40,008
Inventories	$	201,439	$	172,383

There were no amounts included in inventories associated with matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at September 29, 2023 and December 31, 2022.

10. INVENTORIES (CONTINUED)

At September 29, 2023 and December 31, 2022, $22.9 million and $24.7 million, respectively, of K-MAX® inventory was included in contracts and other work in process inventory and finished goods on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately $9.5 million of the K-MAX® inventory will be sold after September 30, 2024, based upon the requirements to support the fleet for the foreseeable future. In December 2022, the Company began a review of all businesses and programs to increase efficiencies, improving working capital management and focus on sustainable and consistent revenue and profit generating activities. As a result, the Company determined it would discontinue K-MAX® aircraft production and wrote off $44.5 million of inventory associated with the program as of December 31, 2022. Additionally, production material for the K-MAX® includes long lead parts, which the Company evaluates for alternative use as received. Any write-offs related to these parts are not expected to have a material adverse effect on the Company's results of

operations or financial position. Inventory write-offs for the three-month and nine-month fiscal periods ended September 29, 2023 were $0.4 million and $1.0 million, respectively.

At September 29, 2023 and December 31, 2022, $5.4 million and $6.2 million, respectively, of SH-2G(I) inventory was included in contracts and other work in process inventory on the Company's Condensed Consolidated Balance Sheets. Management believes that approximately $4.1 million of the SH-2G(I) inventory will be sold after September 30, 2024. This balance represents spares requirements and inventory to be used on SH-2G programs.

XML

Goodwill and Other Intangible Assets, Net

9 Months Ended

Sep. 29, 2023

Intangible Assets, Net (Including Goodwill) [Abstract]

Goodwill and Other Intangible Assets, Net

GOODWILL AND OTHER INTANGIBLE ASSETS, NET

Goodwill

The following table sets forth the change in the carrying amount of goodwill for each reportable segment and for the Company:

	Engineered Products		Precision Products		Structures		Total
In thousands
Gross balance at December 31, 2022	$	363,785	$	41,375	$	66,559	$	471,719
Accumulated impairment	—		(25,306)		(66,559)		(91,865)
Net balance at December 31, 2022	363,785		16,069		—		379,854
Additions	1,487		—		—		1,487
Impairments	—		—		—		—
Foreign currency translation	(1,098)		—		—		(1,098)
Ending balance at September 29, 2023	$	364,174	$	16,069	$	—	$	380,243
Accumulated impairment at end of period	$	—	$	(25,306)	$	(66,559)	$	(91,865)

In accordance with ASC 350 - Intangibles - Goodwill and Other ("ASC 350"), the Company evaluates goodwill for possible impairment on an at least annual basis. The Company is currently in the process of updating its long-term forecast, which it will use to complete its annual evaluation during the fourth quarter. Management has determined that the Company will perform a quantitative assessment, rather than a qualitative assessment, for the Precision Products reporting unit, a division of the Precision Products segment which manufactures and produces the JPF. The quantitative assessment could result in a determination that there has been an impairment of some or all of the goodwill associated with this reporting unit. At September 29, 2023, the goodwill associated with the Precision Products reporting unit is $16.1 million.

11. GOODWILL AND OTHER INTANGIBLE ASSETS, NET (CONTINUED)

Other Intangible Assets

Other intangible assets consisted of:

		At September 29,				At December 31,
		2023				2022
	Amortization Period	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
In thousands
Customer lists / relationships	6-38 years	$	363,269	$	(51,311)	$	363,549	$	(41,695)
Developed technologies	7-20 years	44,923		(20,582)		45,028		(17,508)
Trademarks / trade names	15-40 years	16,619		(3,583)		16,681		(3,153)
Non-compete agreements and other	1-15 years	17,332		(14,516)		17,336		(7,974)
Patents	17 years	551		(494)		551		(484)
Total intangible assets		$	442,694	$	(90,486)	$	443,145	$	(70,814)

XML

Debt

9 Months Ended

Sep. 29, 2023

Debt Disclosure [Abstract]

Debt Disclosure

DEBT

Credit Agreement

On June 21, 2023 (the "Closing Date"), the Company closed an amended and restated $740.0 million Credit Agreement (the "Credit Agreement") with JPMorgan Chase Bank, N.A., as Administrative Agent and as Collateral Agent. The Credit Agreement amends and restates the Company's previously existing credit facility in its entirety to, among other things: (i) extend the maturity date to June 21, 2028; (ii) reduce the aggregate amount of revolving commitments from $800.0 million to $740.0 million; (iii) modify the financial covenants set forth in Article 6 of the previously existing credit facility; and (iv)

effectuate certain additional modifications set forth in the previously existing facility, including its pricing. Capitalized terms used but not defined within this discussion of the Credit Agreement have the meanings ascribed thereto in the Credit Agreement, which with amendments is included as Exhibit 10.5 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2023.

The financial covenants associated with the Credit Agreement require that (i) the Consolidated Total Net Leverage Ratio, as defined by the Credit Agreement, cannot be greater than 5.00 to 1.00 for any quarter ending on or after the Closing Date through September 28, 2023, 4.75 to 1.00 for each quarter ending thereafter through September 26, 2024, 4.50 to 1.00 for each quarter ending thereafter through September 25, 2025 and 4.00 to 1.00 for each quarter ending thereafter. The Company may elect to increase the Consolidated Total Net Leverage Ratio by 0.50 to 1.00 if the Company consummates a Material Permitted Investment, which shall not exceed 5.00 to 1.00 for each of the four consecutive quarters that included the fiscal quarter in which the Material Permitted Investment is consummated. As of September 29, 2023, the Consolidated Total Net Leverage Ratio was 3.89, as calculated in accordance with the Credit Agreement.

In addition to the Consolidated Total Net Leverage Ratio, as defined in the Credit Agreement and discussed above, the financial covenants associated with the Credit Agreement also include a requirement that (i) the Interest Coverage Ratio cannot be less than 3.00 to 1.00; and (ii) Liquidity cannot be less than (a) an amount equal to 50% of the aggregate principal amount of the Convertible Notes as of the last day of the third quarter of 2023 and (b) an amount equal to 100% of the aggregate principal of the 2024 Convertible Notes in the fourth quarter of 2023 and the first quarter of 2024. The Company was in compliance with these financial covenants as of and for the quarter ended September 29, 2023, and management does not anticipate noncompliance in the foreseeable future.

Interest rates on amounts outstanding under the Credit Agreement are variable based on the SOFR. The interest rate at September 29, 2023 was 7.13%. We are required to pay a quarterly commitment fee on the unused revolving loan commitment amount at a rate ranging from 0.200% to 0.350% per annum, based on the Senior Secured Net Leverage Ratio. Fees for outstanding letters of credit range from 1.375% to 2.250%, based on the Senior Secured Net Leverage Ratio. At September 29, 2023, $382.0 million was outstanding under the revolving credit facility and total average bank borrowings were $391.9 million during the nine-month fiscal period ended September 29, 2023. Total average bank borrowings were $120.7 million during the year ended December 31, 2022.

12. DEBT (CONTINUED)

Credit Agreement - continued

The following table shows the amounts available for borrowing under the Company's revolving credit facility:

	September 29, 2023		December 31, 2022
In thousands
Total facility	$	740,000	$	800,000
Amounts outstanding, excluding letters of credit	382,000		363,000
Amounts available for borrowing, excluding letters of credit	358,000		437,000
Letters of credit under the credit facility(1)(2)	70,549		51,630
Amounts available for borrowing	$	287,451	$	385,370
Amounts available for borrowing subject to EBITDA, as defined by the Credit Agreement(3)	$	129,313	$	196,256

(1) The Company has entered into standby letters of credit issued on the Company's behalf by financial institutions, and directly issued guarantees to third parties primarily related to advances received from customers and the guarantee of future performance on certain contracts. Letters of credit generally are available for draw down in the event the Company does not perform its obligations.

(2) Of these amounts, $65.1 million and $46.1 million in letters of credit relate to a JPF DCS contract in the periods ended September 29, 2023 and December 31, 2022, respectively.

(3) The Company's Convertible Notes will mature in 2024. The Company currently expects to settle the Convertible notes with available borrowing capacity under our Credit Agreement; however we are assessing potential options for the refinancing of these instruments prior to their scheduled maturity. With the extension of the Credit Agreement, the Company maintained sufficient capacity to use proceeds from this facility to repay the Convertible Notes. The amounts available for borrowing subject to EBITDA represents amounts available for borrowing after considering the Company's total debt obligations including its Credit Agreement and Convertible Notes.

Debt issuance costs in connection with the Credit Agreement have been capitalized. The Company incurred $4.8 million of debt issuance costs in connection with the amendment of the Credit Agreement in 2023, which are being amortized over the term of the agreement with the debt issuance costs associated with the previous existing credit facility for lenders that remained in the Credit Agreement. In the second quarter of 2023, the Company recorded a write-off of debt issuance costs of $0.6 million

related to lenders that are no longer participating in the Credit Agreement. Total amortization expense for the three-month fiscal periods ended September 29, 2023 and September 30, 2022 was $0.4 million and $0.7 million, respectively. Total amortization expense for the nine-month fiscal periods ended September 29, 2023 and September 30, 2022 was $1.6 million and $1.2 million, respectively.

XML

Pension Plans

9 Months Ended

Sep. 29, 2023

Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]

Compensation and Employee Benefit Plans

PENSION PLANS

Components of net pension cost for the Qualified Pension Plan and Supplemental Employees’ Retirement Plan ("SERP") were as follows:

	For the Three Months Ended
	Qualified Pension Plan				SERP
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Service cost	$	1,445	$	840	$	—	$	—
Interest cost on projected benefit obligation	7,296		4,300		44		22
Expected return on plan assets	(9,573)		(10,544)		—		—
Amortization of net loss	1,923		1,064		—		16
Net pension cost (income)	$	1,091	$	(4,340)	$	44	$	38

13. PENSION PLANS (CONTINUED)

	For the Nine Months Ended
	Qualified Pension Plan				SERP
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Service cost	$	4,336	$	2,522	$	—	$	—
Interest cost on projected benefit obligation	21,888		12,899		132		66
Expected return on plan assets	(28,720)		(31,633)		—		—
Amortization of net loss	5,770		3,193		—		46
Net pension cost (income)	$	3,274	$	(13,019)	$	132	$	112

No contributions have been or are expected to be made to the qualified pension plan during 2023. The Company contributed $0.4 million to the SERP through the end of the third quarter of 2023 and plans to contribute an additional $0.1 million to the SERP in 2023. No contributions were made to the qualified pension plan during 2022. For the 2022 plan year, the Company contributed $0.5 million to the SERP.

XML

Commitments and Contingencies

9 Months Ended

Sep. 29, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

COMMITMENTS AND CONTINGENCIES

New Hartford Property

In connection with the sale of the Company’s Music segment in 2007, the Company assumed responsibility for meeting certain requirements of the Connecticut Transfer Act (the “Transfer Act”) that applied to the transfer of the New Hartford, Connecticut, facility leased by that segment for guitar manufacturing purposes (“Ovation”). Under the Transfer Act, those responsibilities essentially consist of assessing the site's environmental conditions and remediating environmental impairments, if any, caused by Ovation's operations prior to the sale. The site is a multi-tenant industrial park, in which Ovation and other unrelated entities lease space. The environmental assessment process, which began in 2008, has been completed and site remediation is in process.

The Company's estimate of its portion of the cost to assess the environmental conditions and remediate this site is $2.3 million, all of which has been accrued. The remediation has been nearly completed and the Company continues to monitor the results of the remediation. The total amount paid to date in connection with these environmental remediation activities is $1.8 million. At September 29, 2023, the Company had $0.5 million accrued for these environmental remediation activities. A portion ($0.1 million) of the accrual related to this property is included in other current liabilities and the balance is included in other long-term liabilities. The remaining balance of the accrual reflects the total anticipated cost of completing these environmental remediation activities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time.

Bloomfield Property

In connection with the Company’s 2008 purchase of the portion of the Bloomfield campus that Kaman Aerospace Corporation had leased from NAVAIR, the Company assumed responsibility for environmental remediation at the facility as may be required under the Transfer Act and is currently remediating the property under the guidance of the Connecticut Department of Environmental Protection. The assumed environmental liability of $10.3 million was determined by taking the undiscounted estimated remediation liability of $20.8 million and discounting it at a rate of 8%. This remediation process will take many years to complete. The total amount paid to date in connection with these environmental remediation activities is $15.5 million. At September 29, 2023, the Company had $2.3 million accrued for these environmental remediation activities. A portion ($0.4 million) of the accrual related to this property is included in other current liabilities, and the balance is included in other long-term liabilities. Although it is reasonably possible that additional costs will be paid in connection with the resolution of this matter, the Company is unable to estimate the amount of such additional costs, if any, at this time.

14. COMMITMENTS AND CONTINGENCIES (CONTINUED)

Offset Agreement

The Company has entered into offset agreements as a condition to obtaining orders from a Middle Eastern customer for the Company's JPF product. Offset agreements are designed to return economic value to the foreign country by requiring the Company to engage in activities supporting local defense or commercial industries, promoting a balance of trade, developing in-country technology capabilities or addressing other local development priorities. Such agreements may be satisfied through activities that do not require a direct cash payment, including transferring technology, providing manufacturing, training and other consulting support to in-country projects and the purchase by third parties of supplies from in-country vendors. The agreements may also be satisfied through the Company's use of cash for activities, such as subcontracting with local partners, purchasing supplies from in-country vendors, providing financial support for in-country projects and making investments in local ventures. At September 29, 2023, the aggregate amount of the Company's offset agreements had an outstanding notional value of approximately $220.9 million, which is equal to sixty percent of the value of the contracts as defined by the agreement between the customer and the Company. The amount ultimately applied against offset agreements is based on negotiations with the customer and may require cash outlays that represent only a fraction of the notional value in the offset agreement.

The Company continues to work with the customer to further define the requirements to satisfy the offset agreements. In February 2023, the Company announced that it received a Business Plan Approval Letter to establish a manufacturing and final assembly facility in collaboration with an in-country vendor, which will enhance the technological capabilities available in this country. At September 29, 2023, the Company continues to work with the Tawazun Council to identify a suitable in-country vendor to support the manufacturing and final assembly facility as the Company is no longer working with the previously announced vendor. Offset programs typically extend over several years and may provide for penalties in the event the Company fails to perform according to offset requirements. The satisfaction of the offset requirements will be determined by the customer. In the event the offset requirements of the contracts are not met, the Company could be liable for potential penalties up to $18.8 million payable to the customer. Failure to satisfy the offset requirements could also negatively impact the Company's ability to attract future orders from this customer. The Company considers these potential penalties to be a reduction to the transaction price in its determination of the value of the performance obligations within these contracts. At September 29, 2023, $18.8 million in contract liabilities associated with the potential penalties of the offset requirements were included on the Company's Condensed Consolidated Balance Sheets.

Guarantees

During 2020, the Company and the USG entered into a Guaranty Agreement, pursuant to which the Company agreed to guarantee the full, complete and satisfactory performance of its subsidiary, Kaman Precision Products, Inc. ("KPPI") under all current and future contracts with the USG. As of the date of this filing, the only contract in place between KPPI and the USG relates to the production and sale of the JPF. KPPI fulfilled the requirements of Option 16 in the second quarter of 2023 and the USG has indicated that they will not award the Company any future options. The guaranty will remain in effect until the USG has confirmed that the Company has completed all obligations and the Company requests the expiration, which is expected to occur before the end of the fiscal year. The guaranty was provided in lieu of a periodic financial capability review by the Financial Capacity Team ("FCT") of the Defense Contract Management Agency ("DCMA"). The Company is unable to estimate the maximum potential amount of future payments under the guaranty as it is dependent on costs incurred by the USG in the event of default. Although the Company believes the risk of default is low given the maturity and operational performance of the JPF program, there can be no assurance that the guaranty will not have a material adverse effect on the Company's results of operations, financial position and cash flows.

On September 16, 2022, the Company acquired all of the assets and related liabilities of Parker's Aircraft Wheel and Brake division. In association with the acquisition, the Company entered into a novation agreement in which Parker's contractual obligations with respect to Aircraft Wheel and Brake at the time of the acquisition were transferred to the Company. There can be no assurance that this agreement will not have a material adverse effect on the Company's results of operations, financial position and cash flows.

XML

Computation of Earnings Per Share

9 Months Ended

Sep. 29, 2023

Earnings Per Share Reconciliation [Abstract]

Computation of Earnings Per Share

COMPUTATION OF EARNINGS PER SHARE

The computation of basic earnings per share is based on net earnings divided by the weighted average number of shares of common stock outstanding for each period. The computation of diluted earnings per share reflects the common stock equivalency of dilutive options granted to employees under the Company's stock incentive plan, shares issuable on redemption of its convertible notes and shares issuable upon redemption of outstanding warrants.

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands, except per share amounts
Net earnings (loss)	$	1,466	$	(280)	$	5,952	$	7,369
Basic:
Weighted average number of shares outstanding	28,247		28,037		28,189		27,997
Basic earnings (loss) per share	$	0.05	$	(0.01)	$	0.21	$	0.26
Diluted:
Weighted average number of shares outstanding	28,247		28,037		28,189		27,997
Weighted average shares issuable on exercise of dilutive stock options	103		—		135		79
Total	28,350		28,037		28,324		28,076
Diluted earnings (loss) per share	$	0.05	$	(0.01)	$	0.21	$	0.26

Equity awards

For the three-month and nine-month fiscal periods ended September 29, 2023, respectively, 660,947 and 664,923 shares issuable under equity awards granted to employees were excluded from the calculation of diluted earnings per share as they were anti-dilutive based on the average stock price during the periods. For the three-month and nine-month fiscal periods ended September 30, 2022, respectively, 756,809 and 707,584 shares issuable under equity awards granted to employees were excluded from the calculation of diluted earnings per share as they were anti-dilutive based on the average stock price during the periods. For the three-month fiscal period ended September 30, 2022, an additional 50,792 shares issuable under equity awards, which would have been dilutive if exercised based on the average market price being higher than the exercise price, were excluded from the computation of diluted earnings per share as their effect was antidilutive due to the net loss.

Convertible Notes

For both three-month and nine-month fiscal periods ended September 29, 2023 and September 30, 2022, 3,056,879 shares issuable under Convertible Notes due 2024 were excluded from the diluted earnings per share calculation because their effect was antidilutive.

XML

Share-based Arrangements

9 Months Ended

Sep. 29, 2023

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Share-based Payment Arrangement

16. SHARE-BASED ARRANGEMENTS

The Company accounts for stock options, restricted stock awards ("RSAs"), restricted stock units ("RSUs") and performance stock units ("PSUs") as equity awards and measures the cost of all share-based payments, including stock options, at fair value on the grant date and recognizes this cost in the statement of operations. The Company also has an employee stock purchase plan, which is accounted for as a liability award. Compensation expense for stock options, RSAs, RSUs and PSUs is recognized on a straight-line basis over the vesting period of the awards. Throughout the course of the vesting period, the Company monitors the achievement level for the return on invested capital ("ROIC") metric of the PSUs compared to the ROIC target and adjusts the number of shares expected to be earned, and the related compensation expense recorded thereafter, to reflect the most probable outcome. The PSUs granted in 2023 and 2022 assumed a 100% achievement level. Share-based compensation expense recorded for the three-month and nine-month fiscal periods ended September 29, 2023 was $1.3 million and $5.2 million, respectively. For the nine-month fiscal period ended September 29, 2023, $0.3 million was recorded to restructuring and severance costs and the remaining amount was recorded to selling, general and administrative expenses on the Company's Condensed Consolidated Statements of Operations. No share-based compensation expense was recorded to restructuring and severance costs in the three-month fiscal period ended September 29, 2023. Share-based compensation expense recorded for the three-month and nine-month fiscal periods ended September 30, 2022 was $1.3 million and $6.1 million, respectively. For the nine-month fiscal period ended September 30, 2022, $0.2 million was recorded to restructuring and severance costs and the remaining amounts were recorded to selling, general and administrative expenses on the Company's Condensed Consolidated Statements of Operations. Restructuring and severance costs associated with share-based compensation for the three-month fiscal period ended September 30, 2022 were not material.

Stock option activity was as follows:

	For the Three Months Ended			For the Nine Months Ended
	September 29, 2023			September 29, 2023
	Options	Weighted - average exercise price		Options	Weighted - average exercise price
Options outstanding at beginning of period	615,742	$	54.31	710,782	$	54.12
Granted	48,987	$	24.48	48,987	$	24.48
Exercised	—	$	—	—	$	—
Forfeited or expired	(5,505)	$	63.09	(100,545)	$	53.45
Options outstanding at September 29, 2023	659,224	$	52.02	659,224	$	52.02

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. The following table indicates the weighted-average assumptions used in estimating fair value:

	For the Nine Months Ended
	September 29, 2023			September 30, 2022
Expected option term (years)	6.9			6.5
Expected volatility	40.2		%	35.5		%
Risk-free interest rate	4.0		%	2.9		%
Expected dividend yield	3.3		%	2.0		%
Per share fair value of options granted	$	8.17		$	10.22

16. SHARE-BASED ARRANGEMENTS (CONTINUED)

Restricted stock award and restricted stock unit activity were as follows:

	For the Three Months Ended			For the Nine Months Ended
	September 29, 2023			September 29, 2023
	Restricted  Stock	Weighted- average grant date fair value		Restricted  Stock	Weighted- average grant date fair value
Restricted Stock outstanding at beginning of period	227,196	$	32.58	159,521	$	45.78
Granted	26,740	$	24.31	167,572	$	24.53
Vested	(34,507)	$	42.02	(99,239)	$	45.08
Forfeited or expired	(13,960)	$	32.98	(22,385)	$	35.58
Restricted Stock outstanding at September 29, 2023	205,469	$	29.89	205,469	$	29.89

Performance stock unit activity was as follows:

	For the Three Months Ended			For the Nine Months Ended
	September 29, 2023			September 29, 2023
	Performance Stock	Weighted- average grant date fair value		Performance Stock	Weighted- average grant date fair value
Performance Stock outstanding at beginning of period	314,552	$	45.00	172,144	$	60.44
Granted	—	$	—	178,385	$	32.03
Vested	—	$	—	—	$	—
Forfeited or expired	(34,705)	$	42.98	(70,682)	$	48.89
Performance Stock outstanding at September 29, 2023	279,847	$	45.25	279,847	$	45.25

The fair value of the PSUs based on total shareholder return ("TSR") was estimated on the date of grant using a Monte-Carlo simulation model. The following table indicates the weighted-average assumptions used in estimating fair value:

	For the Nine Months Ended
	September 29, 2023			September 30, 2022
Expected term (years)	2.9			2.9
Expected volatility	41.2		%	39.4		%
Risk-free interest rate	4.4		%	1.7		%
Expected dividend yield	3.3		%	1.9		%
Per share fair value of performance stock granted	$	38.83		$	68.10

XML

Shareholders' Equity and Accumulated Other Comprehensive Income

9 Months Ended

Sep. 29, 2023

Stockholders' Equity Note [Abstract]

Shareholders' Equity and Accumulated Other Comprehensive Income

SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME

Changes in shareholders’ equity for the three-month and nine-month fiscal periods ended September 29, 2023, and September 30, 2022, were as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Beginning balance(1)	$	686,329	$	777,623	$	680,756	$	795,453
Comprehensive (loss) income	(2,864)		(9,334)		9,579		(15,502)
Dividends declared (per share of common stock, $0.20 and $0.20 and $0.60 and $0.60, respectively)	(5,650)		(5,604)		(16,915)		(16,791)
Employee stock plans and related tax benefit	495		430		1,465		1,696
Purchase of treasury shares	(277)		(64)		(780)		(762)
Share-based compensation expense	1,262		1,334		5,190		6,145
Impact of change in accounting standard(2)	—		—		—		(5,854)
Ending balance	$	679,295	$	764,385	$	679,295	$	764,385

(1) For the three-month and nine-month fiscal periods ended September 30, 2022, the Company revised its previously issued financial statements for errors related to (1) the accounting for certain labor costs at one business in the Precision Products segment and (2) the net realizable value on certain portions of the Company's inventory at another business in the Structures segment. The impact of these items on the beginning shareholders' equity and accumulated other comprehensive income balances noted above was approximately $1.3 million and $0.9 million, respectively. Refer to Note 2, Accounting Changes, for further information.

(2) At January 1, 2022, the Company adopted Accounting Standard Update 2020-06, "Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity" ("ASU 2020-06"). Refer to Note 1, Summary of Significant Accounting Policies, of the Company's Annual Report on Form 10-K for the year ended December 31, 2022 for further information on the adoption of ASU 2020-06.

17. SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME (CONTINUED)

The components of accumulated other comprehensive income (loss) are shown below:

	For the Three Months Ended
	September 29, 2023		September 30, 2022
In thousands
Foreign currency translation:
Beginning balance	$	1,398	$	(6,707)
Net loss on foreign currency translation	(5,766)		(9,875)
Other comprehensive income (loss), net of tax	(5,766)		(9,875)
Ending balance	$	(4,368)	$	(16,582)
Pension and other post-retirement benefits(1):
Beginning balance	$	(153,394)	$	(118,495)
Amortization of net loss, net of tax expense of $445 and $259, respectively	1,478		821
Other comprehensive income, net of tax	1,478		821
Ending balance	$	(151,916)	$	(117,674)
Derivative instruments(2):
Beginning balance	$	1,532	$	—
Gain on derivative instruments, net of tax expense of $138 and $0, respectively	460		—
Reclassification to net income, net of tax benefit of $(151) and $0, respectively	(502)		—
Other comprehensive income (loss), net of tax	(42)		—
Ending balance	$	1,490	$	—
Total accumulated other comprehensive loss	$	(154,794)	$	(134,256)

(1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost.

(See Note 13, Pension Plans, for additional information.)

(2) See Note 9, Derivative Financial Instruments, for additional information regarding derivative instruments.

17. SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME (CONTINUED)

	For the Nine Months Ended
	September 29, 2023		September 30, 2022
In thousands
Foreign currency translation:
Beginning balance	$	(2,071)	$	8,765
Net loss on foreign currency translation	(2,297)		(25,347)
Other comprehensive income (loss), net of tax	(2,297)		(25,347)
Ending balance	$	(4,368)	$	(16,582)
Pension and other post-retirement benefits(1):
Beginning balance	$	(156,350)	$	(120,157)
Amortization of net loss, net of tax expense of $1,336 and $756, respectively	4,434		2,483
Other comprehensive income, net of tax	4,434		2,483
Ending balance	$	(151,916)	$	(117,674)
Derivative instruments(2):
Beginning balance	$	—	$	7
Gain on derivative instruments, net of tax expense of $692 and $0, respectively	2,298		—
Reclassification to net income, net of tax benefit of $(243) and $0, respectively	(808)		(7)
Other comprehensive income (loss), net of tax	1,490		(7)
Ending balance	$	1,490	$	—
Total accumulated other comprehensive loss	$	(154,794)	$	(134,256)

(1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost.

(See Note 13, Pension Plans, for additional information.)

(2) See Note 9, Derivative Financial Instruments, for additional information regarding derivative instruments.

XML

Income Taxes

9 Months Ended

Sep. 29, 2023

Income Tax Disclosure [Abstract]

Income Taxes

INCOME TAXES

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
Effective Income Tax Rate	24.0	%	28.9	%	28.5	%	18.1	%

The effective income tax rate represents the combined federal, state and foreign tax effects attributable to pretax earnings for the period. The effective tax rate for the three-month fiscal period ended September 29, 2023 decreased when compared to the corresponding rate in the prior year period, attributable to higher net earnings in the current period. The effective rate for the nine-month fiscal period ended September 29, 2023 increased when compared to the corresponding rate in the prior year period, primarily driven by a charge to record additional valuation allowances relating to the Company’s state tax loss carryforwards, partially offset by a benefit relating to the reversal of uncertain tax positions.

XML

Subsequent Events	9 Months Ended
	Sep. 29, 2023
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTSThe Company has evaluated subsequent events through the issuance date of these financial statements. No material subsequent events were identified that require disclosure.

XML

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net earnings (loss)	$ 1,466	$ (280)	$ 5,952	$ 7,369

XML

Insider Trading Arrangements	3 Months Ended
	Sep. 29, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Basis of Presentation Basis of Presentation (Policies)

9 Months Ended

Sep. 29, 2023

Basis of Presentation [Abstract]

Consolidation, Policy [Policy Text Block]

BASIS OF PRESENTATION

In the opinion of management, the condensed consolidated financial information reflects all adjustments necessary for a fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented, but do not include all disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). All such adjustments are of a normal recurring nature, unless otherwise disclosed in this report. Certain amounts in prior year financial statements and notes thereto have been reclassified to conform to current year presentation. The condensed consolidated financial statements for the period ended September 29, 2023 should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

The Company has a calendar year-end; however, its first three fiscal quarters follow a 13-week convention, with each quarter ending on a Friday. The third quarters for 2023 and 2022 ended on September 29, 2023, and September 30, 2022, respectively.

XML

Accounting Changes and Error Corrections (Tables)

9 Months Ended

Sep. 29, 2023

Accounting Changes and Error Corrections [Abstract]

Schedule of Change in Accounting Estimate [Table Text Block]

Net changes in revenue associated with cost growth on the Company's over time contracts were as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Net change in revenue due to change in profit estimates	$	(3,123)	$	(892)	$	(5,987)	$	580

Schedule of Changes in Accounting Estimates - Revision

The revision to the accompanying unaudited condensed consolidated balance sheet, condensed consolidated statements of operations, condensed consolidated statements of comprehensive income and condensed consolidated statement of cash flows are as follows. There were no changes to the consolidated statement of stockholders' equity that have not otherwise been reflected in the condensed consolidated balance sheets, condensed consolidated statements of operations, and condensed consolidated statements of comprehensive income as detailed in the tables below.

Condensed Consolidated Balance Sheet
In thousands
	December 31, 2022
	As Previously Reported		Adjustments		As Corrected
Assets
Inventories(1)	$	176,468	$	(4,085)	$	172,383
Income tax refunds receivable	13,981		862		14,843
Total	$	190,449	$	(3,223)	$	187,226
Shareholders' equity
Retained earnings	$	688,457	$	(3,223)	$	685,234

(1) At December 31, 2022, the adjustments to inventories consisted of an adjustment of $2.5 million for certain labor costs at a business within the Precision Products segment and an adjustment of $1.6 million for the net realizable value on certain portions of the inventory at a business within the Structures segment.

2. ACCOUNTING CHANGES (CONTINUED)

Revision of Previously Issued Consolidated Financial Statements - continued

Condensed Consolidated Statements of Operations
In thousands, except per share amounts
	For the Three Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Cost of sales	$	116,179	$	1,147	$	117,326
Income tax expense	128		(242)		(114)
Net earnings	625		(905)		(280)
Basic earnings per share	$	0.02	$	(0.03)	$	(0.01)
Diluted earnings per share	$	0.02	$	(0.03)	$	(0.01)
	For the Nine Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Cost of sales	$	332,299	$	1,709	$	334,008
Income tax expense	1,992		(361)		1,631
Net earnings	8,717		(1,348)		7,369
Basic earnings per share	$	0.31	$	(0.05)	$	0.26
Diluted earnings per share	$	0.31	$	(0.05)	$	0.26

Condensed Consolidated Statements of Comprehensive Income (Loss)
In thousands
	For the Three Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Comprehensive (loss) income	$	(8,429)	$	(905)	$	(9,334)
	For the Nine Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Comprehensive (loss) income	$	(14,154)	$	(1,348)	$	(15,502)

Condensed Consolidated Statement of Cash Flows
In thousands
	For the Nine Months Ended September 30, 2022
	As Previously Reported		Adjustments		As Corrected
Net earnings	$	8,717	$	(1,348)	$	7,369
Inventories	(21,187)		1,709		(19,478)
Income tax refunds receivable	(2,040)		(361)		(2,401)
Net cash used in operating activities	(33,700)		—		(33,700)

XML

Business Combinations (Tables)

9 Months Ended

Sep. 29, 2023

Acquisitions [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed

This acquisition was accounted for under the acquisition method. The assets acquired and liabilities assumed were recorded based on their fair values at the date of acquisition as follows (in thousands):

Accounts receivable	$	7,635
Contract assets	171
Inventories	11,246
Property, plant and equipment	7,686
Goodwill	171,277
Other intangible assets(1)	250,500
Contract costs, noncurrent	41
Liabilities	(5,729)
Net assets acquired	442,827
Less cash received	—
Net consideration	$	442,827

Business Acquisition, Pro Forma Information [Table Text Block]

Pro Forma Information (Unaudited) - continued

	For the Three Months Ended	For the Nine Months Ended
	September 30, 2022	September 30, 2022
In thousands
Net sales	188,554	543,817
Net earnings	8,949	17,035

XML

Segment and Geographic Information (Tables)

9 Months Ended

Sep. 29, 2023

Revenue [Abstract]

Reconciliation of Revenue from Segments to Consolidated

Summarized financial information by business segment is as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Net sales:
Engineered Products	$	123,598	$	92,052	$	380,437	$	263,269
Precision Products	27,098		46,282		93,128		135,098
Structures	32,335		33,670		99,166		92,451
Net sales	$	183,031	$	172,004	$	572,731	$	490,818
Operating income (loss):
Engineered Products	$	29,026	$	14,156	$	78,924	$	40,665
Precision Products	(3,241)		5,296		(3,996)		10,725
Structures	(3,020)		(642)		(3,769)		(2,121)
Corporate expense	(9,828)		(20,196)		(29,499)		(42,728)
Other unallocated (expenses) income, net(1)	(1,065)		685		(4,541)		(2,467)
Operating income (loss)	$	11,872	$	(701)	$	37,119	$	4,074
Interest expense, net	9,405		3,614		29,349		8,088
Non-service pension and post-retirement benefit income, net	(310)		(5,142)		(930)		(15,429)
Other expense, net	849		1,221		377		2,415
Earnings (loss) before income taxes	$	1,928	$	(394)	$	8,323	$	9,000

(1) Other unallocated expenses, net include program inventory impairment, restructuring and severance costs and net loss on disposition of assets.

Disaggregation of Revenue [Table Text Block]

Disaggregation of Revenue

The following tables disaggregate segment revenue by major product line:

	For the Three Months Ended
	September 29, 2023
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	18,859	$	7,541	$	17,324	$	43,724
Safe and Arm Devices	—		12,890		—		12,890
Commercial, Business & General Aviation	61,550		5,459		13,374		80,383
Medical	23,005		—		1,637		24,642
Industrial & Other	20,184		1,208		—		21,392
Total revenue	$	123,598	$	27,098	$	32,335	$	183,031
	For the Three Months Ended
	September 30, 2022
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	13,356	$	5,171	$	20,805	$	39,332
Safe and Arm Devices	—		37,460		—		37,460
Commercial, Business & General Aviation	39,852		2,457		11,006		53,315
Medical	21,782		—		1,859		23,641
Industrial & Other	17,062		1,194		—		18,256
Total revenue	$	92,052	$	46,282	$	33,670	$	172,004

	For the Nine Months Ended
	September 29, 2023
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	57,362	$	20,502	$	55,461	$	133,325
Safe and Arm Devices	—		49,486		—		49,486
Commercial, Business & General Aviation	190,471		19,548		38,232		248,251
Medical	73,463		—		5,473		78,936
Industrial & Other	59,141		3,592		—		62,733
Total revenue	$	380,437	$	93,128	$	99,166	$	572,731
	For the Nine Months Ended
	September 30, 2022
	Engineered Products		Precision Products		Structures		Total
In thousands
Defense	$	32,351	$	17,122	$	53,158	$	102,631
Safe and Arm Devices	—		96,345		—		96,345
Commercial, Business & General Aviation	109,874		18,119		33,138		161,131
Medical	65,614		—		6,155		71,769
Industrial & Other	55,430		3,512		—		58,942
Total revenue	$	263,269	$	135,098	$	92,451	$	490,818

4. REVENUE AND SEGMENT INFORMATION (CONTINUED)

Disaggregation of Revenue - continued

The following table disaggregates total revenue by product types.

	For the Three Months Ended								For the Three Months Ended
	September 29, 2023								September 30, 2022
	Engineered Products		Precision Products		Structures		Total		Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	47	%	3	%	18	%	68	%	40	%	2	%	19	%	61	%
Aftermarket	20	%	5	%	—	%	25	%	14	%	3	%	—	%	17	%
Safe and Arm Devices	—	%	7	%	—	%	7	%	—	%	22	%	—	%	22	%
Total revenue	67	%	15	%	18	%	100	%	54	%	27	%	19	%	100	%
	For the Nine Months Ended								For the Nine Months Ended
	September 29, 2023								September 30, 2022
	Engineered Products		Precision Products		Structures		Total		Engineered Products		Precision Products		Structures		Total
Original Equipment Manufacturer	47	%	3	%	17	%	67	%	41	%	4	%	19	%	64	%
Aftermarket	20	%	4	%	—	%	24	%	12	%	4	%	—	%	16	%
Safe and Arm Devices	—	%	9	%	—	%	9	%	—	%	20	%	—	%	20	%
Total revenue	67	%	16	%	17	%	100	%	53	%	28	%	19	%	100	%

Research and Development

The following table presents research and development costs by segment:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Engineered Products	$	1,620	$	2,106	$	6,738	$	6,470
Precision Products	2,387		1,812		8,308		7,599
Structures	15		19		76		196
Total research and development costs	$	4,022	$	3,937	$	15,122	$	14,265

Schedule of Change in Accounting Estimate [Table Text Block]

Net changes in revenue associated with cost growth on the Company's over time contracts were as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Net change in revenue due to change in profit estimates	$	(3,123)	$	(892)	$	(5,987)	$	580

Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]

Backlog at September 29, 2023 and December 31, 2022, and the portion of backlog the Company expects to recognize revenue on over the next twelve months is as follows:

	September 29, 2023(1)		December 31, 2022
	(in thousands)
Engineered Products	$	363,228	$	322,452
Precision Products	100,712		134,903
Structures	254,633		263,581
Total Backlog	$	718,573	$	720,936

(1) The Company expects to recognize revenue on approximately 69% of backlog as of September 29, 2023 over the next twelve months.

^[1]

[1] The Company expects to recognize revenue on approximately 69% of backlog as of September 29, 2023 over the next twelve months.

XML

Restructuring Costs (Tables)

9 Months Ended

Sep. 29, 2023

Restructuring Costs [Abstract]

Restructuring and Related Costs

The following table summarizes the accrual balances by cost type for the restructuring actions:

	Severance		Other(1)		Total
In thousands
Restructuring accrual balance at December 31, 2022(2)	$	6,629	$	—	$	6,629
Provision	2,147		625		2,772
Cash payments	(5,767)		(625)		(6,392)
Changes in foreign currency exchange rates	(2)		—		(2)
Restructuring accrual balance at September 29, 2023	$	3,007	$	—	$	3,007

XML

Accounts Receivable, Net (Tables)

9 Months Ended

Sep. 29, 2023

Accounts Receivable, after Allowance for Credit Loss [Abstract]

Schedule of Accounts Receivable, Net

Accounts receivable, net consisted of the following:

	September 29, 2023		December 31, 2022
In thousands
Trade receivables	$	42,931	$	31,126
U.S. Government contracts:
Billed	16,333		14,150
Cost and accrued profit - not billed	2,460		661
Commercial and other government contracts
Billed	46,751		41,520
Cost and accrued profit - not billed	1,069		2,268
Less allowance for doubtful accounts	(2,897)		(2,066)
Accounts receivable, net	$	106,647	$	87,659

Financing Receivable, Allowance for Credit Loss [Table Text Block]

The following table summarizes the activity in the allowance for doubtful accounts in the nine-month fiscal period ended September 29, 2023:

In thousands
Balance at December 31, 2022	$	(2,066)
Provision	(1,495)
Amounts written off	307
Recoveries	356
Changes in foreign currency exchange rates	1
Balance at September 29, 2023	$	(2,897)

Accounts Receivable Due to Contract Changes, Negotiated Settlements and Claims for Unanticipated Cost

There were no amounts included in accounts receivable, net for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at September 29, 2023 and December 31, 2022.

XML

Contract Assets, Contract Costs and Contract Liabilities (Tables)

9 Months Ended

Sep. 29, 2023

Revenue from Contract with Customer [Abstract]

Activity Related to Contract Assets, Contract Costs, and Contract Liabilities

Activity related to contract assets, contract costs and contract liabilities was as follows:

	September 29, 2023		December 31, 2022		$ Change		% Change
In thousands
Contract assets	$	100,709	$	113,182	$	(12,473)	(11.0)	%
Contract costs, current portion(1)	$	139	$	695	$	(556)	(80.0)	%
Contract costs, noncurrent portion(2)	$	643	$	673	$	(30)	(4.5)	%
Contract liabilities, current portion	$	7,884	$	4,081	$	3,803	93.2	%
Contract liabilities, noncurrent portion	$	19,653	$	20,515	$	(862)	(4.2)	%

There were no amounts included in contract assets for matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at September 29, 2023 and December 31, 2022.

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 29, 2023

Fair Value Disclosures [Abstract]

Schedule of Fair Value of Financial Instruments That Are Not Carried At Fair Value

The following table presents the carrying value and fair value of financial instruments that are not carried at fair value:

	September 29, 2023				December 31, 2022
	Carrying Value		Fair Value		Carrying Value		Fair Value
In thousands
Debt (1)	$	581,500	$	547,294	$	562,500	$	547,393

(1) These amounts are classified within Level 2.

XML

Inventories (Tables)

9 Months Ended

Sep. 29, 2023

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventories consisted of the following:

	September 29, 2023		December 31, 2022
In thousands
Raw materials	$	35,228	$	24,572
Contracts and other work in process (including certain general stock materials)	127,779		107,803
Finished goods	38,432		40,008
Inventories	$	201,439	$	172,383

Inventory Due to Contract Changes, Negotiated Settlements and Claims for Unanticipated Contract Costs

There were no amounts included in inventories associated with matters such as contract changes, negotiated settlements and claims for unanticipated contract costs at September 29, 2023 and December 31, 2022.

XML

Goodwill and Other Intangible Assets, Net (Tables)

9 Months Ended

Sep. 29, 2023

Intangible Assets, Net (Including Goodwill) [Abstract]

Schedule of Goodwill

The following table sets forth the change in the carrying amount of goodwill for each reportable segment and for the Company:

	Engineered Products		Precision Products		Structures		Total
In thousands
Gross balance at December 31, 2022	$	363,785	$	41,375	$	66,559	$	471,719
Accumulated impairment	—		(25,306)		(66,559)		(91,865)
Net balance at December 31, 2022	363,785		16,069		—		379,854
Additions	1,487		—		—		1,487
Impairments	—		—		—		—
Foreign currency translation	(1,098)		—		—		(1,098)
Ending balance at September 29, 2023	$	364,174	$	16,069	$	—	$	380,243
Accumulated impairment at end of period	$	—	$	(25,306)	$	(66,559)	$	(91,865)

Schedule of Acquired Finite-Lived Intangible Assets by Major Class

Other intangible assets consisted of:

		At September 29,				At December 31,
		2023				2022
	Amortization Period	Gross Amount		Accumulated Amortization		Gross Amount		Accumulated Amortization
In thousands
Customer lists / relationships	6-38 years	$	363,269	$	(51,311)	$	363,549	$	(41,695)
Developed technologies	7-20 years	44,923		(20,582)		45,028		(17,508)
Trademarks / trade names	15-40 years	16,619		(3,583)		16,681		(3,153)
Non-compete agreements and other	1-15 years	17,332		(14,516)		17,336		(7,974)
Patents	17 years	551		(494)		551		(484)
Total intangible assets		$	442,694	$	(90,486)	$	443,145	$	(70,814)

XML

Debt (Tables)

9 Months Ended

Sep. 29, 2023

Debt Disclosure [Abstract]

Schedule of Line of Credit Facilities

The following table shows the amounts available for borrowing under the Company's revolving credit facility:

	September 29, 2023		December 31, 2022
In thousands
Total facility	$	740,000	$	800,000
Amounts outstanding, excluding letters of credit	382,000		363,000
Amounts available for borrowing, excluding letters of credit	358,000		437,000
Letters of credit under the credit facility(1)(2)	70,549		51,630
Amounts available for borrowing	$	287,451	$	385,370
Amounts available for borrowing subject to EBITDA, as defined by the Credit Agreement(3)	$	129,313	$	196,256

XML

Pension Plans (Tables)

9 Months Ended

Sep. 29, 2023

Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract]

Schedule of Net Benefit Costs

Components of net pension cost for the Qualified Pension Plan and Supplemental Employees’ Retirement Plan ("SERP") were as follows:

	For the Three Months Ended
	Qualified Pension Plan				SERP
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Service cost	$	1,445	$	840	$	—	$	—
Interest cost on projected benefit obligation	7,296		4,300		44		22
Expected return on plan assets	(9,573)		(10,544)		—		—
Amortization of net loss	1,923		1,064		—		16
Net pension cost (income)	$	1,091	$	(4,340)	$	44	$	38

13. PENSION PLANS (CONTINUED)

	For the Nine Months Ended
	Qualified Pension Plan				SERP
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Service cost	$	4,336	$	2,522	$	—	$	—
Interest cost on projected benefit obligation	21,888		12,899		132		66
Expected return on plan assets	(28,720)		(31,633)		—		—
Amortization of net loss	5,770		3,193		—		46
Net pension cost (income)	$	3,274	$	(13,019)	$	132	$	112

XML

Computation of Earnings Per Share (Tables)

9 Months Ended

Sep. 29, 2023

Earnings Per Share Reconciliation [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands, except per share amounts
Net earnings (loss)	$	1,466	$	(280)	$	5,952	$	7,369
Basic:
Weighted average number of shares outstanding	28,247		28,037		28,189		27,997
Basic earnings (loss) per share	$	0.05	$	(0.01)	$	0.21	$	0.26
Diluted:
Weighted average number of shares outstanding	28,247		28,037		28,189		27,997
Weighted average shares issuable on exercise of dilutive stock options	103		—		135		79
Total	28,350		28,037		28,324		28,076
Diluted earnings (loss) per share	$	0.05	$	(0.01)	$	0.21	$	0.26

XML

Share-based Arrangements (Tables)

9 Months Ended

Sep. 29, 2023

Share-Based Payment Arrangement, Noncash Expense [Abstract]

Stock Option Activity

Stock option activity was as follows:

	For the Three Months Ended			For the Nine Months Ended
	September 29, 2023			September 29, 2023
	Options	Weighted - average exercise price		Options	Weighted - average exercise price
Options outstanding at beginning of period	615,742	$	54.31	710,782	$	54.12
Granted	48,987	$	24.48	48,987	$	24.48
Exercised	—	$	—	—	$	—
Forfeited or expired	(5,505)	$	63.09	(100,545)	$	53.45
Options outstanding at September 29, 2023	659,224	$	52.02	659,224	$	52.02

Fair Value Assumptions

The fair value of each option award is estimated on the date of grant using the Black-Scholes option valuation model. The following table indicates the weighted-average assumptions used in estimating fair value:

	For the Nine Months Ended
	September 29, 2023			September 30, 2022
Expected option term (years)	6.9			6.5
Expected volatility	40.2		%	35.5		%
Risk-free interest rate	4.0		%	2.9		%
Expected dividend yield	3.3		%	2.0		%
Per share fair value of options granted	$	8.17		$	10.22

Restricted Stock Award and Restricted Stock Unit Activity

Restricted stock award and restricted stock unit activity were as follows:

	For the Three Months Ended			For the Nine Months Ended
	September 29, 2023			September 29, 2023
	Restricted  Stock	Weighted- average grant date fair value		Restricted  Stock	Weighted- average grant date fair value
Restricted Stock outstanding at beginning of period	227,196	$	32.58	159,521	$	45.78
Granted	26,740	$	24.31	167,572	$	24.53
Vested	(34,507)	$	42.02	(99,239)	$	45.08
Forfeited or expired	(13,960)	$	32.98	(22,385)	$	35.58
Restricted Stock outstanding at September 29, 2023	205,469	$	29.89	205,469	$	29.89

Share-based Payment Arrangement, Performance Shares, Activity

Performance stock unit activity was as follows:

	For the Three Months Ended			For the Nine Months Ended
	September 29, 2023			September 29, 2023
	Performance Stock	Weighted- average grant date fair value		Performance Stock	Weighted- average grant date fair value
Performance Stock outstanding at beginning of period	314,552	$	45.00	172,144	$	60.44
Granted	—	$	—	178,385	$	32.03
Vested	—	$	—	—	$	—
Forfeited or expired	(34,705)	$	42.98	(70,682)	$	48.89
Performance Stock outstanding at September 29, 2023	279,847	$	45.25	279,847	$	45.25

Schedule of Share-based Payment Awards, Performance Shares, Valuation Assumptions

The following table indicates the weighted-average assumptions used in estimating fair value:

	For the Nine Months Ended
	September 29, 2023			September 30, 2022
Expected term (years)	2.9			2.9
Expected volatility	41.2		%	39.4		%
Risk-free interest rate	4.4		%	1.7		%
Expected dividend yield	3.3		%	1.9		%
Per share fair value of performance stock granted	$	38.83		$	68.10

XML

Shareholders' Equity and Accumulated Other Comprehensive Income (Tables)

9 Months Ended

Sep. 29, 2023

Stockholders' Equity Note [Abstract]

Schedule of Stockholders Equity

Changes in shareholders’ equity for the three-month and nine-month fiscal periods ended September 29, 2023, and September 30, 2022, were as follows:

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
In thousands
Beginning balance(1)	$	686,329	$	777,623	$	680,756	$	795,453
Comprehensive (loss) income	(2,864)		(9,334)		9,579		(15,502)
Dividends declared (per share of common stock, $0.20 and $0.20 and $0.60 and $0.60, respectively)	(5,650)		(5,604)		(16,915)		(16,791)
Employee stock plans and related tax benefit	495		430		1,465		1,696
Purchase of treasury shares	(277)		(64)		(780)		(762)
Share-based compensation expense	1,262		1,334		5,190		6,145
Impact of change in accounting standard(2)	—		—		—		(5,854)
Ending balance	$	679,295	$	764,385	$	679,295	$	764,385

Schedule of Accumulated Other Comprehensive Income (Loss)

The components of accumulated other comprehensive income (loss) are shown below:

	For the Three Months Ended
	September 29, 2023		September 30, 2022
In thousands
Foreign currency translation:
Beginning balance	$	1,398	$	(6,707)
Net loss on foreign currency translation	(5,766)		(9,875)
Other comprehensive income (loss), net of tax	(5,766)		(9,875)
Ending balance	$	(4,368)	$	(16,582)
Pension and other post-retirement benefits(1):
Beginning balance	$	(153,394)	$	(118,495)
Amortization of net loss, net of tax expense of $445 and $259, respectively	1,478		821
Other comprehensive income, net of tax	1,478		821
Ending balance	$	(151,916)	$	(117,674)
Derivative instruments(2):
Beginning balance	$	1,532	$	—
Gain on derivative instruments, net of tax expense of $138 and $0, respectively	460		—
Reclassification to net income, net of tax benefit of $(151) and $0, respectively	(502)		—
Other comprehensive income (loss), net of tax	(42)		—
Ending balance	$	1,490	$	—
Total accumulated other comprehensive loss	$	(154,794)	$	(134,256)

(1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost.

(See Note 13, Pension Plans, for additional information.)

(2) See Note 9, Derivative Financial Instruments, for additional information regarding derivative instruments.

17. SHAREHOLDERS' EQUITY AND ACCUMULATED OTHER COMPREHENSIVE INCOME (CONTINUED)

	For the Nine Months Ended
	September 29, 2023		September 30, 2022
In thousands
Foreign currency translation:
Beginning balance	$	(2,071)	$	8,765
Net loss on foreign currency translation	(2,297)		(25,347)
Other comprehensive income (loss), net of tax	(2,297)		(25,347)
Ending balance	$	(4,368)	$	(16,582)
Pension and other post-retirement benefits(1):
Beginning balance	$	(156,350)	$	(120,157)
Amortization of net loss, net of tax expense of $1,336 and $756, respectively	4,434		2,483
Other comprehensive income, net of tax	4,434		2,483
Ending balance	$	(151,916)	$	(117,674)
Derivative instruments(2):
Beginning balance	$	—	$	7
Gain on derivative instruments, net of tax expense of $692 and $0, respectively	2,298		—
Reclassification to net income, net of tax benefit of $(243) and $0, respectively	(808)		(7)
Other comprehensive income (loss), net of tax	1,490		(7)
Ending balance	$	1,490	$	—
Total accumulated other comprehensive loss	$	(154,794)	$	(134,256)

(1) These accumulated other comprehensive income components are included in the computation of net periodic pension cost.

(See Note 13, Pension Plans, for additional information.)

(2) See Note 9, Derivative Financial Instruments, for additional information regarding derivative instruments.

XML

Income Taxes (Tables)

9 Months Ended

Sep. 29, 2023

Income Tax Disclosure [Abstract]

Schedule of Effective Income Tax Rates

	For the Three Months Ended				For the Nine Months Ended
	September 29, 2023		September 30, 2022		September 29, 2023		September 30, 2022
Effective Income Tax Rate	24.0	%	28.9	%	28.5	%	18.1	%

XML

Accounting Changes and Error Corrections (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022	Dec. 31, 2022
Change in Accounting Estimate [Line Items]
Income tax refunds receivable	$ 4,680		$ 4,680		$ 14,843
Total Revision to Assets					187,226
Retained earnings	674,271		674,271		685,234
Cost of sales	117,977	$ 117,326	368,246	$ 334,008
Income tax expense (benefit)	462	(114)	2,371	1,631
Net earnings (loss)	$ 1,466	$ (280)	$ 5,952	$ 7,369
Basic earnings per share (in usd per share)	$ 0.05	$ (0.01)	$ 0.21	$ 0.26
Diluted earnings per share from continuing operations	$ 0.05	$ (0.01)	$ 0.21	$ 0.26
Comprehensive (loss) income	$ (2,864)	$ (9,334)	$ 9,579	$ (15,502)
Inventories			(30,952)	(19,478)
Income tax refunds receivable			10,158	(2,401)
Net cash provided by operating activities			29,673	(33,700)
Inventories	$ 201,439		$ 201,439		172,383
Revision of Prior Period, Adjustment
Change in Accounting Estimate [Line Items]
Income tax refunds receivable					862
Total Revision to Assets					(3,223)
Retained earnings					(3,223)
Cost of sales		1,147		1,709
Income tax expense (benefit)		(242)		(361)
Net earnings (loss)		$ (905)		$ (1,348)
Basic earnings per share (in usd per share)		$ (0.03)		$ (0.05)
Diluted earnings per share from continuing operations		$ (0.03)		$ (0.05)
Comprehensive (loss) income		$ (905)		$ (1,348)
Inventories				1,709
Income tax refunds receivable				(361)
Net cash provided by operating activities				0
Inventories					(4,085)
Revision of Prior Period, Adjustment | Precision Products
Change in Accounting Estimate [Line Items]
Inventories					2,500
Revision of Prior Period, Adjustment | Structures
Change in Accounting Estimate [Line Items]
Inventories					1,600
Previously Reported
Change in Accounting Estimate [Line Items]
Income tax refunds receivable					13,981
Total Revision to Assets					190,449
Retained earnings					688,457
Cost of sales		116,179		332,299
Income tax expense (benefit)		128		1,992
Net earnings (loss)		$ 625		$ 8,717
Basic earnings per share (in usd per share)		$ 0.02		$ 0.31
Diluted earnings per share from continuing operations		$ 0.02		$ 0.31
Comprehensive (loss) income		$ (8,429)		$ (14,154)
Inventories				(21,187)
Income tax refunds receivable				(2,040)
Net cash provided by operating activities				$ (33,700)
Inventories					$ 176,468

XML

Business Combinations (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 29, 2023	Mar. 31, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022	Sep. 16, 2022
Acquired Indefinite-lived Intangible Assets [Line Items]
Goodwill, Purchase Accounting Adjustments		$ 1,500
Business Acquisition, Pro Forma Revenue	$ 188,554			$ 543,817
Business Acquisition, Pro Forma Net Income (Loss)	8,949			17,035
Pro Forma, Nonrecurring Adjustment, Increase in Depreciation Expense	100			500
Pro Forma, Nonrecurring Adjustment, Finite Lived Assets Amortization	1,800			7,900
Pro Forma, Nonrecurring Adjustment, Reduction in Acquisition Related Expense	(10,100)			(12,100)
Pro Forma Nonrecurring Adjustment, Increase in Interest Expense	3,400			11,400
Pro Forma Nonrecurring Adjustment, Increase in Income Tax Expense	1,000
Pro Forma Nonrecurring Adjustment, Reduction in Income Tax Expense	(1,600)
Parker Aircraft Wheels & Brakes
Acquired Indefinite-lived Intangible Assets [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net						$ 442,827
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents						0
Business Combination, Consideration Transferred				442,827
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables						7,635
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contract Assets						171
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory						11,246
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment						7,686
Business Acquisition, Goodwill, Expected Tax Deductible Amount						171,277
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles						250,500
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities						41
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities						$ (5,729)
Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual	16,900		$ 2,700	56,600	$ 2,700
Business Combination, Pro Forma Information, Earnings or Loss of Acquiree since Acquisition Date, Actual	$ 1,900		$ (1,100)	$ 5,800	$ (1,100)

XML

Segment and Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 29, 2023	Dec. 31, 2022	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Net sales	$ 183,031		$ 172,004	$ 572,731	$ 490,818
Operating Income (Loss)	11,872		(701)	37,119	4,074
Interest expense, net	9,405		3,614	29,349	8,088
Non-service pension and post-retirement benefit income	(310)		(5,142)	(930)	(15,429)
Other expense, net	$ 849		$ 1,221	$ 377	$ 2,415
Revenue, Net, Percentage	100.00%		100.00%	100.00%	100.00%
Research and Development Expense	$ 4,022		$ 3,937	$ 15,122	$ 14,265
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	1,928		(394)	8,323	9,000
Program Inventory Impairment	417	$ 44,500	0	1,013	0
Net earnings (loss)	1,466		(280)	5,952	7,369
Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	43,724		39,332	133,325	102,631
Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 12,890		$ 37,460	$ 49,486	$ 96,345
Revenue, Net, Percentage	7.00%		22.00%	9.00%	20.00%
Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 80,383		$ 53,315	$ 248,251	$ 161,131
Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	24,642		23,641	78,936	71,769
Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 21,392		$ 18,256	$ 62,733	$ 58,942
Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	68.00%		61.00%	67.00%	64.00%
Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	25.00%		17.00%	24.00%	16.00%
Engineered Products
Disaggregation of Revenue [Line Items]
Net sales	$ 123,598		$ 92,052	$ 380,437	$ 263,269
Operating Income (Loss)	$ 29,026		$ 14,156	$ 78,924	$ 40,665
Revenue, Net, Percentage	67.00%		54.00%	67.00%	53.00%
Research and Development Expense	$ 1,620		$ 2,106	$ 6,738	$ 6,470
Engineered Products | Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	18,859		13,356	57,362	32,351
Engineered Products | Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 0		$ 0	$ 0	$ 0
Revenue, Net, Percentage	0.00%		0.00%	0.00%	0.00%
Engineered Products | Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 61,550		$ 39,852	$ 190,471	$ 109,874
Engineered Products | Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	23,005		21,782	73,463	65,614
Engineered Products | Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 20,184		$ 17,062	$ 59,141	$ 55,430
Engineered Products | Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	47.00%		40.00%	47.00%	41.00%
Engineered Products | Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	20.00%		14.00%	20.00%	12.00%
Precision Products
Disaggregation of Revenue [Line Items]
Net sales	$ 27,098		$ 46,282	$ 93,128	$ 135,098
Operating Income (Loss)	$ (3,241)		$ 5,296	$ (3,996)	$ 10,725
Revenue, Net, Percentage	15.00%		27.00%	16.00%	28.00%
Research and Development Expense	$ 2,387		$ 1,812	$ 8,308	$ 7,599
Precision Products | Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	7,541		5,171	20,502	17,122
Precision Products | Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 12,890		$ 37,460	$ 49,486	$ 96,345
Revenue, Net, Percentage	7.00%		22.00%	9.00%	20.00%
Precision Products | Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 5,459		$ 2,457	$ 19,548	$ 18,119
Precision Products | Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	0		0	0	0
Precision Products | Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 1,208		$ 1,194	$ 3,592	$ 3,512
Precision Products | Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	3.00%		2.00%	3.00%	4.00%
Precision Products | Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	5.00%		3.00%	4.00%	4.00%
Structures
Disaggregation of Revenue [Line Items]
Net sales	$ 32,335		$ 33,670	$ 99,166	$ 92,451
Operating Income (Loss)	$ (3,020)		$ (642)	$ (3,769)	$ (2,121)
Revenue, Net, Percentage	18.00%		19.00%	17.00%	19.00%
Research and Development Expense	$ 15		$ 19	$ 76	$ 196
Structures | Military and Defense, other than fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	17,324		20,805	55,461	53,158
Structures | Missile and Bomb Fuzes [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 0		$ 0	$ 0	$ 0
Revenue, Net, Percentage	0.00%		0.00%	0.00%	0.00%
Structures | Commercial Aerospace [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 13,374		$ 11,006	$ 38,232	$ 33,138
Structures | Medical [Member]
Disaggregation of Revenue [Line Items]
Net sales	1,637		1,859	5,473	6,155
Structures | Other [Member]
Disaggregation of Revenue [Line Items]
Net sales	$ 0		$ 0	$ 0	$ 0
Structures | Original Equipment Manufacturer [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	18.00%		19.00%	17.00%	19.00%
Structures | Aftermarket [Member]
Disaggregation of Revenue [Line Items]
Revenue, Net, Percentage	0.00%		0.00%	0.00%	0.00%
Corporate Segment
Disaggregation of Revenue [Line Items]
Operating Income (Loss)	$ (9,828)		$ (20,196)	$ (29,499)	$ (42,728)
Other unallocated expenses, net
Disaggregation of Revenue [Line Items]
Operating Income (Loss)	$ (1,065)		$ 685	$ (4,541)	$ (2,467)

XML

Revenue Changes in Revenue due to Estimates in Over Time Contracts (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Change in Accounting Estimate [Line Items]
Net sales	$ 183,031	$ 172,004	$ 572,731	$ 490,818
Performance obligations satisfied in previous periods [Member]
Change in Accounting Estimate [Line Items]
Reductions in Revenues	$ (3,123)	$ (892)	$ (5,987)	$ 580

XML

Revenue Unfulfilled Performance Obligations (Details) - USD ($) $ in Thousands	Sep. 29, 2023	Dec. 31, 2022
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	$ 718,573	$ 720,936
Revenue, Remaining Performance Obligation, Percentage	69.00%
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 718,573	720,936
Engineered Products
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	363,228	322,452
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	363,228	322,452
Precision Products
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	100,712	134,903
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	100,712	134,903
Structures
Unfulfilled Performance Obligations [Abstract]
Revenue, Remaining Performance Obligation, Amount	254,633	263,581
Disaggregation of Revenue [Line Items]
Revenue, Remaining Performance Obligation, Amount	$ 254,633	$ 263,581

XML

Restructuring Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring and severance costs	$ 571	$ (243)	$ 3,033	$ 2,853
Restructuring accrual, beginning balance					$ 6,629
Increase (Decrease) in Restructuring Reserve			2,772
Restructuring Reserve, Period Increase (Decrease)			(6,392)
Restructuring Reserve, Foreign Currency Translation Gain (Loss)			(2)
Restructuring accrual, ending balance	3,007		3,007
Share-based compensation expense	1,262	1,334	5,190	6,145
Restructuring accrual, long-term portion					1,000
Severance Costs				1,000
Restructuring and Severance
Restructuring Cost and Reserve [Line Items]
Share-based compensation expense	0		300	200
Transformation severance
Restructuring Cost and Reserve [Line Items]
Restructuring and severance costs	600		3,000
Restructuring accrual, beginning balance					6,629
Increase (Decrease) in Restructuring Reserve			2,147
Restructuring Reserve, Period Increase (Decrease)			(5,767)
Restructuring Reserve, Foreign Currency Translation Gain (Loss)			(2)
Restructuring accrual, ending balance	3,007		3,007
Transformation other
Restructuring Cost and Reserve [Line Items]
Restructuring accrual, beginning balance					$ 0
Increase (Decrease) in Restructuring Reserve			625
Restructuring Reserve, Period Increase (Decrease)			(625)
Restructuring Reserve, Foreign Currency Translation Gain (Loss)			0
Restructuring accrual, ending balance	$ 0		$ 0
G&A Reduction Efforts
Restructuring Cost and Reserve [Line Items]
Severance Costs		$ (200)		$ 1,900

XML

Accounts Receivable, Net - Schedule of Accounts Receivable, Net (Details) - USD ($) $ in Thousands	Sep. 29, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Less allowance for doubtful accounts	$ (2,897)	$ (2,066)
Accounts receivable, net	106,647	87,659
Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	42,931	31,126
U.S. Government contracts | Billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	16,333	14,150
U.S. Government contracts | Not billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	2,460	661
Commercial and other government contracts | Billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	46,751	41,520
Commercial and other government contracts | Not billed | Accounts Receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	$ 1,069	$ 2,268

XML

Accounts Receivable, Net Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 29, 2023	Dec. 31, 2022
Allowance for Doubtful Accounts [Abstract]
Less allowance for doubtful accounts	$ (2,897)	$ (2,066)
Provision for Other Credit Losses	(1,495)
Accounts Receivable, Allowance for Credit Loss, Writeoff	307
Accounts Receivable, Allowance for Credit Loss, Recovery	356
Financing Receivable, Allowance for Credit Loss, Foreign Currency Translation	$ 1

XML

Accounts Receivable, Net - Accounts Receivable due to contract changes, negotiated settlements and claims for unanticipated cost (Details) - USD ($) $ in Thousands	Sep. 29, 2023	Dec. 31, 2022
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Contracts Receivable, Claims and Uncertain Amounts	$ 0	$ 0

XML

Contract Assets, Contract Costs and Contract Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Contract assets	$ 100,709		$ 100,709		$ 113,182
Contract assets, change			$ (12,473)
Contract assets, change (as percent)			(11.00%)
Capitalized Contract Cost, Net, Current	139		$ 139		695
Capitalized costs, current portion, change			$ (556)
Capitalized costs, current portion, change (as percent)			(80.00%)
Capitalized Contract Cost, Net, Noncurrent	643		$ 643		673
Capitalized costs, noncurrent portion, change			$ (30)
Capitalized costs, noncurrent portion, change (as percent)			(4.50%)
Contract liabilities, current portion	7,884		$ 7,884		4,081
Contract liabilities, current portion, change			$ 3,803
Contract liabilities, current portion, change (as percent)			93.20%
Contract liabilities, noncurrent portion	19,653		$ 19,653		20,515
Contract liabilities, noncurrent portion, change			$ (862)
Contract liabilities, noncurrent portion, change (as percent)			(4.20%)
Capitalized contract cost, amortization	100	$ 200	$ 300	$ 500
Revenue recognized related to contract liabilities	1,200	$ 200	1,700	$ 1,400
Contract Changes Negotiated Settlements and Claims [Member]
Disaggregation of Revenue [Line Items]
Contract assets	0		0		0
Costs to Fulfill [Member]
Disaggregation of Revenue [Line Items]
Capitalized Contract Cost, Net	800		800		1,400
Costs to Obtain [Member]
Disaggregation of Revenue [Line Items]
Capitalized Contract Cost, Net	$ 0		$ 0		$ 0

XML

Fair Value Measurements - Fair Value of Financial Instruments not carried at Fair Value (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 29, 2023	Dec. 31, 2022	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Money Market Funds, at Carrying Value	$ 5,400	$ 100		$ 5,400
Goodwill, Impairment Loss				0
Program Inventory Impairment	417	44,500	$ 0	1,013	$ 0
Level 2 | Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt	581,500	562,500		581,500
Level 2 | Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt	$ 547,294	$ 547,393		$ 547,294

XML

Derivative Financial Instruments (Details) $ in Millions	9 Months Ended
	Sep. 29, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative, Notional Amount	$ 175.0
Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months	$ 1.6

XML

Inventories - Schedule of Inventory (Details) - USD ($) $ in Thousands	Sep. 29, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 35,228	$ 24,572
Contracts and other work in process (including certain general stock materials)	127,779	107,803
Finished goods	38,432	40,008
Inventories	$ 201,439	$ 172,383

XML

Inventories - Inventory Due to Contract Changes, Negotiated Settlements and Claims for Unanticipated Contract Costs (Details) - USD ($) $ in Thousands	Sep. 29, 2023	Dec. 31, 2022
Inventory Disclosure [Abstract]
Inventory due to contract changes, negotiated settlements and claims for unanticipated contract costs	$ 0	$ 0

XML

Inventories - Other Inventory Information (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 29, 2023	Dec. 31, 2022	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Schedule of Inventory [Line Items]
Inventories	$ 201,439	$ 172,383		$ 201,439
Program Inventory Impairment	417	44,500	$ 0	1,013	$ 0
K-MAX®
Schedule of Inventory [Line Items]
Inventory, gross	22,900	24,700		22,900
Inventory noncurrent	9,500			9,500
SH 2GA Super Seasprite Program
Schedule of Inventory [Line Items]
Inventory, gross	5,400	$ 6,200		5,400
Inventory noncurrent	$ 4,100			$ 4,100

XML

Goodwill and Other Intangible Assets, Net - Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 29, 2023	Dec. 31, 2022
Goodwill [Roll Forward]
Gross balance at beginning of period		$ 471,719
Accumulated impairment	$ (91,865)	(91,865)
Net balance at beginning of period	379,854
Additions	1,487
Impairments	0
Foreign currency translation	(1,098)
Net balance at end of period	380,243	379,854
Engineered Products
Goodwill [Roll Forward]
Gross balance at beginning of period		363,785
Accumulated impairment	0	0
Net balance at beginning of period	363,785
Additions	1,487
Impairments	0
Foreign currency translation	(1,098)
Net balance at end of period	364,174	363,785
Precision Products
Goodwill [Roll Forward]
Gross balance at beginning of period		41,375
Accumulated impairment	(25,306)	(25,306)
Net balance at beginning of period	16,069
Additions	0
Impairments	0
Foreign currency translation	0
Net balance at end of period	16,069	16,069
Structures
Goodwill [Roll Forward]
Gross balance at beginning of period		66,559
Accumulated impairment	(66,559)	(66,559)
Net balance at beginning of period	0
Additions	0
Impairments	0
Foreign currency translation	0
Net balance at end of period	0	$ 0
KPP-Orlando
Goodwill [Roll Forward]
Net balance at end of period	$ 16,100

XML

Goodwill and Other Intangible Assets, Net - Other Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 29, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Amount	$ 442,694	$ 443,145
Accumulated Amortization	(90,486)	(70,814)
Customer lists / relationships
Finite-Lived Intangible Assets [Line Items]
Gross Amount	363,269	363,549
Accumulated Amortization	(51,311)	(41,695)
Developed technologies
Finite-Lived Intangible Assets [Line Items]
Gross Amount	44,923	45,028
Accumulated Amortization	(20,582)	(17,508)
Trademarks / trade names
Finite-Lived Intangible Assets [Line Items]
Gross Amount	16,619	16,681
Accumulated Amortization	(3,583)	(3,153)
Non-compete agreements and other
Finite-Lived Intangible Assets [Line Items]
Gross Amount	17,332	17,336
Accumulated Amortization	$ (14,516)	(7,974)
Patents
Finite-Lived Intangible Assets [Line Items]
Amortization Period	17 years
Gross Amount	$ 551	551
Accumulated Amortization	$ (494)	$ (484)
Minimum | Customer lists / relationships
Finite-Lived Intangible Assets [Line Items]
Amortization Period	6 years
Minimum | Developed technologies
Finite-Lived Intangible Assets [Line Items]
Amortization Period	7 years
Minimum | Trademarks / trade names
Finite-Lived Intangible Assets [Line Items]
Amortization Period	15 years
Minimum | Non-compete agreements and other
Finite-Lived Intangible Assets [Line Items]
Amortization Period	1 year
Maximum | Customer lists / relationships
Finite-Lived Intangible Assets [Line Items]
Amortization Period	38 years
Maximum | Developed technologies
Finite-Lived Intangible Assets [Line Items]
Amortization Period	20 years
Maximum | Trademarks / trade names
Finite-Lived Intangible Assets [Line Items]
Amortization Period	40 years
Maximum | Non-compete agreements and other
Finite-Lived Intangible Assets [Line Items]
Amortization Period	15 years

XML

Debt (Details) $ in Thousands	3 Months Ended				9 Months Ended		12 Months Ended
	Mar. 29, 2024	Sep. 29, 2023 USD ($)	Jun. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 29, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2025	Sep. 25, 2025	Sep. 26, 2024	Sep. 28, 2023	Jun. 21, 2023 USD ($)	Dec. 13, 2019 USD ($)
Line of Credit Facility [Line Items]
Consolidated Total Net Leverage Ratio		3,890			3,890
Total Average Bank Borrowings					$ 391,900		$ 120,700
Amortization of debt issuance costs					2,985	$ 1,882
Deferred Debt Issuance Cost, Writeoff			$ 600
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Amortization of debt issuance costs		$ 400		$ 700	1,600	$ 1,200
Credit Agreement 2019 | Revolving Credit Facility [Member]
Debt Disclosure [Abstract]
Line of Credit Facility, Maximum Borrowing Capacity		740,000			740,000		800,000						$ 800,000
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		740,000			740,000		800,000						$ 800,000
Long-term Line of Credit		382,000			382,000		363,000
Line of Credit Facility Remaining Borrowing Capacity Excluding LOCs		358,000			358,000		437,000
Letters of Credit Outstanding, Amount		70,549			70,549		51,630
Line of Credit Facility, Remaining Borrowing Capacity		287,451			287,451		385,370
Line of Credit Facility Remaining Borrowing Capacity subject to EBITDA limitations		$ 129,313			$ 129,313		196,256
Credit Agreement 2023
Debt Disclosure [Abstract]
Debt Instrument, Basis Points		1.00			1.00
Line of Credit Facility [Line Items]
Consolidated Total Indebtedness to Consolidated EBITDA, Ratio											5.00
Debt Instrument, Basis Points		1.00			1.00
Minimum Liquidity Debt Covenant under Credit Agreement					0.50
Line of Credit Facility, Interest Rate at Period End		7.13%			7.13%
Consolidated Total Indebtedness to Consolidated EBITDA, Elected Increase		0.50			0.50
Consolidated Total Indebtedness to Consolidated EBITDA, Ratio, Material Permitted Investment		5.00			5.00
Credit Agreement 2023 | Forecast
Line of Credit Facility [Line Items]
Consolidated Total Indebtedness to Consolidated EBITDA, Ratio, Q4 2024 - Q3 2025									4.50
Consolidated Total Indebtedness to Consolidated EBITDA, Ratio, Q4 2025 & thereafter								4.00
Minimum Liquidity Debt Covenant under Credit Agreement	1
Consolidated Total Indebtedness to Consolidated EBITDA, Ratio, Q4 2023 - Q3 2024										4.75
Credit Agreement 2023 | Maximum
Line of Credit Facility [Line Items]
Debt Instrument, Interest Coverage Ratio		3.00			3.00
Credit Agreement 2023 | Minimum
Line of Credit Facility [Line Items]
Debt Instrument, Interest Coverage Ratio		1.00			1.00
Credit Agreement 2023 | Revolving Credit Facility [Member]
Debt Disclosure [Abstract]
Line of Credit Facility, Maximum Borrowing Capacity												$ 740,000
Line of Credit Facility [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity												740,000
Debt Issuance Costs, Line of Credit Arrangements, Gross												$ 4,800
Credit Agreement 2023 | Revolving Credit Facility [Member] | Maximum
Line of Credit Facility [Line Items]
Line of Credit Facility, Commitment Fee Percentage					0.35%
Credit Agreement 2023 | Revolving Credit Facility [Member] | Minimum
Line of Credit Facility [Line Items]
Line of Credit Facility, Commitment Fee Percentage					0.20%
Credit Agreement 2023 | Letter of Credit | Maximum
Line of Credit Facility [Line Items]
Line of Credit Facility, Commitment Fee Percentage					2.25%
Credit Agreement 2023 | Letter of Credit | Minimum
Line of Credit Facility [Line Items]
Line of Credit Facility, Commitment Fee Percentage					1.375%
Letter of Credit | Revolving Credit Facility [Member] | JPF
Line of Credit Facility [Line Items]
Letters of Credit Outstanding, Amount		$ 65,100			$ 65,100		$ 46,100

XML

Pension Plans - Pension plan net periodic benefit costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Qualified Pension Plan
Defined Benefit Plan Disclosure
Service cost	$ (1,445)	$ (840)	$ (4,336)	$ (2,522)
Interest cost on projected benefit obligation	7,296	4,300	21,888	12,899
Expected return on plan assets	(9,573)	(10,544)	(28,720)	(31,633)
Amortization of net loss	1,923	1,064	5,770	3,193
Net pension cost (income)	1,091	(4,340)	3,274	(13,019)
SERP
Defined Benefit Plan Disclosure
Service cost	0	0	0	0
Interest cost on projected benefit obligation	44	22	132	66
Expected return on plan assets	0	0	0	0
Amortization of net loss	0	16	0	46
Net pension cost (income)	$ 44	$ 38	$ 132	$ 112

XML

Pension Plans - Contributions (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022
Qualified Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans
Contributions paid-to-date		$ 0.0
Expected future contributions	$ 0.0
SERP
Defined Benefit Plans and Other Postretirement Benefit Plans
Contributions paid-to-date	0.4	$ 0.5
Expected future contributions	$ 0.1

XML

Commitments and Contingencies (Details) $ in Millions	9 Months Ended
	Sep. 29, 2023 USD ($)
Loss Contingencies [Line Items]
Notional Value of Contract, Percent	60.00%
Offset Agreement
Loss Contingencies [Line Items]
Notional amount	$ 220.9
Estimate of possible loss	18.8
Contract with Customer, Liability	18.8
New Hartford
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	2.3
Payments for environmental remediation	1.8
New Hartford | Other accruals and payables
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	0.1
New Hartford | Accruals and payables and other long-term liabilties
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	0.5
Bloomfield
Loss Contingencies [Line Items]
Estimate of environmental remediation cost	2.3
Payments for environmental remediation	15.5
Environmental liability	10.3
Estimated remediation liability	$ 20.8
Discount rate (as a percent)	8.00%
Bloomfield | Other accruals and payables
Loss Contingencies [Line Items]
Accrual for Environmental Loss Contingencies, Liabilities, Other Accruals & Payables	$ 0.4

XML

Computation of Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Earnings Per Share Reconciliation [Abstract]
Net earnings (loss)	$ 1,466	$ (280)	$ 5,952	$ 7,369
Basic:
Weighted average number of shares outstanding (in shares)	28,247	28,037	28,189	27,997
Basic earnings per share (in usd per share)	$ 0.05	$ (0.01)	$ 0.21	$ 0.26
Diluted:
Weighted average shares issuable on exercise of dilutive stock options (in shares)	103	0	135	79
Diluted (in shares)	28,350	28,037	28,324	28,076
Diluted earnings per share from continuing operations	$ 0.05	$ (0.01)	$ 0.21	$ 0.26

XML

Computation of Earnings Per Share - Narrative (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
2024 Notes
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Aggregate shares to be issued upon conversion, convertible	3,056,879	3,056,879	3,056,879	3,056,879
Stock Compensation Plan
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from EPS	660,947	756,809	664,923	707,584
Equity Securities
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities		50,792

XML

Share-based Arrangements - Compensation Arrangements by Share-based Payment Award (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Stock compensation expense	$ 1,262	$ 1,334	$ 5,190	$ 6,145
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage			100.00%	100.00%
Selling, General and Administrative Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award
Stock compensation expense	1,300	$ 1,300	$ 5,200	$ 6,100
Restructuring and Severance
Share-based Compensation Arrangement by Share-based Payment Award
Stock compensation expense	$ 0		$ 300	$ 200

XML

Share-based Arrangements - Stock Options Activity (Details) - Stock Options - $ / shares	3 Months Ended	9 Months Ended
	Sep. 29, 2023	Sep. 29, 2023	Sep. 30, 2022	Jun. 30, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at beginning of the period (in shares)	615,742	710,782
Granted (in shares)	48,987	48,987
Exercised (in shares)	0	0
Forfeited or expired (in shares)	(5,505)	(100,545)
Outstanding at end of period (in shares)	659,224	659,224
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options outstanding at beginning of period, Weighted-average exercise price (in usd per share)	$ 52.02	$ 52.02		$ 54.31	$ 54.12
Granted, Weighted-average exercise price (in usd per share)	24.48	24.48
Exercised, Weighted-average exercise price (in usd per share)	0	0
Forfeited or expired, Weighted average exercise price (in usd per share)	63.09	53.45
Options outstanding end of period, Weighted-average exercise price (in usd per share)	$ 52.02	$ 52.02		$ 54.31	$ 54.12
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Expected option term		6 years 10 months 24 days	6 years 6 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate		40.20%	35.50%
Risk-free interest rate		4.00%	2.90%
Expected dividend yield		3.30%	2.00%
Per share fair value of options granted (in usd per share)		$ 8.17	$ 10.22

XML

Share-based Arrangements - Restricted Stock Activity (Details) - Restricted Stock Awards - $ / shares	3 Months Ended	9 Months Ended
	Sep. 29, 2023	Sep. 29, 2023
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Restricted Stock outstanding at beginning of the period (in shares)	227,196	159,521
Granted (in shares)	26,740	167,572
Vested (in shares)	(34,507)	(99,239)
Forfeited or expired (in shares)	(13,960)	(22,385)
Restricted Stock outstanding at end of period (in shares)	205,469	205,469
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Restricted Stock outstanding at beginning of period, Weighted-average grant date fair value (usd per share)	$ 32.58	$ 45.78
Granted, Weighted Average Grant Date Fair Value (usd per share)	24.31	24.53
Vested, Weighted Average Grant Date Fair Value (usd per share)	42.02	45.08
Forfeited or expired, Weighted Average Grant Date Fair Value (usd per share)	32.98	35.58
Restricted Stock outstanding at end of period Weighted-average grant date fair value (usd per share)	$ 29.89	$ 29.89

XML

Share-based Arrangements Performance Shares (Details) - $ / shares	3 Months Ended	9 Months Ended
	Sep. 29, 2023	Sep. 29, 2023	Sep. 30, 2022	Jun. 30, 2023	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		100.00%	100.00%
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage		100.00%	100.00%
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Expected option term		6 years 10 months 24 days	6 years 6 months
Risk-free interest rate		4.00%	2.90%
Expected dividend yield		3.30%	2.00%
Per share fair value of options granted (in usd per share)		$ 8.17	$ 10.22
Restricted Stock Awards
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	205,469	205,469		227,196	159,521
Granted (in shares)	26,740	167,572
Vested (in shares)	(34,507)	(99,239)
Forfeited or expired (in shares)	(13,960)	(22,385)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 29.89	$ 29.89		$ 32.58	$ 45.78
Granted, Weighted Average Grant Date Fair Value (usd per share)	24.31	24.53
Vested, Weighted Average Grant Date Fair Value (usd per share)	42.02	45.08
Forfeited or expired, Weighted Average Grant Date Fair Value (usd per share)	$ 32.98	$ 35.58
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	279,847	279,847		314,552	172,144
Granted (in shares)	0	178,385
Vested (in shares)	0	0
Forfeited or expired (in shares)	(34,705)	(70,682)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 45.25	$ 45.25		$ 45.00	$ 60.44
Granted, Weighted Average Grant Date Fair Value (usd per share)	0	32.03
Vested, Weighted Average Grant Date Fair Value (usd per share)	0	0
Forfeited or expired, Weighted Average Grant Date Fair Value (usd per share)	$ 42.98	$ 48.89
Expected option term		2 years 10 months 24 days	2 years 10 months 24 days
Expected volatility		41.20%	39.40%
Risk-free interest rate		4.40%	1.70%
Expected dividend yield		3.30%	1.90%
Per share fair value of options granted (in usd per share)		$ 38.83	$ 68.10

XML

Shareholders' Equity and Accumulated Other Comprehensive Income - Changes in Shareholders' Equity (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022	Dec. 31, 2022
Schedule of Capitalization, Equity [Line Items]
Common Stock, Dividends, Per Share, Declared	$ 0.20	$ 0.20	$ 0.60	$ 0.60
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance(1)	$ 686,329	$ 777,623	$ 680,756	$ 795,453
Comprehensive (loss) income	(2,864)	(9,334)	9,579	(15,502)
Dividends declared (per share of common stock, $0.20 and $0.20 and $0.60 and $0.60, respectively)	(5,650)	(5,604)	(16,915)	(16,791)
Employee stock plans and related tax benefit	495	430	1,465	1,696
Purchase of treasury shares	(277)	(64)	(780)	(762)
Share-based compensation expense	1,262	1,334	5,190	6,145
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(5,766)	(9,875)	(2,297)	(25,347)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]		0		(5,854)
Ending balance	679,295	764,385	679,295	764,385
Retained earnings	674,271		674,271		$ 685,234
Previously Reported
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance(1)		1,300		900
Comprehensive (loss) income		$ (8,429)		$ (14,154)
Retained earnings					$ 688,457
Accounting Standards Update 2020-06 Cumulative Effect, Period of Adoption
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	$ 0		$ 0

XML

Shareholders' Equity and Accumulated Other Comprehensive Income - Accumulated Other Comprehensive Income (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022	Jun. 30, 2023	Dec. 31, 2022	Jul. 01, 2022	Dec. 31, 2021
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance(1)	$ 686,329	$ 777,623	$ 680,756	$ 795,453
Other Comprehensive Income (Loss), before Reclassifications, Net of Tax	(5,766)	(9,875)	(2,297)	(25,347)
Other comprehensive (loss) income	(4,330)	(9,054)	3,627	(22,871)
Ending balance	679,295	764,385	679,295	764,385
Other Comprehensive Income, Derivative Instruments	1,490	0	1,490	0	$ 1,532	$ 0	$ 0	$ 7
Other Comprehensive Income (Loss), Derivative Instruments, Unrealized Loss / Gain, Tax	138	0	692	0
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	(502)	0	(808)	(7)
Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax	$ 445	$ 259	$ 1,336	$ 756
Common Stock, Dividends, Per Share, Declared	$ 0.20	$ 0.20	$ 0.60	$ 0.60
Unrealized Gain (Loss) on Cash Flow Hedging Instruments	$ 460	$ 0	$ 2,298	$ 0
Other Comprehensive Income, Derivative Instruments, Reclassification to Net Income, Tax	(151)	0	(243)	0
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	(13)	0	449	0
Other Comprehensive Income, Other, Net of Tax	(42)	0	1,490	(7)
Total accumulated other comprehensive loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Ending balance	(154,794)	(134,256)	(154,794)	(134,256)
Foreign currency translation
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance(1)	1,398	(6,707)	(2,071)	8,765
Other comprehensive (loss) income	(5,766)	(9,875)	(2,297)	(25,347)
Ending balance	(4,368)	(16,582)	(4,368)	(16,582)
Pension and other post-retirement benefits
Accumulated Other Comprehensive Income (Loss) [Line Items]
Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent	1,478	821	4,434	2,483
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance(1)	(153,394)	(118,495)	(156,350)	(120,157)
Other comprehensive (loss) income	1,478	821	4,434	2,483
Ending balance	$ (151,916)	$ (117,674)	$ (151,916)	$ (117,674)

XML

Income Taxes - Effective Income Tax Rate (Details)	3 Months Ended		9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022	Sep. 29, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Effective Income Tax Rate	24.00%	28.90%	28.50%	18.10%

XML

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	$ 24,154,000
Cash, Including Discontinued Operations	us-gaap_CashIncludingDiscontinuedOperations	$ 140,800,000